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Abstract 
Brain blood flow increases, evoked by neuronal activity, power neural computation and are the basis 
of BOLD functional imaging. However, it is controversial whether blood flow is controlled solely by arteriole 
smooth muscle, or also by capillary pericytes. The experimental work within this thesis examines capillary 
pericytes, and the role they play in neurovascular coupling in physiological and pathological conditions. 
I show that pericytes can be identified using several protein markers and that, using the same 
technique, pericytes can be distinguished from other perivascular cell types.  
I demonstrate that pericytes respond to the neurotransmitters noradrenaline and glutamate. 
Noradrenaline depolarizes pericytes and constricts capillaries, and this constriction reflects pericyte 
contraction while glutamate, mimicking neuronal activity, hyperpolarizes pericytes and dilates capillaries, and 
this dilation reflects pericyte relaxation. Glutamate-evoked dilation is mediated by prostaglandin E2 or a related 
compound acting at EP4 receptors, but requires nitric oxide release to suppress synthesis of the 
vasoconstrictor 20-HETE.  
In pathology, I show that pericytes die when exposed to ischaemia. This may lead to pericytes 
irreversibly constricting capillaries and to damage of the blood-brain barrier. Pericyte death increases on 
reperfusion after ischaemia, and is reduced by block of glutamate receptors or Ca
2+
 removal, but not by 
scavenging reactive oxygen species.  
These data establish pericytes as active regulators of capillary tone and thus as potential regulators of 
brain blood flow. My data also suggest prevention of pericyte death as a strategy to reduce the long-lasting 
blood flow decrease which contributes to neuronal death after stroke. 
This thesis also contains a discussion of how energy supply to the brain alters with age, and how this 
may affect the BOLD signal. 
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Chapter 1: Introduction 
1.1 Overview 
This thesis is concerned with pericytes, a type of perivascular cell located on capillaries. In this thesis I will 
report on the identification and classification of these cells and investigate the role they play in regulating 
capillary function under physiological and pathophysiological conditions. In this introduction, I will provide the 
general background needed to understand the experiments described in the Results chapters. More specific 
background relevant to each set of experiments is presented in the Introduction to each Results chapter. 
1.2 Energy supply to the brain 
The brain comprises 2% of the body’s weight but uses 20% of the body’s resting energy production 
(Clark and Sokoloff, 1999). This high energetic demand is due to the large amount of ion pumping activity, 
mainly within neurons, mediated by the Na
+
/K
+_
ATPase (Attwell and Laughlin, 2001), which is needed to pump 
out ions whose entry generates synaptic and action potentials. Because of this large energy consumption, the 
blood flow to the brain needs to be highly controlled. Increases in neural activity, and thus increases in energy 
demand, are associated with a compensatory local increase in cerebral blood flow.  
Neurovascular coupling is the mechanism by which neuronal activity produces an increase of local 
blood flow (also termed functional hyperaemia). Roy and Sherrington (1890) postulated that chemical 
products of metabolism affected the vessel wall, altering the vessel calibre, and it is often assumed that 
functional hyperaemia serves to adjust the blood flow to meet energy needs. Accumulation of the metabolic 
products adenosine and lactate do contribute to activity-induced blood flow increases (Gordon et al., 2008; Ko 
et al., 1990), and metabolic CO2 generation may promote blood flow after conversion to H
+
 by carbonic 
anhydrase (Colonnese et al., 2008). However, the idea that a metabolic need signal, such as a fall of oxygen 
or glucose concentration, is the main trigger of increased blood flow in response to neuronal activity has been 
superseded with the discovery that neurotransmitter mediated pathways alter blood flow (Akgören et al., 1994; 
Li & Iadecola, 1994; Zonta et al., 2003; reviewed by Attwell et al., 2010), and that block of these pathways 
greatly reduces functional hyperaemia without affecting energy use by the tissue (Leithner et al., 2010; 
Offenhauser et al., 2005; St Lawrence et al., 2003).  
The supply of oxygen and glucose to neurons occurs mainly across the walls of capillaries in the brain 
parenchyma (but with some oxygen passing across arteriolar walls: Yaseen et al., 2011; Kasischke et al., 
2011). The amount of blood flow providing these nutrients is thought to be determined by the contractile tone 
of smooth muscle cells around arterioles, which controls the diameter of the vessels and hence the resistance 
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to blood flow. Although the basal tone setting the resting blood flow is, in part, set by mediators released from 
endothelial cells lining the blood vessels, changes in blood flow in response to neuronal activity are evoked by 
events in neurons and astrocytes situated in close proximity to the vasculature. In brief, the release of 
neurotransmitters from active neurons generates neuron- and astrocyte-derived messengers (Fig. 1.1) which 
either modulate ion channel activity in the smooth muscle, leading to a change of calcium concentration, or 
change the calcium-sensitivity of the contractile apparatus, both of which lead to altered contraction (reviewed 
by Attwell et al., 2010; Iadecola, 2004; Koehler et al., 2009).  
1.2.1 Neurovascular coupling via neuronal nitric oxide   
 Neuronal activity can dilate blood vessels as a result of synaptically released glutamate binding to 
NMDA (N-methyl-D-aspartate) receptors on neurons, causing a calcium influx, which activates neuronal nitric 
oxide synthase (nNOS) (Garthwaite et al., 1988). Nitric oxide then diffuses to the vasculature where it 
produces vessel dilation, in part via the activation of guanylate cyclase and generation of cGMP (Fig. 1.1; 
Busija et al., 2007), which promotes relaxation (see section 1.4). Nitric oxide is reported to act as a direct 
mediator of neuronally evoked blood flow responses in the cerebellum (Akgören et al., 1996) whereas in the 
cerebral cortex, although it is necessary for NO to be present in order for neural activity induced dilation to 
occur, changes of the level of NO are not the primary mediator of vasodilation (Lindauer et al., 1999). In 
Chapter 4 I will demonstrate a similar phenomenon for capillary pericytes in the cerebellum. In the cortex 
nNOS is often found in GABAergic inhibitory interneurons near blood vessels (for reviews see Estrada and 
DeFelipe, 1998; Hamel, 2006), which can also express other vasoconstrictive mediators such as neuropeptide 
Y and somatostatin (Cauli et al., 2004). Other interneurons, which lack nNOS (Estrada and DeFelipe, 1998), 
may release vasoactive intestinal peptide which mediates dilation. In human cortex, in addition to being 
present in interneurons, nNOS is also expressed by a subpopulation of excitatory pyramidal cells (Judas et al., 
1999; Wallace et al., 1995), and it has also been reported in excitatory pyramidal cells of the rat hippocampus 
(Burette et al., 2002).  
1.2.2 Neurovascular coupling via astrocytes 
Astrocytes are large glial cells, which extend many processes that envelope surrounding synapses. In 
humans, an individual astrocyte may be able to sense the activity at ~2 million synapses (Oberheim et al., 
2006). Astrocytes also form perivascular endfeet on blood vessels (Simard et al., 2003), and so have an 
anatomy suitable for signalling from neurons to arterioles to control blood flow.  
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Astrocytes show a rise of intracellular calcium concentration in response to synaptic activity, partly as 
a result of metabotropic glutamate receptors being activated by synaptic glutamate release (Porter and 
McCarthy, 1996). There is some evidence, however, that the metabotropic receptor thought to be responsible 
for the activity-induced calcium concentration increase (mGluR5), is only expressed by astrocytes during 
development (Sun et al., 2013). Other mGluRs (mGluR2/3) may raise [Ca
2+
]i through activation of L-type 
voltage-gated calcium channels (Haak et al., 1997), or via their G-protein subunit coupling to PLC (Zeng et al., 
2003), and ATP released during neuronal activity also contributes to astrocyte [Ca
2+
]i rises (Newman, 2001). 
Calcium concentration rises in astrocytes can lead to arteriole dilation (Gordon et al., 2008; Takano et al., 
2006; Zonta et al., 2003). This occurs mainly as a result of calcium activating the enzyme phospholipase A2 
(Fig. 1.1) to generate arachidonic acid and its vasoactive metabolites, which include prostaglandins, 
epoxyeicosatrienoic acids (EETs) and 20-hydroxyeicosatetraenoic acid (20-HETE).  
Prostaglandins are produced from arachidonic acid by cyclooxygenase (COX) enzymes, both forms of 
which (COX1 in astrocytes and COX2 in astrocytes and neurons) are involved in blood flow control (Niwa et 
al., 2000; Takano et al., 2006). COX initially produces prostaglandin H2 which is then converted to the 
vasodilator prostaglandin E2 by PGE synthase. PGE2 relaxes smooth muscle by acting through EP4 receptors 
to activate cyclic AMP production (Davis et al., 2004), promoting relaxation (see section 1.4). Prostaglandins 
also hyperpolarize arteriolar smooth muscle cells by activating calcium-dependent potassium channels 
(Serebryakov et al., 1994), reducing voltage-gated Ca
2+
 entry and thus decreasing contraction. The actions of 
prostaglandins are terminated by re-uptake into cells expressing the prostaglandin transporter. Experiments in 
Chapter 4 test the role of prostaglandins in causing dilation of capillaries by pericytes.  
EETs are produced in astrocytes from arachidonic acid by epoxygenases, a class of cytochrome 
P450 enzyme (Alkayed et al., 1996; Amruthesh et al., 1993). EETs can hyperpolarize and thus relax smooth 
muscle by activating a Ca
2+
 influx through TRPV4 channels, which in turn activates large conductance (BKCa) 
Ca
2+
-activated K
+
 channels (Campbell et al., 1996; Earley et al., 2005). EETs may also cause relaxation by 
inhibiting vasoconstricting thromboxane A2 receptors (Behm et al., 2009). EETs are inactivated by soluble 
epoxide hydrolase which converts epoxides to their corresponding dihydroxyeicosatrienoic acids (Fang et al., 
2001; Iliff et al., 2010; Spector et al., 2004), although EETs can also be inactivated by COX activity or by slow 
insertion into phospholipid stores (Bernstrom et al., 1992; Ellis et al., 1990). In Chapter 4, I test the role of EET 
release in generating dilation of capillaries by pericytes.   
Arachidonic acid formed in astrocytes can also diffuse to arteriolar smooth muscle and be converted 
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into 20-HETE by the ω-hydroxylase enzyme, CYP4A (Gebremedhin et al., 1998; Metea and Newman, 2006; 
Mulligan and MacVicar, 2004). 20-HETE constricts smooth muscle by activating protein kinase C, inhibiting 
potassium channels, depolarizing the cells and thus increasing voltage-gated Ca
2+
 influx (Lange et al., 1997). 
NO released by neural activity inhibits CYP4A and thus reduces 20-HETE mediated constriction (Roman, 
2002), an effect which will be crucial for the interpretation of my data in Chapter 4. 
Activity-evoked [Ca
2+
]i rises can also increase blood flow by opening calcium-activated potassium 
channels in astrocytes. This leads to an increase in extracellular potassium concentration that enhances the 
conductance of inward-rectifying K
+
 channels in smooth muscle, causing hyperpolarization and vessel dilation 
(Filosa et al., 2006).  
1.3 Vasoconstriction by noradrenaline, dopamine and 5-HT 
For the activity-evoked dilation of arteriolar smooth muscle described above to occur, there has to be 
a tonic constriction of the arterioles, which is partly produced by aminergic input to the vessels. We will see in 
Chapter 4 that similar events occur in capillary pericytes. Within the brain parenchyma, blood vessels are 
close to noradrenergic terminals of neurons from the locus coeruleus, which appear to release their 
transmitter close to astrocyte endfeet (Cohen et al., 1997; Paspalas and Papadopoulos, 1996). Noradrenaline 
constricts brain blood vessels (Raichle et al., 1975). In part this may be because it increases astrocytic [Ca
2+
]i 
by acting on α1 receptors (Bekar et al., 2008; Duffy and MacVicar, 1995) leading to vessel constriction, 
presumably via the 20-HETE pathway described above (Mulligan & MacVicar, 2004). Noradrenergic 
innervation can also directly affect vascular smooth muscle. Smooth muscle cells express both Gq coupled α1 
and Gi coupled α2 receptors (Drew and Whiting, 1979) and activation of these receptors increases [Ca
2+
]i 
leading to vessel constriction (Vanhoutte and Rimele, 1982). α1 adrenergic receptors are thought to be 
responsible for neuron-mediated vasoconstriction as these receptors are located close to locus coeuruleus 
nerve terminals, whereas α2 receptors are located away from the nerve terminals (McGrath, 1983; McGrath and 
Wilson, 1988). Smooth muscle cells also express Gs coupled β adrenergic receptors (Lowe and Gilboe, 1971). 
Activation of which leads to dilation through increased cAMP production, although noradrenaline has a higher 
affinity for α adrenoceptors (Molinoff, 1984). Dopaminergic fibres from the ventral tegmental area and 5-HT-
releasing axons from the raphe nucleus may also contribute to vasoconstriction (Cohen et al., 1996; Krimer et 
al., 1998). The arteriole tone set by aminergic input may affect how much blood flow increase is produced by 
the mainly glutamate-mediated signalling pathways which dilate vessels in response to neuronal activity. For 
example dilations evoked by raised extracellular [K
+
] or by raising astrocyte [Ca
2+
]i pharmacologically are 
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larger when the vessels are more preconstricted by a thromboxane agonist (Blanco et al., 2008).  
1.4 Regulation of smooth muscle tone 
As mentioned in section 1.2, blood flow is regulated by the diameter of blood vessels, which is 
determined by the tone of the smooth muscle cells that line these vessels. Vasoactive agents released from 
astrocytes and neurons control the tone of the smooth muscle cells by altering the membrane potential, and 
thus the intracellular calcium concentration, as well as by altering the sensitivity to Ca
2+
 of the contractile 
proteins involved in contraction via changes in cyclic nucleotide levels and phosphorylation. Smooth muscle 
contraction, like all muscle contraction, is controlled by cross bridge cycling of actin and myosin. Unlike in 
striated (skeletal and cardiac) muscle, the actin and myosin in smooth muscle is not organized into well-
defined sarcomere structures. The intracellular calcium concentration increase triggering contraction is 
produced by calcium entry as well as release from intracellular stores, and the actin binding proteins 
regulating contraction are different from those in skeletal and cardiac muscle. 
Smooth muscle contraction is regulated by cross-bridge cycling of myosin light chain (MLC) and α 
smooth muscle actin (αSMA; Webb, 2003). The interaction between these proteins is controlled by changes of 
intracellular calcium concentration (Hathaway et al., 1991), which alters the activity of myosin light chain 
kinase (MLCK), as shown in Figure 1.2. 
Vasoconstrictive substances bind to receptors on the cell surface and lead to entry of extracellular 
calcium (in the case of ligand-gated ion channels) or the release of calcium from intracellular stores (in the 
case of G protein-coupled receptors). Calcium entry from the extracellular space is required for smooth 
muscle contraction as the sarcoplasmic reticulum is not as complex as in skeletal muscle and does not 
contain enough calcium to produce sustained contraction on its own. Calcium combines with calmodulin and, 
once four calcium ions have bound, the complex activates MLCK, which phosphorylates MLC. MLC 
phosphorylation increases the affinity of myosin for αSMA, so the filaments interact and contraction occurs 
(Sanders, 2008). Smooth muscle contraction is tonic and the muscle will remain contracted as long as calcium 
is bound to calmodulin and MLC remains phosphorylated. When the intracellular calcium concentration drops 
below the affinity of calmodulin for Ca
2+
, the calcium-calmodulin complex disassembles and the phosphate is 
removed from the MLC via MLCP. This decreases the affinity of myosin for αSMA, which inhibits interaction 
and results in relaxation.   
Smooth muscle tone is also regulated by the cyclic nucleotides, cAMP and cGMP and their 
downstream protein kinases, PKA and PKG. Vasodilatory substances increase the concentration of cyclic 
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nucleotides, which leads to a reduction in the [Ca
2+
]i by decreasing IP3-mediated calcium release from the 
sarcoplasmic reticulum, by phosphorylating the IP3R or by decreasing PLC activity (via cGMP-dependent 
protein kinases) and therefore reducing IP3 production (Fritsch et al., 2004; Rapoport, 1986). Cyclic GMP also 
reduces the [Ca
2+
]i by enhancing Ca
2+
 uptake into the sarcoplasmic reticulum (Cornwell et al., 1991). Cyclic 
nucleotides also reduce calcium influx into smooth muscle cells, by inhibiting VGCCs (voltage gated calcium 
channels), and increase calcium efflux, by activating the plasma membrane Ca
2+
-ATPase (Xiong and 
Sperelakis, 1995; Rashatwar et al., 1987). Another method through which cyclic nucleotides promote 
relaxation is through activation of potassium channels, leading to potassium efflux (Aiello et al., 1995; 
Natarajan et al., 2010; Standen and Quayle, 1998). As well as promoting membrane hyperpolarization and 
thus reducing the [Ca
2+
]i, cyclic nucleotides can alter the relationship between calcium concentration and MLC 
phosphorylation and thus the Ca
2+
 sensitivity of the contractile myofilaments. Cyclic AMP-dependent protein 
kinase can inhibit MLC kinase by phosphorylating the calmodulin-binding domain thus decreasing the affinity 
for binding (Conti and Adelstein, 1981), while PKG increases MLC phosphatase activity by phosphorylating its 
regulatory subunit (Nakamura et al., 2007). Finally, cyclic nucleotide-dependent protein kinases are thought to 
phosphorylate the heat shock-related protein, HSP20, which leads to dissociation of contractile force from 
MLC phosphorylation. This may occur through dissociation of the contractile apparatus from specific focal 
contacts, such as dense bodies and dense plaques, which provide a framework for the attachment of 
contractile structures to the cytoskeleton (Woodrum et al., 1999). 
1.5 An overview of pericytes 
Capillaries are not surrounded by a continuous layer of smooth muscle but instead have spatially 
separated contractile cells called pericytes at intervals along their length (see Figure 1.3). Here I will introduce 
pericytes, the main focus of this thesis. 
1.5.1 Pericyte morphology 
 Pericytes are vascular mural cells. These cells can be identified by their rounded cell body and their 
position on capillaries, and have been described as having a “bump on a log” morphology (see Figure 1.3). 
Less visible are the processes that extend along vessels, and may even extend to contact multiple vessels 
(Williamson et al., 1980). On a single vessel, primary processes run parallel to the long axis of the vessel. 
These processes then branch into secondary processes that wrap circumferentially around the capillary 
(Figure 1.3; Forbes et al., 1977). Pericytes are present on pre-capillary arterioles, capillaries and post-capillary 
 23 
venuoles. The morphology of pericytes on these different vessel types varies. Pericytes on larger vessels 
appear similar to smooth muscle cells. Vascular smooth muscle cells are orientated in a circular manner 
around arteries and show very little variation in morphology (Figure 1.3; Walmsley and Canham, 1979; Peters 
et al., 1983) but their morphology becomes more varied at the level of arterioles (Ushiwata and Ushiki, 1990). 
Here smooth muscle cells have rounded cell bodies and numerous processes (Ushiwata and Ushiki, 1990) 
and thus distinguishing between smooth muscle cells and pericytes at this level can be difficult. At true 
capillaries, pericytes are thought to have less complex processes (Zimmermann, 1923).  
In this thesis I report experiments studying capillary pericytes. I identify these cells using the 
morphology described above. I ensure that I am studying capillaries by identifying vessels that are under 10 
μm in diameter and lack a continuous smooth muscle lining. Capillaries consist of a layer of thin, elongated 
endothelial cells making up the tunica intima. These cells are in very close contact with the mural cells, 
pericytes, which form the tunica media. Both endothelial cells and pericytes are completely covered by 
basement membrane (Sims, 1986). The perivascular space beyond the basement membrane (referred to as 
the Virchow-Robin space at the arteriole level) has been found to contain meningeal cells and immune cells 
(Bechmann et al., 2007). This perivascular space is less evident at the level of capillaries. Beyond the 
perivascular space is the juxtavascular space where astrocyte endfeet lie (astrocyte foot processes lie 20 nm 
from the capillary endothelium) and further immune cells, such as microglia, are observed. Distinguishing 
between pericytes and other perivascular cells becomes difficult at the capillary level because of the absence 
of the Virchow-Robin space and the term pericyte is frequently used in the literature to demote any 
microvascular periendothelial mesenchymal cell (Armulik et al., 2011). In Chapter 3 I will report experiments 
that define better the cell types in this perivascular location on capillaries. 
Pericytes cover 22%-37% of the cerebral capillary surface (Frank et al., 1987; Mathiisen et al., 2010). 
The average distance between pericyte cell bodies in the CNS is 50 μm (de Oliveira, 1966) and each cell’s 
processes usually span several endothelial cells along the capillary (Armulik et al., 2011). The ratio of the 
number of endothelial cells to the number of pericytes is between 1:1 and 3:1 in the CNS (Mathiisen et al., 
2010; Sims, 1986; Pardridge et al., 1999). 
Electron microscopy has revealed details about the relationship of the contacts between pericytes and 
endothelial cells. These cells are connected through several kinds of specialized contacts. ‘Peg and socket’ 
contacts are interdigitating attachments where pericyte cytoplasmic fingers insert into endothelial 
invaginations, while adhesion plaques are points at which microfilament bundles in pericytes are located close 
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to electron-dense material in endothelial cells (Courtoy and Boyles, 1983). Pericytes and endothelial cells also 
make tight junctions with each other (Tilton et al., 1979; Larson et al., 1987; Díaz-Florez et al., 2009).  
 1.5.2 Pericyte surface markers 
There is no single, entirely specific pericyte marker. This may be because pericytes are a 
heterogeneous population (Sims, 1991; Allt and Lawrenson, 2001; Dore-Duffy, 2006). Table There are 
however many markers which can be specific to pericytes depending on tissue type, species, vessel size, 
differentiation, and which are up and down regulated in conjunction with developmental stage. Table 1 shows 
a list of known pericyte markers. Here I will discuss some of the problems encountered when using these 
markers.  
The pericyte marker I mainly used in this thesis is NG2 (neural glial protein 2, or high-molecular-
weight melanoma-associated antigen, HMW MAA; Ozerdem et al., 2001). NG2 is a chondroitin sulfate 
proteoglycan involved in vasculogenesis and angiogenesis (Stallcup, 2002; Fukushi et al., 2004). It is known 
that NG2 is not only expressed by pericytes, but is also expressed by multiple cell types, including 
oligodendrocyte precursor cells (Nishiyama et al., 1991; 1996; see Table 1) which can be distinguished by 
their non-vascular location, and expression of olig2 and PDGFRα. There are also some claims that endothelial 
cells express NG2 (Schrappe et al., 1991; Grako and Stallcup, 1995; Corselli et al., 2010; but see below). 
Another commonly used pericyte marker, PDGFRβ (Lindahl et al., 1997), a tyrosine-kinase receptor involved 
in angiogenesis and blood brain barrier formation and maintenance, is also expressed by multiple cell types 
including fibroblasts, astrocytes, certain tumour cells and neurons (Lindahl et al., 1997; Smits et al., 1991; 
Beazely et al., 2006). Using a marker that also labels other cell types may lead to confusion when identifying 
pericytes. 
Early studies found that pericytes express α-smooth muscle actin (αSMA; Herman and D’Amore, 
1985; Skalli et al., 1989), a contractile protein involved in smooth muscle contraction, and this is still often 
used as a pericyte marker (Yemisci et al., 2009; Fernández-Klett, 2010). There has been some controversy, 
however, about whether this protein is expressed by all pericytes or, rather, just by pericytes on larger 
vessels, which appear more morphologically similar to smooth muscle cells (Nehls and Drenckhahn, 1991). 
Pericyte expression of αSMA has also been shown to vary greatly between in vitro and in vivo experiments, 
since 60-80% of pericytes are labelled by αSMA antibody in vitro, whereas in vivo αSMA antibody only labels 
1-10% of pericytes (Nehls and Drenckhahn, 1991). There is also controversy over pericyte expression of 
another contractile protein, desmin (Fujimoto and Singer, 1987; Nehls et al, 1992), which is an intermediate 
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filament expressed near the Z line in sarcomeres in striated muscle and associated with dense bodies in 
smooth muscle cells (Kargacin et al., 1989). It has been suggested that desmin is not expressed by CNS 
pericytes (Díaz-Flores et al., 1991). It is important to investigate contractile protein expressed by pericytes as 
expression of these proteins supports their role in control of capillary diameter, and thus of blood flow (see 
section 1.6.5 and Chapter 3).  
NG2 positive perivascular cells have been suggested to express the immune cell markers ED2 
(Graeber et al., 1989; Balabanov et al., 1996) and Iba1 (Yokoyama et al., 2006; Matsumoto et al., 2008). A 
study examining ex vivo human CNS cell preparations claimed that the majority of NG2 positive cells belong 
to the microglial lineage (i.e. they expressed CD68 and CD11c; Pouly et al. 1999). The expression of these 
markers by pericytes suggests that they may have a role as an immune cell. This is further discussed in 
section 1.6.4, but my data in Chapter 3 contradict this idea. 
1.6 The many roles of pericytes 
 As described above, pericytes show structural heterogeneity, it is also thought that these cells show 
functional heterogeneity. Here, I discuss the multiple roles that pericytes have been suggested to play in the 
CNS. 
1.6.1 Angiogenesis 
 Pericytes are thought to play a key role in angiogenesis. Pericytes are early recruits to newly 
vascularized tissue during embryogenesis (endothelial cells begin angiogenesis at E12 and pericytes appear 
at E19). They appear at the tip of sprouting vessels and appear to guide newly formed vessels (Nehls et al., 
1992). The balance between the number of endothelial cells and pericytes appears to be highly controlled 
(Frank et al., 1987). Paracrine interactions between pericytes and endothelial cells are involved in initiation of 
vessel growth as well as vessel stabilization. These cells release soluble factors that act in a paracrine 
manner, including platelet derived growth factor B (PDGF-B), transforming growth factor β (TGFβ), vascular 
endothelial growth factor (VEGF) and angiopoietins (Angs).  
Endothelial cells release PDGFB, which is thought to recruit pericytes to growing vessels (Hellström et 
al., 1999; Hirschi et al., 1999; Betsholtz, 2004). Mice deficient in the PDGFβ receptor, which is expressed in 
pericytes, show attenuation of pericyte recruitment to sprouting capillaries, and these vessels are found to be 
unstable (Lindblom et al., 2003). Pericytes also release several factors that contribute to vessel development 
and stabilization. TGFβ is activated by pericyte-endothelial cell interaction and inhibits endothelial cell 
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proliferation and migration (Orlidge and D’Amore, 1987; Sato and Rifkin, 1989). TGFβ also promotes 
differentiation of pericytes (via the Wnt/beta-catenin pathway: Darland and D’Amore, 2001; Stenman et al, 
2008) and reduces VEGF receptor expression (Bergers and Song, 2005). Vascular endothelial growth factor 
(VEGF) is also released by pericytes (Yamagishi et al., 1999; Darland et al, 2003) and has been found to 
promote transformation of endothelial cells on sprouting vessels into pericytes. The notch receptor, which is 
highly expressed in pericytes (Wang et al., 2008) downregulates endothelial VEGF receptor expression to 
stop vessel growth (Siekmann and Lawson, 2007). Angiopoietins (Ang1) released from pericytes acts on 
tyrosine kinase receptor (Tie-2) on endothelial cells and promote vascular stabilization (Uemura et al., 2002; 
Thurston, 2003). Deficiencies in either Ang1 or Tie2 lead to poor vessel growth (Jones et al., 2001) and 
reduced pericyte expression (Patan, 1998). Another angiopoietin, Ang2, has the converse effect and appears 
to be pro-angiogenic. Overexpression of Ang2 leads to dense vascular networks with poor pericyte coverage 
(Feng et al., 2007). Other factors involved in angiogenesis include NG2, which is expressed on pericytes and 
promotes endothelial cell motility and angiogenesis (Fukushi et al., 2004). NG2 has been shown to be a co-
receptor for PDGF (Grako et al., 1999; Grako and Stallcup, 1995). Receptors for ephrins are expressed on 
endothelial cells and activation of these receptors has been proposed to promote pericyte migration and 
vessel formation (Foo et al., 2006; Salvucci et al., 2009). 
1.6.2 Blood brain barrier maintenance 
 The blood brain barrier (BBB) is a key feature of the CNS. It serves to restrict exchange of substances 
between the circulation and the parenchymal tissue (Betz and Goldstein, 1986), thus protecting the brain from 
injury and disease. A functioning BBB is characterized by tight junctions (restricting paracellular transport), low 
rates of trancytosis, and the expression of specific transporters and enzymes (Ballabh et al., 2004). The BBB 
is made up of endothelial cells, pericytes and basal lamina, and more recently a role of astrocytes in BBB 
control has been reported (Mathiisen et al., 2010). 
The role of pericytes in blood brain barrier maintenance was first considered due to the increased 
ratio of pericytes to endothelial cells observed in the CNS compared to other organs (Frank et al., 1987; 
Shepro and Morel, 1993; Díaz-Flores et al., 2009; Zlokovic, 2008). It is also of note that there are tight 
junctions between endothelial cells and pericytes (Tilton et al., 1979) and that pericytes induce synthesis of 
the molecules that make up the tight junction via Ang1 (Hori et al., 2004). Pericytes also produce extracellular 
matrix that contributes to the BBB (Hartmann et al., 2007). 
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Using transgenic mice with PDGFRβ expressed at half the normal level to downregulate pericyte 
generation, it has been shown that pericytes are necessary for the formation of the BBB (Daneman et al., 
2010) and that the pericyte coverage of a capillary determines its vascular permeability (Armulik et al., 2010; 
Daneman et al., 2010). Pericyte-deficient mice do not show a reduction in endothelial expression of BBB-
specific genes, but instead they fail to down regulate genes which increase vascular permeability (Daneman 
et al., 2010). Pericytes are not only involved in BBB development, but also play a crucial role in maintenance 
of the BBB in adulthood and ageing (Armulik et al., 2010; Bell et al., 2010). As the number of pericytes 
decreases in ageing vascular permeability increases (Bell et al., 2010).  
Formation of the BBB has also been suggested to rely on astrocytes (Janzer and Raff, 1987; Sobue 
et al., 1999) but there is some controversy regarding the timing of astrocyte development and BBB formation 
(Bauer et al., 1993; Kniesel et al., 1996; Daneman et el., 2010), suggesting that pericytes play a more 
important role at this stage. It is likely, however, that astrocytes are involved in maintenance of the BBB. 
1.6.3 Glial scar formation 
 A subtype of pericyte (approximately 10% of the total population) has been seen to give rise to a scar-
forming stromal cell in injured spinal cord (Göritz et al., 2011). These cells migrate from their perivascular 
location, are recruited to the site of injury, and become positive for fibroblast markers. They function to ‘seal’ 
the injured tissue by producing extensive networks of extracellular matrix proteins, which will eventually form 
connective tissue and make up the stromal component of scar tissue. This structure is formed in order to 
prevent further damage. Previously it had been thought that astrocytes were the only cells that played this 
role, and thus it was referred to as the glial-scar (Sofroniew, 2009). Astrocytes do comprise part of the glial 
scar, and this astrocytic component surrounds the stromal cells. Pericytes have also been found to form 
dermal scars, and kidney and liver fibrosis (Humphreys et al., 2010; Sundberg et al., 1996; Wirz et al., 2008). 
1.6.4 Pluripotent cell 
 Pericytes are considered to be multipotent precursors for several different cell types (Dore-Duffy et al., 
2006, 2008). Several researchers have identified pericytes as potential progenitors of mesenchymal stem 
cells (Zimmerlin et al., 2011; Crisan et al., 2008; Corselli et al., 2010). Much like pericytes, mesenchymal stem 
cells are a cell type that is not clearly defined in the literature. There is no specific marker for mesenchymal 
stem cells and their characteristics differ throughout the literature (Javazon et al., 2004). Mesenchymal stem 
cells are said to be ‘captured’ by developing vessels and become pericytes, but to retain nascent stem cell 
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properties (Bautch, 2011). Pericytes show mesenchymal stem cell marker expression (Corselli et al., 2010; 
Crisan et al., 2008)  
Evidence has also been found for pericytes transforming into many other cell types including smooth 
muscle cells (Meyrick and Reid, 1978; Sims, 1986; Rhodin and Fujita, 1989), adipocytes (Cinti et al., 1984), 
chondrocytes (Reilly et al., 1998) and neurons (Dore-Duffy et al., 2006). It has also been speculated that 
pericytes are resting microglial cells (Baron and Gallego, 1972; Hager et al., 1975) or a precursor cell for 
macrophages (Maxwell and Kruger, 1965; More and Leblond, 1969). Following irradiation, pericytes are 
suggested to become mobile and penetrate the parenchyma to become microglia (Maxwell and Kruger, 1965), 
and a phagocytic potential of pericytes has been demonstrated multiple times (Cancilla et al., 1972; 
Balabanov et al., 1996; Thomas, 1999). In Chapter 3 of this thesis I will combine transgenic labelling of 
pericytes with antibody labelling of immune cell markers to assess whether pericytes and perivascular immune 
cells share cell markers. 
1.6.5 Contractility 
Pericytes have long been suspected to be contractile cells (Rouget, 1874; Vimtrup, 1922; 
Zimmermann, 1923). This was originally put forward due to the position and structure of these cells. As 
described in section 1.4.1, pericytes have processes that encircled capillaries and contain bands of 
microfilaments and dense bodies similar to smooth muscle cells (Vimtrup, 1922; Zimmermann, 1923). With 
the advent of immunocytochemistry, pericytes were found to express many of the contractile proteins 
expressed in smooth muscle cells. Pericytes express cyclic GMP-dependent protein kinase, and several 
classes of myosin (Joyce et al., 1984; Joyce et al., 1985a; Joyce et al., 1985b). These are essential 
components needed for smooth muscle contraction. It has also been observed that pericytes express 
microfilaments resembling actin and myosin (Le Beux and Wilemot, 1978; Ho, 1985) and that actin 
microfilaments of pericytes can activate myosin ATPase (Chan et al., 1986). Expression of αSMA and desmin 
have been observed (Herman and D’Amore, 1985; Fujimoto & Singer, 1987; Skalli et al., 1989), although 
there is controversy about the proportion, and type, of pericytes that express these proteins (Joyce et al., 
1985; Nehls and Drenkhahn, 1991; Bandopadhyay et al., 2001, see section 1.5.2). However, the contractile 
nature of pericytes has also come into question as these cells do not express functional markers of smooth 
muscle cells such as calponin and caldesmon (Hughes and Chan-Ling, 2004). While actin and myosin are 
expressed in non-contractile cells, as they play a role in structural support, the calcium-binding proteins 
calponin and caldesmon regulate tone and are only found in contractile cells (Frid et al., 1992).  
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Functional evidence for pericyte contractility has been found in culture. Retinal pericytes, cultured on 
a collagen lattice, respond to application of multiple vasoconstricting substances by reducing the surface area 
of the lattice. This change was attributed to contraction of the pericyte (Schor and Schor, 1986; Kelley et al., 
1987, 1988). Constrictions were seen in response to histamine, serotonin, ATP, ET-1, thromboxane and 
angiotensin II (Kelley et al., 1988; Das et al., 1988; Dodge et al., 1991; Matsugi et al., 1997a), whereas 
dilations were observed on application of prostacyclin and adenosine (Dodge et al., 1991; Matsugi et al., 
1997b). Contractility in retinal pericytes in situ has also been observed in response to several substances 
(Schonfelder et al., 1998; Peppiatt et al., 2006).  
Like smooth muscle, pericytes express receptors for vasoactive substances such as noradrenaline 
(Elfont et al., 1989) and the majority (65%) of the noradrenergic innervation of CNS vasculature ends near 
capillaries rather than arterioles (Cohen et al., 1997). Noradrenaline has been found to produce membrane 
depolarization of pericytes (Helbig et al., 1992 – attributed to α1 receptors) via a rise of cAMP concentration 
(Kelley et el., 1988; Markhotina et al., 2007). Other neuronal terminals are located close to capillaries and 
pericytes, including those containing dopamine (Favard et al., 1990; Krimer et al., 1998), GABA (Gragera et 
al., 1993), VIP (vasoactive intestinal peptide; Benagiano et al., 1996), acetylcholine (Arneric et al., 1988) and 
NO (Roufail et al., 1995), which might therefore all be candidates for regulating pericyte tone and capillary 
diameter. 
In retinal pericytes, much like in smooth muscle cells, constrictions appear to be evoked by rises of 
intracellular calcium concentration (Sakagami et al., 1999, 2001; Kamouchi et al., 2004; Sugiyama et al., 
2005; Peppiatt et al., 2006). Calcium responses in ureter pericytes, however, appear to be slower and less 
oscillatory than those seen in smooth muscle cells (Borysova et al., 2013). Pericyte dilations could be 
produced by potassium channel activation leading to hyperpolarization, which decreases Ca
2+
 influx, or by NO 
directly inhibiting voltage-gated Ca
2+
 channels (Li & Puro, 2001; Sakagami et al., 2001). Secondary 
messengers that are thought to be involved in regulating pericyte tone include cGMP, which decreases 
calcium and chloride currents in retinal pericytes and reduces contractile tone (Haefliger et al., 1994; 
Sakagami et al., 2001), and cAMP, which is involved in potassium channel activation in response to PGI2 
(Burnette and White, 2006). Though a great deal of this work has been carried out in retinal pericytes, 
evidence has also been found for pericyte control of capillary diameter in cerebellar slices, where 
noradrenaline causes a constriction of capillaries and glutamate produces a dilation (Peppiatt et al., 2006).  
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Evidence supporting pericyte mediated changes in capillary diameter in vitro suggest that they may 
play a role in blood flow control in vivo. Capillaries are located closer to neurons than to arterioles (8-23 μm 
away compared to 70-160 μm in hippocampus; Lovick et al., 1999), and nerve terminals releasing multiple 
transmitters are located close to capillaries (see above). It therefore appears that these cells are well placed to 
respond rapidly to signals indicating changes in energy demand due to neuronal activity. It is possible that 
these cells receive a signal to which they not only respond but which they also propagate back to larger 
vessels as pericytes and smooth muscle cells may be electrically coupled (Berg et al., 1997; Borysova et al., 
2013). If this were the case, capillaries may be actively involved in the initiation of blood flow changes. 
However some studies have found current and calcium concentration changes in local capillary endothelial 
cells in response to skeletal muscle stimulation, leading to a dilation of upstream arterioles without any dilation 
at the local capillary (Sarelius et al., 2000; Murrant et al., 2004). 
Some evidence for capillary level blood flow control has been found in vivo. In the olfactory bulb, 
tentative evidence for active capillary responses was reported by two-photon imaging (Chaigneau et al., 
2003), and dilations and constrictions of cerebral capillaries have been seen in rat somatosensory cortex on 
forepaw stimulation (Stefanovic et al., 2008) and in rat cortex on hypercapnia (Hutchinson et al., 2006). 
Attenuation of in vivo blood flow responses to whisker stimulation was observed in pericyte-deficient mice that 
have fewer pericytes (Bell et al., 2010). However, Fernández-Klett et al. (2010) have claimed that pericytes do 
not mediate active changes in blood flow, although their illustrations of vessels that did respond, which were 
identified as arterioles, may in fact show capillaries with pericytes on them, implying that pericytes are 
mediating the observed responses. 
1.7 Pathology of ischaemia 
In Chapter 6 of this thesis, I examine the response of pericytes to a common CNS pathology, 
ischaemia. Brain ischaemia is a critical reduction in cerebral blood flow that leads to irreversible brain damage 
in conditions such as stroke. Stroke is one of the leading causes of death and disability in developed 
countries. In this thesis I use incubation in solution lacking oxygen and glucose (in brain slices) and middle 
cerebral artery occlusion (MCAO) as animal models of stroke. The reduced supply of oxygen and glucose 
occurring in ischaemia, during stroke or MCAO, results in various extracellular and intracellular changes that 
finally lead to impaired neuronal function and cell death. In this overview I will highlight the main changes in 
cellular physiology evoked by ischaemia. 
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1.7.1 Energy failure 
One of the most profound features of ischaemia is the energy failure due to inhibition of oxidative 
phosphorylation. The lack of oxygen supply initially results in glycolysis becoming the major source of ATP 
production but as this process is much less efficient than oxidative phosphorylation (producing 2 as opposed 
to 28 ATP molecules per molecule of glucose), and because local stores of glycolytic intermediates and of 
astrocyte glycogen are no longer being replenished by glucose arriving in the blood, the cell is soon deprived 
of sufficient ATP (Lipton, 1999). That leads to an inhibition of cellular kinases and ATP-dependent pumps, 
notably the Na
+
/K
+
-ATPase, on which 75% of the brain energy is used (Attwell and Laughlin, 2001). This 
causes a severe run down of transmembrane ionic gradients, which results in membrane depolarization. 
1.7.2 Ionic imbalance 
Impaired energy supply is the direct cause of the ion homeostasis disruption in ischaemia. As 
mentioned above, the Na
+
/K
+
-ATPase fails during ischaemia due to ATP depletion. Under normal conditions 
the Na
+
/K
+ 
pump results in potassium influx, returning K
+
 that exits the cell under resting conditions, because 
cell resting potentials are more positive than the Nernst potential for K
+
. In ischaemia, this pump does not 
function, so the extracellular potassium concentration ([K
+
]o) rises. Increased extracellular [K
+
] causes 
depolarization of neurons and glia, and initially some action potential firing and an excessive synaptic vesicle 
release triggered by a [Ca
2+
]i rise that is action potential independent (Katchman and Hershkowitz, 1993). 
After several minutes a regenerative increase of [K
+
]o occurs, resulting in [K
+
]o rising to 40 mM in anoxia and 
approximately 55mM in ischaemia (Hansen, 1985). This is observed alongside a reduction of extracellular 
sodium concentration ([Na
+
]o) by a similar amount due to a sodium flux into the cell. These changes 
depolarize cells to about -20mV; an event termed the anoxic depolarization. 
1.7.3 Glutamate release and excitotoxicity  
The initial depolarization, and increase in intracellular calcium concentration, causes excessive 
synaptic release of neurotransmitters, including glutamate. Glutamate release in ischaemia also occurs 
through reversal of glutamate transporters, and indeed this is the main release route for glutamate during 
severe ischaemia (Szatkowski and Attwell, 1994; Rossi et al., 2000; Hamann et al., 2005; See Figure 1.4). 
Under physiological conditions, glutamate transporters are responsible for glutamate uptake, which is 
very important in maintaining the extracellular glutamate concentration at a value that does not activate 
glutamate receptors. Glutamate transport is Na
+
-dependent and electrogenic: for each glutamate anion 
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entering the cell, three Na
+
 ions and one proton enter, and one K
+
 ion moves out of the cell. However in 
ischaemia, the ionic gradient rundown, and associated depolarization, cause the transporter to reverse and 
pump glutamate out of the cell (Rossi et al., 2000). This process generates a massive increase in the 
extracellular glutamate concentration, reaching up to approximately 100 µM (Globus et al., 1991; Phillis et al., 
1996), and leads to the overactivation of glutamate receptors. The resulting activation of NMDA receptors in 
particular permits an excessive calcium influx, the effect of which is described below. 
1.7.4 Calcium influx 
A massive calcium influx from the extracellular space during ischaemia is triggered by multiple factors 
(Figure 1.4). Predominantly, as mentioned above, it is caused by activation of AMPA and NMDA receptors 
when the extracellular glutamate level increases (Rossi et al., 2000; Hamann et al., 2005; for a review see 
Seisjö, 1988, and Lipton, 1999). However, activation of other channels and receptors may also contribute to 
the Ca
2+
 influx: acid sensing ion channels (Xiong et al., 2004), transient receptor potential channels (Aarts et 
al., 2003; Lipski et al., 2006) and ATP receptors (P2X7: Domercq et al., 2010) are all Ca
2+
-permeable and 
open during ischaemia. In addition, membrane depolarization opens voltage-gated calcium channels, and the 
rise of [Na
+
]i produced by glutamate-gated Na
+
 entry reverses the action of the Na
+
/Ca
2+
 exchanger, both of 
which result in a further increase in the intracellular calcium concentration (Hertz, 2008). At the same time, 
calcium extrusion from the cell by the ATP-dependent calcium pump is blocked because of ATP depletion 
(Nestler et al., 2008). 
The calcium concentration rise in the cell cytoplasm can also have an intracellular source. Calcium-
induced calcium release (CICR) occurs at the endoplasmic reticulum through activation of ryanodine receptors 
(Lipton, 1999; Nestler et al., 2008). Additionally, activation of Gq-coupled metabotropic glutamate receptors 
leads to the production of inositol trisphosphate, which also causes calcium release from the endoplasmic 
reticulum (Nestler et al., 2008). During ischaemia, the sequestration of calcium into the endoplasmic reticulum 
is blocked, as this process is dependent on ATP. As intracellular [Ca
2+
]
 
increases, Ca
2+
 is taken up into the 
mitochondria (Sciamanna et al., 1992; Schinder et al., 1996). This leads to mitochondrial depolarization and 
opening of the mitochondrial permeability transition pore (MPTP; Halestrap, 2006), which causes the release 
of apoptogenic proteins and generates reactive oxygen species (ROS; Piantadosi and Zhang, 1996; Starkov 
et al., 2004). 
All of these factors contribute to an increase in intracellular calcium concentration from approximately 
50 nM under normal conditions to approximately 2.5 µM during ischaemia (Lipton, 1999). This causes 
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overstimulation of normally well-controlled Ca
2+ 
dependent processes. The increased activation of proteases, 
such as calpain, leads to cleavage of the Na
+
-Ca
2+ 
exchanger and the plasma membrane Ca
2+ 
-ATPase, 
which prevents calcium efflux (Bano and Nicotera, 2007). Elevated [Ca
2+
]i also leads to an increased activation 
of lipases, such as phospholipases A (PLA) and C (PLC) (Raichle, 1983), whose action causes breakdown of 
membrane phospholipids and may result in decreased membrane integrity. Activation of lipases also leads to 
the production of free fatty acids, including arachidonic acid (AA), which in turn stimulates the production of 
eicosanoids, such as 20-HETE (Tegtmeier et al., 1990). Eicosanoids can exacerbate the ischaemic insult by 
promoting vasoconstriction and platelet aggregation and in this way further block the supply of oxygen and 
glucose to the affected area (Raichle, 1983).  
The promotion of reactive radical formation by Ca
2+
 is not restricted to the production of eicosanoids. 
Binding of nitric oxide (NO) synthase to the Ca
2+
-calmodulin complex, when [Ca
2+
]i rises, initiates the 
production of NO from arginine (Lipton, 1999), which may result in the formation of highly increased levels of 
reactive nitrogen species, the downstream effects of which are described below. 
1.7.5 Formation of reactive radicals 
Excitotoxicity is frequently associated with the formation of reactive radicals (also known as free 
radicals or reactive oxygen and nitrogen species; ROS and RNS respectively). Free radicals are molecules 
with an unpaired electron in an outer shell; this unpaired electron causes the molecule to be unstable and 
highly reactive, targeting membrane fatty acids with double bonds and protein sulphydryl groups, which 
greatly destabilises their structures and leads to changes in their properties (Nester et al., 2008). 
The production of ROS and RNS requires the presence of some oxygen, and greatly increases in the 
penumbra of an ischaemic area where some oxygen is still provided by unblocked vessels nearby, and during 
reperfusion, when blood flow is restored after ischaemia. Due to their high activity, free radicals (which may 
normally serve as second messengers in various signalling pathways) become pathological, causing DNA 
damage, lipid peroxidation and severe protein oxidation, which can lead to increased membrane permeability, 
prolonged inhibition of protein synthesis and promotion of DNA cleavage, including cleavage via the activation 
of pro-apoptotic signalling systems such as mitogen-activated protein kinases (MAPKs; Matsuzawa and Ichijo, 
2005), which eventually cause extensive apoptotic cell death (Raichle, 1983; Siesjö, 1988; Lipton, 1999). 
The formation of superoxide anion, which may be initiated by phospholipase activation, is a 
prerequisite for the formation of other ROS, and it is involved in the RNS pathway. Superoxide anions 
transformed by superoxide dismutase (SOD) react with nitric oxide to form peroxynitrite (Saran et al., 1990). 
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Peroxynitrite causes lipid peroxidation and protein oxidation, which leads to membrane disruption and enzyme 
inactivation (Halliwell, 1992).  Peroxynitrite is also a precursor of other RNS radicals (e.g. 
nitrosoperoxycarbonate). 
In ischaemia, therefore, the greatly increased Ca
2+
 flux into the cell may lead to excessive ROS 
formation (through the activation of phospholipases; Raichle, 1983) and RNS formation (by NO synthase 
stimulation; Lipton, 1999). Most of the free radicals, however, are formed during reperfusion after ischaemia. 
Upon a sudden increase in oxygen level, mitochondria drastically raise their level of superoxide production 
due to side reactions of electron carriers along the respiratory chain (mostly complexes I and III: Sugawara 
and Chan, 2003; Sugawara et al., 2004). Additionally, radicals are formed during the autooxidation of many 
compounds (e.g. catecholamines) and in the xanthine oxidase reaction (Lipton, 1999). 
1.7.6 Vascular response to ischaemia  
 Ischaemia is associated with obstruction of the downstream microvasculature even after reperfusion 
of the occluded supply arteries occurs (as a result of endogenous clot removal mechanisms or clot removal 
surgically or with tissue plasminogen activator). This phenomenon of vascular no-reflow was first observed by 
Ames and colleagues (1968). In their study, a period of global ischaemia was followed by injection of colloidal 
carbon into the intracerebral vasculature. Following ischaemia, large regions of brains showed no dye filled 
vessels, signifying a failure of reperfusion. Subsequent experiments that have investigated blood flow after 
ischaemia and reperfusion found that, upon reperfusion, a brief period of hyperperfusion (‘reactive 
hyperaemia’) was followed by a long lasting decrease in blood flow (Hauck et al., 2004). The flow in capillaries 
was also noticeably more heterogeneous and 6.4% of capillaries showed no flow at all. Capillary diameter was 
also reduced, suggesting that ischaemia and reperfusion caused capillary constriction. The responsivity of 
vessels following ischaemia is also affected (Leffler et al., 1989).  
These data suggest that, even when circulation is restored following ischaemia, blood flow may not be 
restored enough to adequately fuel neuronal processes. A chronic decrease in blood flow following ischaemia 
may exacerbate neuronal death by limiting oxygen and glucose delivery to, and removal of CO2 from, the 
tissue that is struggling to recover from metabolic disruption. Microcirculatory failure despite successful 
opening of the occluded artery may thus be one of the factors accounting for the low success rate of 
reperfusion therapies (Juttler et al., 2006).  
Blood flow regulation by pericytes is thought to have a pathological role in the brain. Ischaemia leads 
to a constriction of retinal capillaries near pericytes (Peppiatt et al., 2006). The contractility of pericytes is 
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regulated by the intracellular calcium concentration (Peppiatt et al., 2006; Kamouchi et al., 2004). In 
pathological conditions such as ischaemia, when ATP is depleted, there is expected to be a failure in calcium 
removal from pericytes leading to an uncontrolled rise in intracellular calcium concentration. Reactive oxygen 
species have been shown to increase the calcium concentration in cultured human pericytes (Kamouchi et al., 
2007) and to induce constriction of capillaries following MCAO, despite successful reperfusion of the artery, 
indicating a contribution to the no-reflow phenomenon (Yemisci et al., 2009). In the latter study, capillaries 
were found to be ‘pinched off’ at localised points, trapping erythrocytes, and these constrictions were 
attributed to pericyte contractions. Previous studies have attributed capillary constriction following ischaemia 
and reperfusion to aggregation of polymorphonuclear leukocytes (del Zoppo et al., 1991; Mori et al., 1992), 
activated platelet and fibrin deposition (del Zoppo, 2008), or swelling of glia and endothelial cells (Ames et al., 
1968; Ito et al., 2011). 
There is also evidence that pericytes are vulnerable to death following exposure to reactive oxygen 
species and hypoxia in culture (Shojaee et al., 1999; Yu et al., 2012), and following MCAO and reperfusion in 
vivo (Fernández-Klett et al., 2013). Pericyte death may, therefore, contribute to the long lasting constriction 
and reduced blood flow seen following ischaemia. 
Modelling studies have found that even small perturbations in capillary geometry and flow produced 
by ischaemia can lead to increased heterogeneity of capillary blood flow, which reduces tissue oxygen 
extraction, compounding the effects of the ischaemia (Jespersen and Østergaard, 2012). Consequently, even 
sparse pericyte constriction may contribute to no-reflow, not only by reducing blood flow, but also by 
increasing heterogeneity of blood flow, and thus impairing oxygenation. In Chapter 6 I investigate the pericyte 
response to ischaemia. 
1.8 The structure and role of the cerebellum 
In chapter 4, I report experiments on capillary diameter in the molecular layer of the cerebellum. This 
brain region was chosen as it is well described in the literature, the microcircuits have been examined in 
depth, and it had been used previously to study pericyte properties by other workers in our lab, so my results 
could be directly compared with those previously obtained. In this section I will give the background 
information on the cerebellum that is needed to understand the experiments that I performed. The anatomy 
and function of the cerebellar cortex can be summarised as follows. 
The main function of the cerebellum is to store motor programmes and use them to provide fine motor 
control. The cerebellum does not initiate movement per se, but it is important for the regulation of precise 
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motor output to confer proper balance, posture and smooth motor movements. The cerebellum is located 
behind the cerebral cortex and has a highly organised and uniform structure. It can be divided into three lobes, 
denoted flocculondular, anterior and posterior, of which the last two can be further divided into the central 
vermis and the two lateral cerebellar hemispheres. My experiments were carried out in the vermis, which is 
composed of multiple folia, each of which is characterised by the same layered structure. Each folium 
comprises grey matter surrounding centrally located white matter. The grey matter can be divided into three 
layers: the granule cell, Purkinje cell and molecular layers. My experiments were carried out on capillaries in 
the molecular layer. This was due to the structure of the cerebellar vasculature, and the sparcity of cell bodies 
to obscure the capillaries of this layer (Kandel et al., 2000). 
The innermost granule cell layer is composed of a high number of densely packed granule cells and a 
smaller number of interneurons (Golgi cells), astrocytes and NG2 positive oligodendrocyte precursor cells. 
Granule cells are distinguished by their small cell body and 4-5 dendrites which receive excitatory synaptic 
input from the mossy fibres and inhibitory input from the Golgi cells (which also receive input from the mossy 
fibres). The mossy fibres are myelinated axons which provide information to the cerebellar cortex on the 
sensory environment (information derived from peripheral receptors) and on the desired motor output 
(information from the cortex and other brain areas). In the granule cell layer this input information is recoded 
into the firing of the granule cells. Each granule cell projects its axon (which is unmyelinated in rodents) 
vertically through the molecular layer where it splits into two branches which travel horizontally in opposite 
directions to form a so-called parallel fibre, which is approximately 4mm long in the adult rat. The parallel fibre 
sends excitatory synapses onto the dendritic tree of approximately 130 Purkinje cells as well as onto the 
dendrites of interneurons, the basket and stellate cells, which inhibit the Purkinje cells. The Purkinje cells have 
their somata arranged in a thin layer – the Purkinje cell layer, which also contains the somata of radial glial 
cells (the Bergmann glia) which send long processes through the molecular layer. The elaborate Purkinje cell 
dendritic tree is flattened in a plane perpendicular to the cerebellar folds, so that the molecular layer mainly 
consists of an array of these dendritic trees, with the parallel fibres running perpendicular to them, like 
telephone wires on a pole. In addition to receiving excitatory synaptic input from the parallel fibres, the 
Purkinje cell also receives excitation from (myelinated) climbing fibres which arise in the inferior olive. This 
input may provide a teaching input to induce plasticity at the parallel fibres and thus correct erroneous motor 
outputs. After integration of the information arriving on the approximately 100,000 synapses impinging on the 
Purkinje cell dendritic tree, the final output from the cerebellum passes via the Purkinje cell output axon 
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through the white matter to the deep cerebellar nuclei, whose cells are inhibited by Purkinje cells. The deep 
cerebellar nuclear neurons then send axons to the premotor cortex, primary motor area and red nucleus to 
modulate the motor output of the body. For the cerebellar cortex to process motor information rapidly, 
information has to arrive on the mossy and climbing fibres and leave on the Purkinje cell axons at high speed. 
This is achieved by these long distance axons in the white matter of the cerebellum being myelinated. In 
addition to the myelinated axons, the white matter consists of oligodendrocytes, astrocytes, microglia and 
blood vessels.  
My experiments were carried out in the molecular layer of the P12 rat vermis, at which age the 
cerebellum is as described above, although synaptic connections and myelin are still developing. 
1.8.1 Vascular supply of the cerebellum 
The cerebellum receives blood supply from three arteries, which are the superior cerebellar artery 
(SCA), the anterior inferior cerebellar artery (AICA) and the posterior inferior cerebellar artery (PICA). Both the 
SCA and the AICA branch from the basilar artery whereas the PICA branches from the vertebral artery. The 
SCA supplies blood to the superior portion of the cerebellum as well as the superior pons and pontomedullary 
junction. The AICA supplies blood to the anterior portion of the inferior cerebellum and part of the caudal pons. 
The PICA supplies blood to the inferior portion of the cerebellum as well as the choroid plexus and much of 
the lateral medulla (Martin, 2012).  
The vascular system within the cerebellar cortex can further be divided into three layers. These are 
the superficial, middle and deep intracortical vascular layers. The superficial layer supplies the molecular layer 
of the cerebellum. The blood vessels in this layer enter the cortex perpendicular to the surface and appear to 
form hairpin loops (Hoddle and Sercombe, 1996). These are the vessels that I have studied. The middle 
intracortical vascular layer terminates in the Purkinje cell layer, where these vessels divide into branches 
extending parallel to the surface connecting with capillaries from the molecular layer and the granule cell 
layer. The deep intravascular vascular layer supplies the granule cell layer. This layer is one of the most 
vascularised regions of the brain (Duvernoy et al., 1983; Akima et al., 1987; Hoddle and Sercombe, 1996). 
1.9 The structure and role of the forebrain 
 In chapter 6, I report experiments on pericyte death in the forebrain, in both the striatum and cortex. 
This brain region was chosen because it is dependent on the middle cerebral artery, which is the most 
common vessel to become occluded in stroke (Stephens and Stilwell, 1969). 
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  The cerebral hemispheres are the mostly highly developed portions of the central nervous system. 
The cerebral cortex is responsible for higher order functions such as thought, language and memory. It is 
made up of six layers that each have a distinct structure and composition. These are the molecular layer 
(layer 1), the external granular layer (layer 2), the external pyramidal layer (layer 3), the internal granular layer 
(layer 4), the internal pyramidal layer (layer 5) and the polymorphic layer (layer 6). 
 The striatum is part of the basal ganglia. This region receives inputs from the sensory-motor and 
association cortex as well as from the rest of the basal ganglia system, and is separated into compartments 
dependent on these inputs. The compartments of the striatum include the sensorimotor compartment, which 
receives input from the sensory cortex and contains the caudate nucleus and the putamen, the associative 
compartment, which receives input from the association cortex and contains the internal capsule, and the 
limbic compartment, which receives input from other parts of the basal ganglia and contains the nucleus 
accumbens. The striatum is responsible for eye movement control and cognition, control of limb and trunk 
movements and control of emotions (Martin, 2012).  
1.9.1 The vascular supply of the forebrain 
 The forebrain receives blood supply through two main pairs of arteries: the anterior circulation, which 
is made up of the internal carotid arteries, and the posterior circulation which is made up of the vertebral 
arteries. The frontal hemispheres are supplied by the anterior circulation. The internal carotid arteries divide 
into the anterior cerebral artery and the middle cerebral artery. Each of these arteries is comprised of deep 
and cortical branches. The deep branches are proximal and supply deep brain grey matter and white matter 
whilst the cortical branches are distal and supply various neuronal laminae of the cerebral cortex. 
There are two sites at which the anterior and posterior circulation communicate. This makes it 
possible for a decreased flow in one system to be compensated for by an increased flow in the other. The 
internal carotid artery and the basilar artery are joined through the circle of Willis (see Figure 1.5). This 
complete anastomotic ring is made up of the anterior cerebral arteries, the posterior communicating arteries, 
and, in rats, the internal carotid arteries. The terminal ends of the cerebral arteries anastomose on the dorsal 
convexity of the cerebral hemisphere (Martin, 2012). 
 The middle cerebral artery is the largest branch of the internal carotid artery and supplies blood to the 
lateral convexity of the cortex. It passes through the lateral sulcus and the surface of the insular cortex as well 
as over the inner opercular surfaces of the frontal, temporal and parietal lobes. The MCA is the most common 
artery to become occluded in stroke (Stephens and Stilwell, 1969).  
 39 
 Pial vessels, which arise from arteries, line the surface of the cortex. In humans, these large vessels 
(260-280 μm diameter) then branch perpendicularly, giving rise to penetrating arterioles. Penetrating arterioles 
can be divided into six different groups according to their morphology, the depth of the cortex that they 
penetrate and their branching pattern (Duvernoy et al., 1981). Group 1 arterioles and venuoles have a small 
diameter (approximately 10 μm) and only penetrate into the molecular layer (layer 1), and possibly the 
external granule layer (layer 2), of the cortex. Group 2 vessels, also known as intermediate vessels have a 
slightly larger diameter (15-25 μm) and reach the external pyramidal layer (layer 3). The third group of vessels 
are a similar diameter to group 2 and reach the internal granule cell layer (layer 4). The vessels that make up 
groups 4-6 all penetrate through the grey matter of the cortex to reach the sub cortical white matter but they 
show different branching properties. Group 6 in particular shows no branching throughout the grey matter and 
only branches in the white matter. This group are known as the medullary vessels. 
 Penetrating arterioles and venules have been found to form a regular pattern, with a single venuole 
being surrounded by a hexagonal array of arterioles (Duvernoy et al., 1981), although more recent studies 
found the ratio of venules to the arterioles to be 1:1.6 (rather than 1:6; Weber et al., 2008). Capillaries form 
dense patterns between these larger vessels and show variation in density throughout the cortical layers. The 
lowest capillary density is found in layer 1 while the highest density is found in layer 4 (Duvernoy et al., 1981; 
Weber et al., 2008). The vascular density in different layers correlates with the synapse number in each layer 
as well as with the average metabolic demand in the layers (Rissle et al., 1993; Woolsey et al., 1996; Tieman 
et al., 2004).  
 The vascular supply to the striatum comes from the MCA, via the lenticulostriate artery, and from the 
ACA, via the recurrent artery of Heubner. The sensorimotor compartment is supplied by the lateral 
lenticulostriate artery, the associative compartment is supplied by the medial lenticulostriate artery, and the 
limbic compartment of the striatum is supplied by the recurrent artery of Heubner. These vessels have similar 
branching patterns; penetrating vessels give rise to two to four secondary branches, these vessels then 
branch again, and the tertiary branches form small pre-capillary arteriole envelopes (Feekes et al., 2005).  
1.10 Relevance to functional brain imaging  
 Because of the high energy use of neurons, the energy supply to the brain must be allocated flexibly 
to brain regions according to neuronal demand. Consequently, blood flow is increased to active areas (Roy 
and Sherrington, 1890), as explained above neural activity leads to ATP expenditure, largely on the pumping 
out from neurons of ions which enter to generate synaptic and action potentials (Attwell and Iadecola, 2002). 
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This evokes an increase in oxygen consumption to regenerate ATP which, within a few seconds, is followed 
by a disproportionate increase of blood flow to the active area. Associated with these local changes in oxygen 
consumption and blood supply, there are changes in the local oxygen concentration, which initially falls due to 
consumption, and then rises above its baseline value when the increased blood flow brings in more oxygen 
(Offenhauser et al., 2005; Enager et al., 2009). Concomitantly, there are changes in the levels of oxygenated 
and deoxygenated haemoglobin. This increase in blood flow, and thus in the level of oxygen and of 
oxygenated haemoglobin, is exploited by blood oxygen level dependent (BOLD) functional imaging, which 
detect the mismatch between energy use and supply in small brain regions. A local increase in signal (which 
is produced by blood flow increasing more than oxygen consumption in the targeted region) is assumed to 
reflect an increase in neuronal activity. This technique works as follows. 
When an object is exposed to a magnetic field, all the protons within the object align themselves with 
(parallel to) or against (antiparallel to) the direction of the imposed magnetic field, B0 (Figure 1.5A-C). Protons 
aligned parallel to B0 have a lower energy than those aligned antiparallel and at any given time there is a 
tendency for a greater number of protons to be aligned parallel to the field. However, for quantum mechanical 
reasons, the magnetic dipole moments of the nuclei are not perfectly aligned with the field, but precess around 
its direction. Pulses of electromagnetic energy (radiofrequency (RF) pulses, B1) which are perpendicular to the 
main field, are then applied to ‘flip’ the protons out of alignment with B0 (Figure 1.5D). The net magnetization 
is now aligned more perpendicular to B0 and continues to precess around the direction of B0 (Figure 1.5D, E) 
The small, oscillating, magnetic field induces a current in the receiver coil and hence produces a magnetic 
resonance signal. When B1 is no longer applied two relaxation processes occur, which result in the loss of 
signal, in two ways: 
(1) Longitudinal relaxation (described by the time constant T1): the protons relax back to their original 
orientation aligned with B0 as energy is dispersed from the protons to neighbouring nuclei (Figure 
1.5F,G);  
(2) Transverse relaxation (also known as ‘spin-spin relaxation’, described by time constant T2): the 
protons go out of phase with the precession of neighbouring protons due to tiny differences in the 
local magnetic field, caused by other magnetic nuclei and atoms moving nearby (Figure 1.5H) 
BOLD contrast depends on the level of deoxyhaemoglobin in the blood. The iron in deoxyhaemoglobin is 
paramagnetic (Pauling & Coryell, 1936) and so creates local inhomogeneties in the magnetic field which result 
in the precessing nuclei no longer moving in phase. During the initial increase in oxygen consumption, oxygen 
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is taken from diamagnetic oxyhaemoglobin, leaving behind paramagnetic deoxyhaemoglobin, which makes 
the magnetic field experienced by protons in surrounding water molecules less homogenous and thus 
decreases the magnetic resonance signal from these protons. However, during the subsequent increase of 
blood flow (which in fact partly overlaps with the increase of O2 consumption), the initial tendency to an 
increase in deoxyhaemoglobin level is converted to a decrease, by the delivery of fresh oxygenated blood with 
a low deoxyhaemoglobin concentration (Fox and Raichle, 1986; Malonek et al., 1997). It is this decrease in 
deoxyhaemoglobin level which increases the signal from the protons and which is thus detected as a BOLD 
signal, because when deoxyhaemoglobin levels decrease there are fewer magnetic field inhomogeneities and 
so transverse relaxation occurs more slowly and the BOLD signal increases (Ogawa et al., 1990). Thus, the 
size of the BOLD fMRI signal is determined by the difference between the amount of blood flow increase, 
which increases the signal, and the use of O2 by neurons, which reduces the signal.  
 It is important to note that the BOLD signal cannot be viewed as a direct read-out of the metabolic 
demand associated with activity in the tissue (indeed, as noted above, O2 consumption decreases the BOLD 
signal). In particular, BOLD signals need not directly report spiking activity in the imaged area, but instead 
reflect the many factors associated with neural activity, which lead to an increase in blood flow. Most 
importantly, neurotransmitters released during synaptic activation are now known to directly influence local 
blood flow and it is thought that the BOLD signal may most closely reflect the excitatory synaptic component, 
rather than the action potential component, of neural activity (reviewed by Attwell & Iadecola, 2002; 
Logothetis, 2008; Attwell et al., 2010).  
Several aspects of the work in this thesis are relevant to understanding functional imaging signals 
such as BOLD fMRI. First, understanding the increase in blood flow which occurs following an increase in 
neuronal activity is necessary to explain where positive BOLD signals will be produced. The signals involved 
in increasing blood flow in response to activity are addressed in Chapters 4 and 5. Secondly, in Chapter 7 I 
consider the problems that may arise from using this indirect measurement of neuronal activity to infer 
meaning from imaging studies that are performed on participants over different stages in development. 
1.11 Aim of this thesis 
 The main aim of the work described in this thesis was to learn more about pericytes, including the role 
that they play in neurovascular coupling and, therefore, energy supply to the brain, in physiological and 
pathological conditions. In Chapter 3, I investigate the expression of multiple pericyte markers and markers for 
other perivascular cell types that have been suggested to overlap with pericytes. In Chapter 4, I study the 
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signalling pathways involved in glutamate-evoked capillary dilation in cerebellar slices. In Chapter 5, I 
investigate the pericyte membrane currents that underlie the constriction and relaxation of pericytes in 
response to vasoactive agents. In Chapter 6, I quantify pericyte death in response to oxygen-glucose 
deprivation and reoxygenation. Using pharmacological agents, I identify some of the signalling pathways 
involved in pericyte death in these conditions. In Chapter 7, I discuss the changes in neurovascular coupling 
and energy use that may occur throughout development, and how these changes would impair evaluation of 
neurological changes in functional imaging studies. 
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Figure 1.1: Signalling pathways mediating neurovascular coupling. When neurons are active they 
release glutamate which generates action potentials in interneurons containing NOS and activates 
metabotropic glutamate receptors (mGluR) in astrocytes. As a result, [Ca
2+
]i rises in both cell types, releasing 
NO and derivatives of arachidonic acid (EETs and prostaglandins) to dilate local arterioles and increase blood 
flow. In addition, arachidonic acid diffuses to arterioles and is converted into 20-HETE which constricts the 
vessels. K
+ 
release from astrocytes via large conductance Ca
2+
-activated K
+
 channels (BKCa channels) may 
also dilate vessels by promoting K
+ 
efflux through smooth muscle inward rectifier K
+
 channels (Kir channels) 
and thus generating hyperpolarization of the smooth muscle. Blood flow changes evoked by release of 
adenosine, lactate and interneuron peptide transmitters are not shown on this diagram. Vasodilation occurs in 
the context of the constriction of arterioles produced by the amine transmitters, noradrenaline, dopamine and 
5-HT. Noradrenaline evokes constriction by acting on α-adrenergic receptors on arteriole smooth muscle and 
on astrocytes. For more details see sections 1.2 and 1.3. 
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Figure 1.2: Regulation of smooth muscle tone. Stimulating ligand can bind to G protein-coupled 
metabotropic receptors on the smooth muscle cell (1). This leads to activation of phospholipase C (PLC) that 
hydrolyses phosphatidyl inositol diphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG; 
2). IP3 binds to a receptor on the sarcoplasmic reticulum (SR) and this elicits a controlled release of calcium 
(3). Stimulating ligand may also bind to ligand-gated calcium channels (LGCC) on the surface of smooth 
muscle cells causing calcium entry (4). Membrane depolarization allows further calcium entry through voltage-
gated calcium channels (VGCC; 5). Crossbridge cycling is regulated by a myosin light chain (MLC) kinase and 
is dependent on both calcium and calmodulin. The phosphorylation of myosin is triggered by the binding of 
calmodulin (with 4 Ca
2+
 bound) to MLC kinase forming a complex. The phosphorylated light chain of myosin 
reacts with actin, and triggers smooth muscle contraction (6). The intracellular calcium concentration is 
regulated by calcium pumps on the sarcoplasmic reticulum, mitochondria and the plasma membrane, as well 
as by sodium-calcium exchangers on the plasma membrane (7). Below the affinity of calmodulin for calcium, 
the MLC are dephosphorylated by MLC phosphatase and muscle relaxes (8). For more detail see section 1.4. 
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Figure 1.3: Organisation of the capillary neurovascular unit. A Rings of smooth muscle encircle arterioles, 
while pericytes send processes along and around capillaries, without fully covering the vessel. B Pericytes are 
located outside the endothelial cells and are separated from them and from the parenchyma by a layer of 
basal lamina. In the parenchyma, astrocyte end-feet and neuronal terminals are closely associated with the 
capillary. From Hamilton et al. (2010). 
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Figure 1.4: Mechanisms of intracellular calcium rise during ischaemia. During ischaemia the extracellular 
concentration of glutamate increases as depolarization triggers synaptic vesicle release, and ATP depletion 
leads to the reversal of glutamate transporters. Glutamate binds to postsynaptic receptors, triggering further 
depolarization and a rise of intracellular calcium concentration through ionotropic glutamate receptors 
(AMPARs and NMDARs) and metabotropic glutamate receptors. The depolarization and Na
+
 entry through 
ionotropic glutamate receptors leads to further entry of calcium through voltage-gated calcium channels 
(VGCC) and reversal of the sodium-calcium exchanger, as well as IP3 mediated calcium release from the 
endoplasmic reticulum (ER). Calcium cannot be removed from the cell or sequestered into organelles as there 
is no ATP to fuel the pumps. The increased intracellular calcium concentration leads to cell death through 
several mechanisms, which are described in section 1.6. 
 47 
 
 
Figure 1.5: Typical normal polygon configuration of the circle of Willis. In humans, the circle of Willis is 
made up of the anterior communicating arteries and the posterior communicating arteries (in the rat the 
interior carotid arteries also contribute to the circle of Willis; see Figure 2.4). This structure creates collaterals 
in the cerebral circulation and allows compensatory flow during partial occlusion. M1 indicates main trunk of 
the middle cerebral artery; A1, pre-communicating part of the anterior cerebral artery; A2, posterior 
communicating part of the anterior cerebral artery; P1, pre-communicating part of the posterior cerebral artery 
P2, posterior communicating part of the posterior cerebral artery; and Ant., anterior. From Hoksbergen et al. 
(2000). 
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Figure 1.6: Basics of MRI. A Each proton (mainly present in water) has a “spin” or magnetic moment. B In 
the absence of an externally applied magnetic field (M=0), the spins of the protons are randomly orientated. C 
In the presence of a magnetic field, B0, protons are aligned roughly parallel or antiparallel to B0, producing a 
net magnetization, M. Each nucleus precesses around the direction of B0. D Following a radiofrequency pulse 
at 90
O
 to B0, the spins are flipped out of alignment with B0. E M continues to precess around the direction of 
B0, producing the MR signal, and initially all proton spins precess in phase with each other. F Gradually the 
spins re-align with B0 – this is called longitudinal relaxation and occurs with a time constant called T1. G 
Recovery of magnetization over time following an RF pulse, grey matter, T1 = 920 ms. H In addition the phase 
alignment of the precessing displaced protons is lost. This transverse relaxation is produced by local 
inhomogeneities in magnetic field produced, e.g. by paramagnetic deoxyhaemoglobin molecules, and occurs 
with a time constant called T2. 
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Table 1.1: Known pericyte markers. Adapted from Armulik et al. (2011). 
 
 
 
 
 
Pericyte marker Gene 
symbol 
Other cell types that express marker References 
NG2 (chondroitin 
sulphate 
proteoglycan 4) 
Cspg4 Developing cartilage, bone, muscle; 
early postnatal skin; adult skin stem 
cells; adipocytes; vSMCs; neuronal 
precursor cells; oligodendrocyte 
precursor cells; endothelial cells; 
microglia; mesenchymal stem cells 
Ozerdem et al., 
2001; 
Ruiter et al., 1993; 
Huang et al., 2010 
PDGFRβ (Platelet 
derived growth factor 
receptor beta) 
Pdgfrb Interstitial mesenchymal cells during 
development; smooth muscle; neurons, 
neuronal precursor cells; myofibroblasts; 
mesenchymal stem cells 
Lindahl et al., 1997;  
Winkler et al., 2010 
CD13 (alanyl 
(membrane) 
aminopeptidase) 
Anpep vSMCs, inflamed and tumour endothelial 
cells; myeloid cells; epithelial cells 
Dermietzel and 
Krause, 1991; 
Kunz et al., 1994 
αSMA (alpha-
smooth muscle 
actin) 
Acta2 vSMCs; myofibroblasts; myoepithelium Nehls and 
Drenckhahn, 1993 
Desmin Des Skeletal, cardiac, smooth muscle Nehls et al., 1992 
Vimentin Vim Neuronal precursor cell Díaz-Flores et al., 
2001 
RGS5 Rgs5 vSMCs; cardiomyocytes? Bondjers et al., 2003; 
Cho et al., 2003 
SUR2 Abcc9 Skeletal, cardiac, smooth muscle; renal 
tubular epithelium 
Bondjers et al., 2006 
Kir6.1 Kcnj vSMCs Bondjers et al., 2006 
Endosialin Cd248 vSMCs, myofibroblasts; fibroblasts; T 
cells 
Christian et al., 2008 
DLK1 (delta-like 1 
homolog) 
Dlk1 vSMCs; hepatoblasts; adipocyte 
progenitors 
Bondjers et al., 2006 
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Chapter 2: Methods 
In this chapter I will describe the general methods used for the experimental studies carried out in this 
thesis. Details of the specific methods used for each study are given in the Methods section of each Results 
chapter.  
2.1 Solutions 
2.1.1 Extracellular solution 
 Brain slices were incubated in or perfused with extracellular solution mimicking cerebrospinal fluid 
(artificial cerebrospinal fluid, aCSF) which contained (in mM): 124 NaCl, 2.5 KCl, 26 NaHCO3, 1 MgCl2, 1 
NaH2PO4, 10 D-glucose, 2 CaCl2, pH 7.4, osmolarity 295-315 mOsm. This solution was gassed with 20% 
O2/5% CO2/75% N2 or 95% O2/5% CO2. For the experiments in Chapter 4 and 5, this solution was perfused 
through the recording chamber by a peristaltic pump at a flow rate of 2-4ml/min.  The solution was heated to 
32-35⁰C (by manually adjusting the current flow through a series of resistors attached to a heating block, 
according to the thermometer reading in the recording chamber). For experiments in Chapter 6, slices were 
incubated in this solution at 37⁰C. 
 The neurotransmitters and other drugs that were added to the extracellular solution are listed in Table 
2.1. To prevent oxidation when using noradrenaline, 100 μM ascorbic acid was added to the extracellular 
solution (Maxwell et al., 1983). 
2.1.2 Ischaemic solution 
 For the experiments in Chapter 6, brain ischaemia was mimicked in vitro. Glycolytic and mitochondrial 
ATP production was blocked by removing glucose and O2. To do this I used a bicarbonate-based solution as 
described in section 2.1.1, but with 7 mM sucrose (substituted for 10 mM D-glucose) and equilibrated with 
95% N2/5% CO2 (substituted for 95% O2/5% CO2). Solution was heated to 37⁰C in a water bath. 
2.1.3 Pipette solution 
The whole-cell patch clamping experiments in Chapter 5 were performed using a potassium-
gluconate based solution containing (in mM):130 K-gluconate, 4 NaCl, 0.5 CaCl2, 10 HEPES, 10 BAPTA, 2 
Na2ATP, 2 MgCl2, 0.5 Na2GTP, 0.05 Alexa Fluor 488, pH set to 7.3 with KOH, 280-300 mOsm. 
2.2 Transgenic mice expressing fluorescent constructs 
NG2-DsRedC57BL/6J mice were a kind gift from Akiko Nishiyama (Department of Physiology and 
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Neurobiology, University of Conneticut, Storrs, CT, USA). These transgenic mice provided a means to identify 
NG2-glia in living brain slices, before patch-clamping them. These mice were generated using the bacterial 
artificial chromosome (BAC) modification technique (Figure 2.1 describes the generation of NG2DsRedBAC 
transgene; Zhu et al., 2008). The NG2-DsRedC57BL/6J mouse line was maintained as a heterozygous 
breeding colony to prevent genetic drift, because the C57BL/6J strain of mice is inbred. 
2.3 Slice and tissue preparation 
2.3.1 Cerebellar slice preparation 
Twelve-day-old Sprague-Dawley rats or 10-15 day old NG2-DsRedC57BL/6J mice were used for the 
preparation of the cerebellar slices for the experiments in Chapter 4 (Sprague-Dawley rats) or in Chapters 3 
and 5 (NG2-DsRedC57BL/6J mice). All animals were killed humanely by cervical dislocation in accordance 
with the Animals (Scientific Procedures) Act (1986). Animals were decapitated following cervical dislocation, 
and the head was immersed in ice-cold oxygenated slicing medium, containing (in mM): 124 NaCl, 2.5 KCl, 26 
NaHCO3, 1 MgCl2, 1 NaH2PO4, 10 D-glucose, 2 CaCl2, pH 7.4, osmolarity 295-315 mOsm (gassed with 95% 
O2/5% CO2). Kynurenic acid (1 mM) was included in the slicing medium to block glutamate receptors, and 
thus reduce potential excitotoxic damage. The scalp was removed and the skull was opened by making lateral 
cuts on either side of the head from posterior to anterior. The skull was removed using forceps and the brain 
was placed in ice-cold oxygenated slicing medium. The cerebellum was separated from the rest of the brain 
by making cuts through the inferior colliculus and the spinal cord, and the cerebellar hemispheres were 
removed. The cerebellar vermis was glued to the cutting stage of a Vibratome (Leica VT1000s) and stabilised 
with an agar block.  The tissue was immersed in ice-cold oxygenated slicing medium throughout the slicing 
process. Sagittal slices of the vermis (200 μm thick) were cut and placed oxygenated slicing medium at room 
temperature until used for imaging or recording. All slices were allowed to recover from slicing for at least 30 
minutes prior to use. 
2.3.2 Forebrain slice preparation 
Sprague-Dawley rats (21 days old) and adult Wistar rats, or 10-15 day old NG2-DsRedC57BL/6J 
mice, were used for the preparation of the forebrain slices for the experiments in Chapter 6 (Sprague-Dawley 
and Wistar rats) and chapters 3 and 5 (NG2-DsRedC57BL/6J mice). Adult Wistar rats were killed by 
anaesthetic overdose while Sprague-Dawley rats and NG2-DsRedC57BL/6J mice were killed as in section 
2.3.1. Brains were removed as described in section 2.3.1. Each hemisphere was isolated using a cut down the 
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midline, glued to the stage of a vibratome (Leica VT1000S or Campden Instruments MA752), and stabilised 
with an agar block. The tissue was immersed in ice-cold oxygenated slicing medium throughout the slicing 
process. Coronal slices of the forebrain (200 μm thick) were cut and placed oxygenated slicing medium at 
room temperature until used for recording. All slices were allowed to recover from slicing for at least 30 
minutes prior to use. 
2.4 Immunocytochemistry 
2.4.1 Live labelling 
 For the experiments in Chapter 3 and 6, slices were incubated with isolectin B4-FITC conjugate (IB4, 
10 μg/ml) for 30 minutes to 1 hour, to label blood vessels. For the experiments in Chapter 6, slices were 
incubated with propidium iodide (PI, 37 μM) for 1 to 2 hours, to label dead cells.  
2.4.2 Antibody labelling 
 In order to label with antibodies, slices were fixed in 4% paraformaldehyde in 0.1 M phosphate-
buffered saline (PBS) for 20 minutes at room temperature. Fixed slices were then washed three times for 15 
minutes in 0.1 M PBS and in order to block generalised secondary antibody staining and permeabilise the 
tissue, slices were treated with solution containing 10% goat serum, 0.05% Triton X-100 and 0.1 M PBS, for 4-
6 hours at room temperature. This was followed by incubation with the primary antibodies listed in table 2.2 for 
12-16 hours. Slices were then washed three times for 20 minutes with 0.1 M PBS, before being incubated with 
goat anti-rabbit secondary antibody (conjugated to AlexaFluor; see Table 2.3). Slices were then washed 
another 3 times and labelled with DAPI (4',6-diamidino-2-phenylindole at 82 μg/L; Molecular Probes) to label 
cell nuclei. Slices were mounted on a microscope slide with Citifluor (glycerol/PBS, Citifluor), covered with a 
0.17 mm thick glass cover slip, and sealed with nail varnish. A control experiment to check for non-specific 
binding of the secondary antibody was performed for each antibody by omitting the primary antibody when 
labelling one slice during the staining procedure. 
2.4.3 Confocal imaging 
 Fixed slices were imaged with a confocal laser scanning microscope (LSM). The confocal microscope 
used was either a Zeiss LSM 510, 700 or 710. Images were obtained using x20 water-immersion or x40 oil 
immersion objectives.  
Imaging with multiple wavelengths was performed as sequential scans at each wavelength, to 
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minimise “bleed through” of emitted fluorescence between imaging channels. The argon laser 488 nm line 
was used to excite FITC and Alexa 488 fluorophores, and the 458 nm laser line of the argon laser was used 
for DsRed, propidium iodide and Alexa fluor 546 fluorophores. The ultraviolet laser 364 nm laser line was 
used for the detection of DAPI. Scanning of areas of interest in slices was done in the x-y and then z 
directions, and averaged 2-6 times depending on the signal. The gain and offset settings were initially chosen 
for each set of images in an experiment depending on the signal intensity being detected. For the experiments 
in Chapter 6, the settings for propidium iodide were kept constant for all slices within an experiment in order to 
compare the cell death between slices. The settings for other fluorophores were adjusted throughout 
experiments to optimise detection of the labelling. 
2.5 Imaging of capillaries 
For bright-field recording of capillary diameter (Chapter 4), capillaries were imaged at 20-50 µm 
depths within the molecular layer of cerebellar slices, using a x40 water immersion objective. Images were 
acquired with a Coolsnap HQ2 CCD camera, and Metafluor software (Molecular Devices). Images were 
acquired every 2-5 sec, with an exposure time of 5 msec. The pixel size was 300 nm. Capillaries were 
classified as vessels lacking a continuous layer of smooth muscle (which is seen around arterioles) and <10 
μm in diameter. Pericytes were identified by their position on the outer walls of capillaries and their 
characteristic ‘bump on a log’ morphology (Kuwabara and Cogan, 1960), but pericyte identification is 
imprecise using bright field illumination (Krueger and Bechmann, 2010). Nevertheless, the distance between 
pericyte cell bodies is only 50 μm in the brain (Hirschi and D’Amore, 1996), so a pericyte soma is expected to 
be present on any given 50 μm length of capillary, even if it is not easily visible (e.g. because it is underneath 
the capillary). Thus, spatially localised capillary constrictions and dilations were attributed to pericytes even 
when the pericyte soma was not clearly visible. The lengths of vessel imaged ranged from approximately 30-
70μm. Vessel internal diameters were measured by manually placing a measurement line (perpendicular to 
the vessel) on the image (at locations which constricted when noradrenaline was applied), using Metamorph 
software. I was blinded as to the timing of drug applications during the measurement process. Drugs were 
superfused for at least 5 minutes. For statistical analysis of the effects of drugs on capillary diameter, the 
diameter measurement for each drug was taken from the last 5 recorded images in that drug. Data in the 
presence of blockers of signalling pathways were compared with interleaved data obtained without the 
blockers. 
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2.6 Patch-clamp set-up 
For patch-clamp recording of pericytes (Chapter 5), both coronal slices of cortex and sagittal slices of 
cerebellum were prepared from P10-15 NG2-DsRed C57BL/6J mice. Pericytes were identified as DsRed-
expressing cells located on capillaries (oligodendrocyte precursor cells also express NG2-DsRed but these 
can be distinguished from pericytes morphologically and by their position in the parenchyma). Pericytes were 
whole cell clamped with ~7-9 MΩ electrodes containing the intracellular solution described in section 2.1.3. 
This solution contained AlexaFluor 488 (1mg/ml), to allow identification of the patch-clamped cell.  
2.6.1 Whole-cell configuration 
 As the patch pipette was lowered into the bath, a 200 msec, -5 mV voltage step was delivered at 5 Hz 
to monitor the pipette resistance before and after contacting the cell membrane. Positive pressure was applied 
to the pipette (through a 1 ml syringe connected to the pipette via tubing) while it was lowered towards the 
cell, to prevent the pipette tip becoming blocked by debris. Upon approaching the cell soma, gentle suction 
was applied to form a high resistance seal (over 1 GΩ) between the cell membrane and the tip of the patch 
pipette, thus achieving cell-attached mode. At this point, the holding potential was set to between -55 and -
75mV (close to the cell’s resting membrane potential) and the pipette capacitance was compensated (using 
the fast and slow electrode compensation controls). Finally, the transition from cell-attached to whole-cell 
configuration was made by applying further suction to break through the piece of membrane at the tip of the 
pipette, thus gaining diffusive and electrical access to the cell’s interior.  
2.6.2 Liquid junction potential and its compensation 
 Because of the different composition of the pipette solution and the bath solution, a potential 
difference (the junction potential) exists at the end of the electrode when it is in the bath, but is not present in 
whole-cell configuration when the pipette solution has diffused into the cell (Fenwick et al., 1982). The junction 
potential depends on the diffusion coefficients of the anions and cations present in each solution, which are 
determined by each ions molecular weight and charge (which affect ion mobility). For the solutions used, the 
principal ions responsible for generating the junction potential were K
+
, Na
+
, Cl
-
and gluconate. K
+ 
ions diffuse 
out of the patch pipette more quickly (Dk = 1.99 x 10
-9
 m
2
s
-1
) than Na
+
 ions diffuse in (DNa = 1.36 x 10
-9
 m
2
s
-1
), 
and gluconate ions diffuse out more slowly (Dgluconate = 1.06 x 10
-9 
m
2
s
-1
) than Cl
-
 ions diffuse in (DCl = 1.99 x 
10
-9
 m
2
s
-1
) (Robinson and Stokes, 1965), so the patch pipette potential becomes more negative than the bath 
potential (Figure 2.2). 
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 The junction potential can be measured experimentally using an agar bridge (containing 4M NaCl) to 
connect the bath solution to a reference electrode. This avoids changes in the reference electrode potential 
following a change in the external solution. When zero current is applied, the junction potential is the 
difference between the voltage value obtained when both the patch electrode and the bath contained the 
same solution (both internal solution, so there is no junction potential) and the value obtained when the bath 
solution was used for experiments (external solution described in 2.1.1). For my experimental solutions, the 
junction potential was measured to be -14mV, and all voltage data have been adjusted accordingly (1.e. -
14mV was added to all voltages measured with patch-clamp). 
2.6.3 The electrical circuit for whole-cell patch-clamp recordings in voltage clamp 
 The cell membrane, which is composed of a lipid bilayer and embedded proteins, is an electrical 
insulator. In contrast, the extracellular and intracellular components are filled with salt solutions, which are 
excellent conductors of current. This combination of the cell membrane (an insulator) and the surrounding 
intra- and extracellular solutions (conductors) forms a capacitor, which can store charge. The charge stored 
(Q) is proportional to the applied voltage (V) and the capacitance, (C), which is a measure of the membrane’s 
capacity for storing charge: 
Q = CV           2.1 
The physical dimensions of the membrane are important for determining the capacitance: the more 
membrane, the more charge can accumulate. Thus, capacitance is proportional to the membrane surface 
area. Importantly, capacitors prevent instantaneous changes in voltage, which affect both the conduction of 
electrical signals in biology and electrophysiological recordings. For example, in excitable cells, local changes 
in membrane potential, such as an action potential travelling along an axon, are subject to a delay in 
propagation due to the time needed for charging the cell membrane, therefore limiting the speed of the action 
potential propagation. Similarly, during whole-cell voltage-clamp recordings, a step change in desired 
membrane potential can only be produced after the charging time of the membrane capacitance. The current 
flowing through a capacitor (C) is proportional to the rate of voltage change (∆V) with time (∆t): 
I = C            2.2 
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In addition to being a capacitor, the cell membrane is a conductor due to the presence of ion channels which 
allow the passage of charged ions. Current flowing through these ion channels can charge or discharge the 
membrane capacitance and therefore cause changes in the membrane potential. The electrical circuit 
equivalent of a spatially compact cell in the whole-cell configuration is represented by a capacitor (the 
membrane capacitance, Cm) and a resistor (the membrane resistor, Rm) connected in parallel, both connected 
in series to a patch electrode (with electrode series resistance, Rs) (Figure 2.3). 
The current flow (I) through this circuit in response to a voltage step (Vs) (Figure 2.3) can be predicted by 
(Tessier-Lavigne et al., 1988): 
 I(t) = .          2.3 
Where t is the time after onset of the voltage step, and , the decay time constant of the current transient, is: 
           2.4 
 At the onset of the voltage step (t=0), the cell capacitance is uncharged and the voltage across it is 
zero. Consequently, just as the voltage step is applied, the voltage across the series resistance is the applied 
voltage step, and the initial current flowing allows calculation of the series resistance (from equation 2.3 at 
t=0) as: 
  =           2.5 
 When the current reaches a steady state (t= ), the cell capacitance is fully charged and no current 
flows through it. The membrane resistance can then be calculated from the voltage step and the current at 
t=  (by rearranging equation 2.3): 
  -          2.6 
Substituting Rs from equation 2.5 gives: 
=           2.7 
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The membrane conductance (Gm) is the inverse of this: 
  =            2.8 
The membrane capacitance can be calculated by rearranging equation 2.4 to give: 
  =            2.9 
 For an electrically compact cell which can be represented by a single-compartment model (Figure 
2.3), the time constant, , can be obtained by fitting the current transient in response to a voltage step with a 
single exponential.  
2.6.4 Series resistance and its compensation 
 In whole-cell patch-clamp experiments, the electrode resistance leads to voltage errors because it is 
in series with the membrane resistance. Because voltage sums across resistors in series, this means that, 
when current flows through the circuit (Figure 2.3), there will be a voltage drop across the electrode’s 
resistance. This means that (a) the cell will not be clamped at the voltage applied to the top of the patch 
electrode, and (b) synaptic currents will be recorded with an error of magnitude. The higher the series 
resistance or the larger the current, the larger the voltage drop. The exact voltage drop for a given series 
resistance and current flow can be calculated using Ohm’s law (V = IR). For example, for a series resistance 
of 10 MΩ and a current flow of 1 nA, the voltage drop would be 10 mV. It is therefore ideal to minimize the 
physical series resistance by using appropriately sized pipette tips and aiming for complete removal of the 
patch of cell membrane at the pipette tip when entering the whole-cell configuration (section 2.6.1). 
The combination of the series resistance with the capacitance of the cell or pipette also creates a 
filtering problem, where any voltage change introduced to the cell will be slowed and distorted. The time 
course of a change in the membrane potential (Vm) as a result of a step voltage command (Vs) is described 
by: 
  =                   2.10 
 In voltage-clamp mode, the series resistance that cannot be physically eliminated can be 
compensated for electronically. A positive feedback circuit is used to add to the command potential a voltage 
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that is proportional to the current flowing. This increases the pipette voltage when current flow and the voltage 
error is greatest, driving extra current through the electrode, which is exactly what would happen if the 
electrode had a lower resistance. In practice, because the positive feedback circuit can lead to oscillation and 
cell death, series resistance can only be compensated by 60-70%. In my experiments, the series resistance 
after compensation was 20-40 MΩ. 
2.7 Cell death experiments 
2.7.1 Oxygen-glucose deprivation 
Coronal forebrain slices were prepared from P21 Sprague-Dawley rats and incubated in aCSF in 
which glucose was replaced with 7 mM sucrose and oxygen was removed by equilibrating solutions with 5% 
CO2 and 95% N2.  Control slices were incubated in aCSF, gassed as usual with 95% O2/5% CO2.  After 60 
min, some slices were immediately fixed in 4% paraformaldehyde, while others were placed in control aCSF, 
to be exposed to glucose and oxygen again for a further 60 min. All solutions also contained 37 µM propidium 
iodide (PI) and FITC-conjugated 10 µg/ml isolectin B4 to label dead cells and blood vessels.  Slices were 
swiftly washed in aCSF prior to fixation and mounted as described in section 2.3.2. PI-positive dead IB4 
labelled cells were counted using ImageJ software. When assessing cell death, I was blind to the condition 
that each tissue slice had undergone (image identities were recoded using a custom-written macro). Cells in 
the 20 µm closest to the slice surface were excluded from analysis to prevent confounds from slicing-induced 
damage, as described in Chapter 6. Dead or alive pericytes were identified by their “bump on a log” 
morphology on vessels surrounded by isolectin B4 labelling.  
2.7.2 Middle cerebral artery occlusion (MCAO) 
The surgery for MCAO was carried out by my colleague Brad Sutherland. All procedures conformed 
to the Animal (Scientific Procedures) Act 1986 (UK), and were approved by the University of Oxford Animal 
Ethics Committee and the Home Office (UK). Male Wistar rats (Harlan, UK) weighing 253-312g, housed on a 
12h light/dark cycle with ad libitum access to food and water, underwent transient middle cerebral artery 
occlusion (MCAO). In brief, animals were anaesthetised with 4% isoflurane and maintained in 1.5-2% 
isoflurane carried in 70% N2O and 30% O2. A midline incision was made in the neck, the right external carotid 
artery was cauterised and cut, and the right common carotid and internal carotid arteries were temporarily 
ligated. Through a small arteriotomy in the external carotid artery stump, a 4-0 nylon filament coated with 
silicone at the tip was advanced up the internal carotid artery to occlude the right middle cerebral artery at its 
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origin. A diagram of the cerebral artery and filament position is included in Figure 2.2A, B. For sham animals, 
the entire procedure was followed except the filament was only advanced up the beginning of the internal 
carotid artery before being withdrawn (see Figure 2.2C). During the sham protocol, blood flow is reduced (as 
the common and internal carotid arteries are ligated) but there still blood entering the anterior cerebral artery 
through the circle of Willis. Following 90 minutes of MCAO, the filament was retracted, and the common 
carotid artery ligation was released to allow maximal reperfusion. Core temperature was maintained at 37°C 
by a rectal thermister probe attached to a heating pad. Cerebral blood flow changes and behavioural changes 
induced by the MCAO were monitored as described in Chapter 6. Animals (including an additional 3 naïve 
control animals) were then anaesthetised, decapitated, and 200 µm forebrain slices were prepared on a 
vibratome (as described in section 2.3.2) and labelled with PI and FITC-isolectin B4 in aCSF for 60 min, then 
washed, fixed, and mounted so that cortical and striatal images could be captured. Live and dead pericytes 
were counted in both regions as described in section 2.7.1 except that dead endothelial cells were also 
counted (identified by their elongated nuclei). The total number of endothelial cells present, and therefore the 
percentage of dead endothelial cells, was estimated from the total number of pericytes, assuming a 1:3 ratio 
of pericytes to endothelial cells (Pardridge, 1999). 
2. 8 Data analysis and statistics  
 Data are presented as mean ± s.e.m. Statistical significance was assessed with 2-tailed Student’s t-
tests samples when samples had a normal distribution. Normality of data was assessed using Kolmogorov–
Smirnov tests. When the distribution was not normal, non-parametric tests were used (Mann-Whitney U or 
Wilcoxon signed-rank test for independent and paired samples respectively). A correction procedure 
equivalent to the Holm-Bonferroni method was used when making multiple comparisons (for N comparisons in 
a given experiment, the most significant p value is multiplied by N, the 2
nd
 most significant by N-1, the 3
rd
 most 
significant by N-2, etc.; the resulting corrected p values are significant at the 5% level when p is less than 
0.05).  
 
 
 
 
 
 
 60 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Generation of NG2-DsRed BAC transgene. Diagram 1 shows the structure of the mouse NG2 
gene (not to scale). Exons are indicated as black blocks. The regions used for 5′ and 3′ homology arms are 
indicated. Diagram 2 shows the structure of the NG2-DsRedBAC-RecA shuttle vector that was used to modify 
the BAC DNA in order to insert the DsRed cDNA and polyadenylation sequence into the BAC clone that 
contained the NG2 gene in the centre. Diagram 3 shows the structure of the modified BAC DNA that was used 
for microinjection into fertilized oocytes (pA signal means polyadenylation signal; ATG, translation initiation 
codon of the NG2 gene; ts ori, temperature-sensitive origin of replication). From Zhu et al. (2008). 
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Figure 2.2: Liquid Junction potential. A potential difference (the junction potential) exists at the interface 
between two solutions with different compositions. When the patch electrode is placed in the bath a junction 
potential exists at the tip of the electrode because the ionic composition of the internal solution inside the 
electrode differs from the external solution in the bath. This junction potential does not exist in the whole-cell 
mode because the electrode solution diffuses into the cell. The junction potential present with the electrode in 
the extracellular solution depends on the diffusion coefficients of the anions and cations present in each 
solution (which depends on their molecular weight and charge, which affects the mobility of ions). For my 
solutions the principal ions responsible for generating the junction potential are K
+
, Na
+
, Cl
-
, and gluconate
-
, all 
of which are represented here. Bicarbonate ions (HCO3
-
) are not depicted due to their small contribution to the 
junction potential. Thicker arrows indicate more movement, due to more free diffusion of the ion. 
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Figure 2.3: Electrical circuit and current measurement in voltage clamp mode. A Electrical circuit model 
for spatially compact cells in whole-cell configuration. B The current response (top trace, I) of a whole-cell 
patch clamped cell to a voltage step (bottom trace, Vs) injected through the patch pipette. The series 
resistance (Rs) is calculated from the peak current recorded at the onset of the voltage pulse (I(t=0)), the 
membrane resistance is calculated from the steady state current, when the membrane is fully charged 
(I(t= )). The cell capacitance (Cm) can be calculated by measuring the decay constant of the current ( ). 
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Figure 2.4: A diagram of the cerebral arteries in rats. Labels denote the: anterior cerebral artery (ACA), 
middle cerebral artery (MCA), posterior cerebral artery (PCA), internal carotid artery (ICA), external carotid 
artery (ECA), common carotid artery (CCA). B Diagram of the MCAO protocol. The CCA and ICA are ligated 
and a filament is inserted into the ECA and advanced to block the MCA, thus there will be no blood flow to the 
brain regions supplied by the MCA during the procedure. C Diagram of the sham protocol. The CCA is ligated 
and a filament is inserted into the ECA, as in B, but not advanced to block the MCA. The blood flow to the 
brain will be reduced due to the CCA ligation and the filament occluding vessels. There will, however, be 
blood flow to the MCA through the circle of Willis. Images have been adapted from Zuo et al. (2012). 
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Table 2.1: Source and concentration of compounds used in this thesis 
Drug Supplier Concentration 
used (μM) 
Noradrenaline (NA) Sigma-Aldrich 2 
Glutamate (Glut) Sigma-Aldrich 500 
Tetrodotoxin (TTX) Alomone labs 1 
L-N
G
-Nitroarginine (L-NNA) Sigma-Aldrich 100 
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one (ODQ) Tocris Bioscience 10 
N-hydroxy-N′-(4-butyl-2-methylphenyl)-formamidine 
(HET0016) 
Cayman Chemical 1 
N-(methylsulfonyl)-2-(2-propynyloxy)-benzene-hexanamide 
(MS-PPOH) 
Cayman Chemical 20 
N-((4'-((3-butyl-1,5-dihydro-5-oxo-1-(2-
(trifluoromethyl)phenyl)-4H-1,2,4-triazol-4-yl)methyl)(1,1'-
biphenyl)-2-yl)sulfonyl)-3-methyl-2-thiophenecarboxamide 
(L161,982) 
Cayman Chemical 1 
D-(-)-2-amino-5-phosphonopentanoic acid (D-AP5) Tocris Bioscience 50 
7-Chlorokynurenic acid  (7-CK) Tocris Bioscience 100 
2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-
sulfonamide (NBQX) 
Tocris Bioscience 25 
(RS)-α-methyl-4-carboxyphenylglycine (MCPG) Sigma-Aldrich 500 
Ru360 Merck Chemicals 50 
Mn(III)tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP) Santa Cruz 150 
N-T-butyl-alpha-phenylnitrone (PBN) Sigma-Aldrich 100 
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Table 2. 2: Source and dilution of primary antibodies used in this thesis 
Primary Antibody Supplier Dilution 
Rabbit anti-NG2 Millipore 1:200 
Rabbit anti-PDGFRβ Santa Cruz 1:200 
Rabbit anti-vWF AbCam 1:200 
Rabbit anti-Iba1 Synaptic Systems 1:1000 
Rabbit anti-desmin Millipore 1:500 
Rabbit anti-αSMA AbCam 1:200 
 
Table 2. 3: Source and dilution of secondary antibodies used in this thesis 
Secondary Antibody Supplier Dilution 
Goat anti-rabbit 488 Molecular Probes 1:1000 
Goat anti-rabbit 546 Molecular Probes 1:1000 
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Chapter 3: Distinguishing pericytes from other perivascular cell classes 
3.1 Introduction  
Identification of pericytes is critical for studying their function. Pericytes can be identified visually using 
certain morphological traits, such as a more rounded nucleus than that of the endothelial cells making up the 
capillary wall. This trait is often described as a ‘bump on a log’ morphology (Kuwabara and Cogan, 1960). 
Identifying pericytes by their morphology and likely location is subjective and may, therefore, not be 
completely accurate. To aid identification of pericytes several markers are commonly used, including neural 
glial proteoglycan 2 (NG2) and platelet-derived growth factor receptor β (PDGFRβ; Armulik et al., 2011). 
Neither of these markers, nor any other known marker, are specific for pericytes. This may be because of the 
heterogeneity of their developmental origins or it may reflect developmental changes that these cells undergo 
(Sims et al., 2000; Allt and Lawrenson, 2001).  
As described in Chapter 1, pericytes are suggested to have several roles including contractility, 
angiogenesis, blood brain barrier maintenance and glial scar formation. It has also been suggested that 
pericytes are pluripotent and have the ability to differentiate into multiple cell types (Dore-Duffy, 2008). 
Although there may be subtypes of pericyte, poorly defined identification methods for pericytes may also lead 
to incorrect identification as pericytes of other, similarly poorly defined, perivascular cells, such as endothelial 
cells, mesenchymal stem cells and perivascular immune cells (Balabanov & Dore Duffy, 1998; Krueger & 
Bechmann, 2009).  
Amongst their many suggested roles, pericytes have been implicated in blood flow regulation at the 
capillary level (Peppiatt et al., 2006; also see Chapter 4). A role for pericytes in blood flow control is supported 
by evidence that they express numerous proteins necessary for generation and regulation of contractility, such 
as cGMP-dependent protein kinase, tropomyosin, smooth muscle isomyosin, desmin and α-smooth muscle 
actin (Joyce, 1984, 1985a, 1985b; Herman & D’Amore, 1985; Fujimoto & Singer, 1987). There has, however, 
been controversy over the heterogeneity of expression of several of these proteins, especially expression of 
α-smooth muscle actin (Skalli, 1986; Nehls and Drenkhahn, 1991; Toribatake et al., 1997) and desmin 
(Fujimoto & Singer, 1987). Some studies suggest that capillaries which branch directly from arterioles and 
venuoles contain contractile protein, whereas pericytes on ‘true’ capillaries, defined as those in the middle of 
the capillary bed, do not express contractile proteins (Nehls and Drenkhahn, 1991), although other studies find 
that α-smooth muscle actin is expressed in some of these ‘true’ capillary cells (Bandopadhyay et al., 2001). 
This distinction is further complicated by controversy over the definition of a capillary (see section 1.5.1). 
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Another suggested role of pericytes is that of a perivascular immune cell (Balabanov et al., 1995) or a 
cell with the ability to transform into a microglial cell (Barón and Gallego, 1972). Evidence put forward for an 
overlap in the population of pericytes and immune cells is the shared expression of pericyte markers and 
markers for immune cells (ED2: Esiri, 1986; Graeber et al., 1989; Balabanov et al., 1995; Thomas, et al., 
1999; Iba1: Yokoyama et al., 2006). It has, however, also been acknowledged that these perivascular immune 
cells may just be ‘pericyte-like’ (Kida et al., 1993; Thomas et al., 1999) and the apparent overlap in markers 
for these cells may be caused by the lack of an accurate marker for either cell type. 
In this chapter I will compare the pericyte populations defined by several commonly used pericyte 
markers, I will explore the expression of contractile proteins in NG2-labelled pericytes, and I will try to 
distinguish NG2-labelled pericytes from endothelial cells and perivascular immune cells. The approach used in 
this Chapter was labelling of brain slices with multiple fluorescent markers and antibodies.  
3.2 Methods 
3.2.1 Preparations 
 Experiments were performed on 200 μm sagittal slices of cerebellum and coronal slices of cortex from 
P12 or P21 Sprague-Dawley rats and P12-14 NG2-DsRed transgenic mice. Tissue preparation and solutions 
used are described in Chapter 2, section 2.3. Immunocytochemistry was carried out as listed in Chapter 2, 
section 2.4. 
3.2.2 Imaging 
 Slices were imaged with a confocal laser scanning microscope (LSM), either a Zeiss LSM 510, 700 or 
710. Images were obtained using a x40 oil immersion or x20 water immersion DIC objective. Images were 300 
microns by 300 microns. Z-stacks were acquired between 20 and 80 microns in depth. 
3.2.3 Analysis and statistics 
 Images were analysed in ImageJ using the cell counter plugin. Where possible, the total number of 
cells expressing each marker was quantified along with the overlap of expression between markers. Data are 
presented as mean ± s.e.m of counts from each image. 
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3.3 Results 
3.3.1 NG2 as a pericyte label 
 NG2 (previously called HMW-MAA (high molecular weight-melanoma associated antigen) and 
chrondroitin sulfate proteoglycan 4 (CSPG4)) is a surface proteoglycan, and is commonly used as a pericyte 
marker (Schlingemann et al., 1990; Ozerdem et al., 2001). I first confirmed that pericytes in both rats and mice 
expressed NG2.  
In rat cortex and cerebellum, I found that rabbit anti-NG2 antibody (Millipore) clearly labelled 
perivascular cells that had the classic ‘bump on a log’ appearance of pericytes (Kuwabara and Cogan, 1960). 
The antibody also outlined the shape of the vessels, which is to be expected, as pericyte processes cover 22 
to 37% of cortical capillaries in the rat (Frank et al., 1987; Mathiisen et al., 2010). Example images of pericytes 
labelled with NG2 antibody can be seen in Figure 3.1A. Because NG2 is a surface membrane proteoglycan, 
the antibody binds to the cell membrane and the resulting fluorescence outlines the pericyte cell bodies as 
well as the processes lining the vessels. 
In transgenic mouse cortex and cerebellum, where DsRed is expressed under the control of the NG2 
promoter (NG2-DsRed; for a description of the transgenic mouse see Chapter 2, section 2.2; Zhu et al., 2008), 
fluorescence is seen within perivascular cells that fit the description of pericytes as well as in processes lining 
the capillaries. In this case the fluorescence is seen within the cell, because the DsRed is a cytoplasmic 
protein produced under the control of the NG2 promoter. 
NG2 is also expressed in other cell types (see table 1) including OPCs (Nishiyama et al., 1991, 1996) 
but we can easily distinguish these cells from pericytes because of the distinct morphology of each cell type. 
OPCs tend to have a slightly larger cell body than pericytes (10-15 μm rather than ~10 μm) and they have 
multiple branched processes that are decorated with filopodia and lamellopodia. These processes have a 
different orientation depending on the brain region, projecting radially in the grey matter and longitudinally in 
the white matter (Levine et al., 2001). Figure 3.1C shows an example of a fluorescent OPC in NG2-DsRed 
tissue.  
These results confirm that expression of NG2 defines pericytes in the cortex and the cerebellum, in 
both rat and mouse. In this thesis, therefore, whenever possible I used NG2 as a pericyte marker. 
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3.3.2 The population of NG2 positive pericytes overlaps with PDGFRβ labelled cells 
 PDGFRβ is often used as a pericyte marker (Krueger and Bechmann, 2010). Data from labs that 
define pericytes by different markers are often compared. Because of this, I tested whether the population of 
pericytes that were labelled in NG2-DsRed mice showed overlap with pericytes labelled with an antibody 
against PDGFRβ (1:200 Santa Cruz).  
Using antibody labelling in transgenic mice expressing DsRed under the NG2 promoter, I found that 
NG2 positive pericytes, in both the cortex and cerebellum, also express PDGFRβ (Figure 3.2A and 3.2B 
respectively). I counted cells in 13 Z-stack images from 6 cortical and 7 cerebellar slices from 4 NG2-DsRed 
animals. I identified 144 NG2-DsRed and 148 PDGFRβ labelled perivascular cells in cortical slices and 274 
NG2-DsRed and 280 PDGFRβ labelled perivascular cells in the cerebellar slices. Pooling data from the 
cerebellum and the cortex, 95.0±2.2% of the cells identified by NG2 labelling also expressed PDGFRβ (Figure 
3.2C) while 96.4±0.9% of cells that are identified by PDGFRβ labelling also expressed NG2 (Figure 3.2D). 
These findings suggest that the vast majority of NG2 positive pericytes also express PDGFRβ. The 
expression of these markers, however, does not show complete overlap and neither marker labels all 
perivascular cells that fit the morphology of pericytes (an example of a cell labelled with NG2 but not PDGFRβ 
can be seen in Figure 3.2A (yellow arrow). It is, therefore, possible that the cells that express NG2 but not 
PDGFR  (or vice versa) are slightly different populations of pericytes with different functions to those that 
express both markers. 
3.3.3 The population of NG2 positive pericytes overlaps with isolectin-B4 labelled cells 
Isolectin-B4 is a known microglial marker (Streit et al., 1987), but it also labels galactosyl epitopes of 
the basement membrane (Peters and Goldstein, 1979). It is, therefore, possible that isolectin-B4 labelling 
reveals pericytes, which are encased by basement membrane. I investigated whether isolectin-B4 conjugated 
to fluorescein isothiocyanate (FITC) could be used to identify pericytes in the cortex and the cerebellum of rats 
and mice. 
In NG2-DsRed mice I found that incubation with isolectin-B4 (10 µg/ml) labelled capillaries in the 
cortex and the cerebellum and that, with this labelling, pericytes could easily be identified by their ‘bump on a 
log’ morphology (see Figure 3.3A and 3.3B respectively). The vast majority of cells identified in this way were 
also positive for NG2 (96.1±2.5% averaged over 5 z-stack images; 67/73 cells from 3 cortical and 2 cerebellar 
brain slices from 2 animals Figure 3.3C). Similarly in rat, isolectin-B4 labelling also allowed identification of 
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pericytes (see Figure 3.3D) with the great majority of pericytes identified using isolectin-B4 labelling also being 
labelled for NG2 (92.6±1.0% or 667/718 cells assessed in 13 z-stack images from 6 cortical slices and 7 
cerebellar slices from 2 animals; Figure 3.3E). All perivascular cells positive for NG2 in both species were 
encased in IB4 labelled basement membrane. 
These results suggest that isolectin-B4 conjugated to FITC, along with morphological assessment of 
cells, is sufficient for identifying the vast majority of pericytes (defined by NG2 labelling) in the cortex and the 
cerebellum of mice and rats. However, much like the finding with PDGFRβ, the overlap in labelling was not 
absolutely complete, perhaps reflecting the existence of a small population of cells with a different function. It 
would be of interest for further study to investigate whether the cells that are encased in basement membrane 
and have the morphology of pericytes but do not express NG2, would be labelled by an antibody for PDGFRβ.  
Using isolectin-B4 conjugated to a fluorescent protein is a favourable method for labelling pericytes, 
compared to using antibody to NG2 or PDGFR  as it is more time efficient than antibody labelling and it 
penetrates into tissue well. Although in most of this thesis identification of pericytes was carried out using 
antibody to NG2 or DsRed expression from the NG2 promoter, the method was used for the majority of 
experiments in Chapter 6. 
3.3.4 The population of NG2 positive pericytes shows heterogeneous expression of desmin and αSMA 
It is not only necessary to identify pericytes, but also to learn more about the proteins that they 
express in relation to their purported functions. One of the roles that pericytes are thought to play is in 
regulation in blood flow. As mentioned above, this role is supported by observations that pericytes can control 
capillary diameter (Peppiatt et al., 2006) as well as several studies showing pericytes express proteins 
necessary for contractility (Joyce 1984, 1985a, b; Herman & D’Amore, 1985; Fujimoto & Singer 1987). It has, 
however, been suggested that not all pericytes express contractile proteins (Skalli, 1986; Nehls and 
Drenkhahn, 1991; Balabanov and Dore-Duffy, 1998; Bandopadhyay et al., 2001). I investigated the proportion 
of NG2-DsRed labelled pericytes that may have contractile properties by labelling brain slices from these mice 
with antibodies for the contractile proteins α-smooth muscle actin (αSMA; 1:200 AbCam) and desmin (an 
intermediate filament found in contractile cells, 1:500 Millipore).  
In the cerebellum, some perivascular NG2 positive cells did express αSMA (Figure 3.4A), but 
expression was rarely seen on smaller vessels (demonstrated by yellow arrows in Figure 3.4A and 3.4B). 
There was little parenchymal αSMA labelling. Similarly, desmin expression was seen on vessels in both the 
cortex (3.5A) and the cerebellum (3.5B) but the labelling appeared stronger in larger vessels (Figure 3.5B). As 
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the desmin labelling did not cover the cell body of perivascular cells, it was not possible to quantify the overlap 
between desmin and NG2 positive cells. NG2 positive pericyte processes cannot be attributed to a particular 
cell body as processes from different pericyte somata appear to overlap on the vessel surface.  
The labelling of NG2-DsRed mice with antibodies to αSMA and desmin suggests that contractile 
proteins are present at the capillary level, however expression of these proteins was not seen in all pericytes 
defined by NG2 expression, and the expression of αSMA appears to be more common in larger vessels. 
These findings agree with previous studies that have suggested that only a small population of pericytes 
express contractile proteins in vivo (Nehls and Drenkhahn, 1991; Nehls 1992; Boado and Pardridge, 1994; 
Ozerdem et al., 2001). However, there are generic problems with this kind of analysis which may lead to false 
positive or false negative assessment of the presence of these proteins in pericyte processes. It is hard to 
resolve whether the αSMA and desmin labelling seen along and around vessels (where it needs to be to 
constrict the capillaries) is in pericyte processes or in endothelial cells, which may lead to endothelial cell 
expression being attributed to pericytes. Alternatively, if the expression of αSMA and desmin is low in 
pericytes, it may fall below the level needed for detection by immunocytochemistry. 
3.3.5 The population of NG2 positive pericytes does not overlap with vWF labelled cells 
The vascular wall of capillaries is composed of endothelial cells, forming the inner lining, along with 
pericytes (Rhodin, 1968). It is generally thought that pericytes can be distinguished from endothelial cells 
through morphology. However, since I was using NG2 as a pericyte marker, I was aware that it has been 
reported that NG2 also labels endothelial cells (Schrappe et al., 1991; Grako and Stallcup, 1995; Pouly et al., 
2001). It is therefore possible that the small population (<5%) of NG2 positive perivascular cells that do not 
label for PDGFRβ are endothelial cells. To investigate this, I used the NG2-DsRed mice and looked for the 
possible presence of NG2-DsRed labelled endothelial cells, by labelling brain slices from these mice with an 
antibody to the known endothelial cell marker, von Willebrand factor (vWF; 1:200 AbCam), a glycoprotein 
involved in clotting.  
Using antibody labelling in NG2-DsRed mice, I counted cells in 9 z-stack images from 4 cortical and 5 
cerebellar slices from 4 NG2-DsRed animals (counting 111 and 175 NG2-DsRed labelled perivascular cells, 
and 244 and 336 vWF positive cells, in the cortex and cerebellum respectively). I found that NG2 positive 
pericytes, in both the cortex and the cerebellum, did not express vWF (Figure 3.6A and 3.6B respectively). 
This implies that pericytes defined by perivascular location and NG2 expression differ from endothelial cells.  
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The ratio of pericytes to endothelial cells that I counted (1:2.2 and 1:1.9 in the cortex and the 
cerebellum respectively) did not fit the ratio that has previously been reported (1:3; Pardridge et al., 1999). 
This may be due to the reliance of my endothelial cell counts on DAPI (nuclear) labelling. Endothelial cells are 
flat cells lining blood vessels and it is, therefore, very difficult to distinguish neighbouring cells, unless their cell 
nuclei are labelled. When the DAPI labelling was weaker I may have underestimated the number of 
endothelial cells, thus giving an apparently increased ratio of pericytes to endothelial cells. On the other hand, 
previous estimates of the pericyte to endothelial cell ratio were made from isolated brain capillaries (Pardridge 
et al., 1999), so the difference in estimates may be due to pericyte damage or removal during isolation. 
This finding contradicts the previous reports that NG2 labels endothelial cells. It has been suggested 
that the previous claims were made due to a reliance on αSMA labelling of pericytes (Ozerdem et al., 2001). 
In those studies, perivascular cells that did not express αSMA were identified as endothelial cells. This 
classification method has been superseded by the belief that αSMA only labels a subset of pericytes (see 
section 3.3.4; Nehls & Drenckhahn, 1991; Verbeek et al., 1994; Bandopadhyay et al., 2001) 
3.3.6 NG2 positive pericytes do not express the immune cell marker Iba-1 
It has been speculated that some cells that are identified as pericytes are in fact perivascular immune 
cells (Graeber et al., 1989; Balabanov 1995; Thomas, 1999). As with the expression of contractile proteins, if 
NG2 positive pericytes label for a marker of immune cells, it may help us to learn more about the function of 
pericytes. Indeed, it has been suggested that these cells express macrophage-like activity (Thomas et al., 
1999; see Chapter 1 section 1.6.4). 
I used an antibody to Iba-1 (ionized calcium-binding adaptor molecule 1; 1:1000, Synaptic systems), 
which is an immune cell marker that labels both ramified and perivascular microglia as well as other monocytic 
cell lines (Ito et al., 1998), and has been found to label perivascular cells encased within the basement 
membrane (Bechmann et al., 2001). I investigated whether NG2 positive pericytes also express Iba-1. I 
counted cells in 15 Z-stack images from 7 cortical and 8 cerebellar slices from 5 NG2-DsRed animals, and 
found that none of 135 (cortex) and 212 (cerebellum) NG2-DsRed labelled perivascular cells co-labelled for 
Iba1 (although Iba1 labelled 110 cells in the cortical slices and 136 cells in the cerebellar slices; Figure 3.7A 
and 3.7B). 
These data strongly suggest that pericytes identified by NG2 are not immune cells. I can, therefore, 
be confident that the cells that I class as pericytes, defined by NG2 expression, are a population separate 
from perivascular immune cells.  
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3.4 Discussion 
 I have investigated the expression of several markers that have been suggested to label pericytes. 
The results indicate that, firstly, pericytes can be identified by labelling for NG2, PDGFRβ or isolectin-B4. 
Secondly, some pericytes appear to express the contractile proteins desmin and αSMA, however further work 
is needed to clarify what proportion of pericytes express these proteins. I also found that based on expression 
of markers, pericytes (defined by NG2 expression) can be distinguished from endothelial cells (defined by 
vWF expression) or perivascular immune cells (defined by Iba-1 expression).  
3.4.1 Pericytes can be identified by NG2, PDGFRβ or isolectin-B4 labelling 
 The absence of a specific marker to label pericytes has exacerbated the confusion surrounding the 
many possible roles of these cells. It is now widely accepted that both NG2 and PDGFRβ can be used to label 
pericytes (Armulik et al., 2011). However, there is some doubt about whether NG2 is consistently expressed 
throughout development (Miller et al., 1995). My labelling was performed on relatively young rats and mice, to 
match the ages of the animals used for functional studies elsewhere in the thesis. The importance of both 
NG2 and PDGFRβ expression in pericytes is supported by the absence of pericytes in animals where these 
proteins have been knocked out or knocked down (Daneman et al., 2010; Winkler et al., 2010; You et al., 
2013). The finding that the cell populations labelled by these two markers are not 100% identical leads to the 
possibility that a small percentage of the cells (<5%) in studies using each of these markers may have 
different properties. The vast majority of the cells are, however, labelled by both markers, suggesting that 
either can be used as reliable markers for pericytes. 
 The finding that isolectin-B4 conjugated to a fluorescent protein can be used to identify pericytes is 
very convenient. Unlike the production, or purchase, of a transgenic mouse or the procedures for antibody 
labelling, isolectin-B4 labelling is cost and time efficient.  
3.4.2 Not all pericytes express contractile proteins 
 The first role suggested for pericytes on their discovery was of a contractile nature (Rouget, 1874; 
Zimmermann, 1923). Supporting that, the first studies looking at protein expression in pericytes, using cultured 
cells, found that pericytes express contractile proteins, including αSMA (Herman and D’Amore, 1985). From 
later studies looking at pericytes in situ or in vivo, however, it appeared that contractile protein expression was 
not universal in this cell type, but that pericytes on larger vessels expressed contractile proteins whereas 
pericytes on ‘true’ capillaries, many branch points away from the arteriole, did not (Nehls and Drenckhahn, 
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1991; Boado and Pardridge, 1994). Nevertheless, studies looking at the function of pericytes have found that 
they are involved in controlling capillary diameter (Peppiatt et al., 2006; Fernández-Klett et al., 2013), so it is 
possible that contractile proteins are expressed even in small capillaries. The finding that capillaries were 
positive for labelling with both αSMA and desmin supports a contractile role for pericytes. However, my study 
is far from thorough enough to make any kind of estimate or assumption about the subtypes of pericytes that 
have this function, and ideally immunocytochemistry at the electron microscopic level would be required to 
determine with certainty which cell types express αSMA and desmin.  
3.4.3 The population of pericytes identified by NG2 is distinct from endothelial cells 
 The heterogeneous expression of contractile proteins may be responsible for the belief that NG2 is 
expressed by endothelial cells as well as pericytes. Early studies used αSMA as a pericyte marker, so that 
any αSMA negative perivascular cell was classed as an endothelial cell (Ozerdem et al., 2001). I found there 
was no expression of NG2 on vWF positive endothelial cells. This finding allows me to continue using NG2 as 
a pericyte marker without worrying about a contamination from endothelial cells within the population of cells 
that I am studying. 
3.4.4 The population of pericytes identified by NG2 is distinct from perivascular immune cells 
It has been suggested that pericytes are perivascular immune cells (Balabanov et al., 1995), or that 
they are confused with a ‘pericyte-like’ perivascular immune cell (Kida et al., 1993; Thomas et al., 1999). I 
found that there was no overlap between the expression of NG2 and Iba-1 in perivascular cells. This finding 
implies that the pericytes identified with NG2 labelling are not immune cells. 
3.4.5 Conclusion 
Overall, my data suggest that there are several potential pericyte markers, but that investigators must 
be aware that the population of pericytes that they identify with a specific marker may not include absolutely 
all pericytes that are identified by other pericyte markers, although the percentage not identified by any 
particular marker is small (<5%).  
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Figure 3. 1: Labelling of NG2 positive cells. A Cortical slices from rat labelled with an antibody to NG2 (red) 
B, C Cortical slices from NG2-DsRed transgenic mice showing NG2 positive pericytes (B) and 
oligodendrocyte precursor cells (OPCs; C).  
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Figure 3. 2: PDGFRβ labelling in NG2-DsRed mice. Cortical (A) and cerebellar (B) slices from NG2-DsRed 
transgenic mice labelled with PDGFRβ (green). Pericytes that are labelled for NG2 (red) and PDGFRβ are 
indicated by white arrows. Yellow arrows indicate perivascular cells that are labelled for NG2 but not PDGFRβ 
C Plot of the percentage of pericytes defined by PDGFRβ labelling which were also NG2 positive.  D Plot of 
the percentage of pericytes defined by NG2 labelling which were also PDGFRβ positive. 
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Figure 3. 3: Isolectin-B4 as a pericyte marker. Cortical (A) and cerebellar (B) slices from NG2-DsRed 
transgenic mice labelled with isolectin B4-FITC conjugate (IB4; green). Pericytes that express NG2 (red) and 
IB4 are indicated by white arrows. Yellow arrows indicate perivascular cells that are labelled with IB4 but not 
NG2. C Plot of the percentage of pericytes in mouse (pooled from cerebellum and cortex) defined by IB4 
labelling which were also NG2-DsRed positive. D Cerebellar slice from rat labelled with IB4 (green) and a 
rabbit anti-NG2 antibody (red). A pericyte labelled with both markers is indicated by white arrow. E Plot of the 
percentage of pericytes in rat (pooled from cerebellum and cortex) defined by IB4 labelling which were also 
NG2 positive. 
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Figure 3. 4: αSMA labelling in DsRed NG2 mice. A Cerebellar slices from NG2-DsRed transgenic mice 
labelled with an antibody to αSMA. Pericytes labelled for αSMA (green) and NG2-DsRed (red) are indicated 
by white arrows. Pericytes labelled with NG2 but not αSMA are indicated by yellow arrows. B Cerebellar slice 
from NG2-DsRed transgenic mice labelled with an antibody to αSMA showing a vessel with no αSMA 
labelling. Pericytes labelled for NG2 but not αSMA are indicated by yellow arrows. 
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Figure 3. 5: Desmin labelling in DsRed NG2 mice. Cortical (A) and Cerebellar (B) slices from NG2-DsRed 
transgenic mice labelled with an antibody to desmin (green). Pericytes labelled for NG2 (red) are indicated by 
white arrows. 
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Figure 3. 6: vWF labelling in DsRed NG2 mice. Cortical (A) and cerebellar (B) slices from NG2-DsRed 
transgenic mice labelled with an antibody to vWF (green). Pericytes that express NG2 (red) are indicated by 
white arrows. 
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Figure 3. 7: Iba-1 labelling in DsRed NG2 mice. Cortical (A) and cerebellar (B) slices from NG2-DsRed 
transgenic mice labelled for Iba-1 (green). Pericytes, labelled with DsRed (red), are indicated by the white 
arrows. Immune cells, labelled for Iba-1 (green), are indicated by the yellow arrows.  
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Chapter 4: Signalling pathways underlying pericyte dilation of CNS capillaries in 
response to glutamate  
4.1 Introduction 
As reviewed in Chapter 1, cerebral blood flow is normally thought to be regulated at the arteriole level, 
but may also be regulated by pericytes, at the capillary level. For arterioles, synaptically released glutamate 
regulates blood flow by sending messengers to influence the smooth muscle around the arterioles. In 
neurons, particularly interneurons (see Chapter 1 section 1.2.1), glutamate acts on N-methyl-D-aspartate 
receptors (NMDARs) to raise [Ca
2+
]i, causing neuronal nitric oxide synthase (nNOS) to produce NO, which 
evokes smooth muscle relaxation and vessel dilation (Faraci and Breese, 1993). Glutamate can also raise 
[Ca
2+
]i in astrocytes by activating metabotropic glutamate receptors (mGluRs; Porter and McCarthy, 1996), 
which leads to arteriole dilation (Zonta et al., 2003; Takano et al., 2006; Gordon et al., 2008). The dilation 
evoked by increases in astrocytic calcium is thought to occur through increased production of arachidonic acid 
and its vasoactive metabolites, which include the vasodilatory prostaglandins (Niwa et al., 2000) and EETs 
(Peng et al., 2002), as well as the vasoconstrictor 20-HETE (Harder et al., 1994). A rise of [Ca
2+
]i in astrocyte 
endfeet may also activate Ca
2+
-gated K
+
 channels (BK(Ca)), releasing K
+
, which also dilates vessels (Filosa et 
al., 2006). (See Chapter 1 section 1.2.2 for a more thorough description of these pathways). It is unknown 
whether these same pathways mediate signaling from neurons to pericytes. 
Control of blood flow at the level of capillaries has been little studied, although these vessels do have 
spatially separated contractile cells called pericytes at intervals along their length. Contractility has been 
observed in cultured retinal pericytes (Kelley et al., 1987, 1988; Das et al., 1988), pericytes in whole retinal 
mounts (Schonfelder et al., 1998) and in cerebellar slices (Peppiatt et al., 2006). There has also been some 
evidence of pericyte contractility in vivo (Fernández-Klett et al., 2010). See Chapter 1.6.5 for a full description 
of current knowledge of pericyte contractility. 
Here, I examine pharmacologically the pathways by which glutamate dilates capillaries imaged in 
cerebellar slices. The approach used was to preconstrict vessels with noradrenaline (mimicking its release 
from the locus coeruleus in vivo, as well as tone generated by blood flow and pressure in vivo) and then to 
apply glutamate (mimicking neuronal activity) to dilate vessels, while applying blockers of mediators thought to 
be involved in the signalling pathways. As a framework for assessing the data, Figure 4.1 shows the signaling 
pathways that control arteriole dilation (from Figure 1.1) transposed to the pericyte situation. 
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4.2 Methods 
4.2.1 Preparations 
Experiments were performed on 200μm sagittal slices of cerebellum from P12 rats. Solutions and 
tissue preparation are described in Chapter 2, sections 2.1.1 and 2.3.1. 
4.2.2 Imaging 
Capillaries, lacking the continuous smooth muscle seen around arterioles and <10μm in diameter, in 
the molecular layer of the cerebellum, were visualised using a CCD video microscopy system, and images 
were captured with Metafluor software (Molecular Devices). Superfusion with each drug (or combination of 
drugs) was maintained for approximately 5 minutes (except when prolonged incubation was needed for drugs 
to act). For drugs manipulating signalling pathways, before testing the effect of the drug on responses to 
noradrenaline and glutamate, each drug was applied to the preparation on its own in order to establish the 
effect of the drug on the baseline capillary diameter (except in the case of MS-PPOH which required 30 
minutes incubation so a pre-drug baseline diameter was not measured). Noradrenaline was then applied and 
the noradrenaline-evoked constriction in the drug was measured. Glutamate was then added in the presence 
of the noradrenaline in order to establish the dilation it produced after preconstriction with noradrenaline.  
4.2.3 Analysis and statistics 
 Images were analysed in Metamorph software (Molecular Devices) and Image-Pro software 
(MediaCybernetics). The inner diameter of the capillary lumen was measured at 5-10 second intervals, 
wherever possible at locations where pericyte somata were visible. For statistical analysis of the effects of 
drugs on capillary diameter, the diameter measurement for each drug was taken from the last 1-5 recorded 
images in that drug. The diameter or diameter change in each condition was measured as shown in Figure 
4.2A. Capillary diameter in the absence of any agents is represented by the letter A. The vessel diameter in 
noradrenaline is represented by the letter B. The change in vessel diameter on glutamate application is 
represented by the letter C. For analysis, these values are expressed as a percentage of the diameter A. 
Thus, on application of noradrenaline the constriction is measured as the diameter in noradrenaline as a 
percentage of the diameter in the absence of any agents, B/A. On application of glutamate the dilation is 
measured as the change in diameter as a percentage of the diameter in the absence of any agents, C/A (see 
Figure 4.2A).  
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Data are presented as mean ± s.e.m. Results in each condition are compared to results in interleaved 
controls. Statistical methods are given in Chapter 2, section 2.8. All statistical analysis was conducted using 
IBM SPSS21 statistics software or Microsoft Excel.  
4.3 Results 
4.3.1 Influence of oxygen concentration on vessel diameter 
The oxygen concentration in the tissue is of concern in in vitro studies. Most brain slice work is carried 
out at high oxygen concentrations, using solution gassed with 95-100% oxygen, leading to concentrations of 
~150-400μM O2 at varying depths in the tissue, whereas using a lower oxygen concentration in the solution 
(20% oxygen) leads to concentrations of 2-130μM in the tissue (Hall et al., 2012). Thus data obtained at 20% 
are more comparable to the physiological range of O2 in vivo, 20-60 μM (Dings et al., 1998), and tissue 
superfused with 95-100% O2 has supra-physiological O2 levels. It has been found that this difference of 
oxygen concentration can change arteriole responses, for example dilation is seen in response to uncaging 
calcium in astrocytes at 20% O2 while constriction is seen at 95% O2 (Gordon et al., 2008).  
This change in capillary response at different oxygen concentrations may in part be due to an effect 
on the enzymes that produce the regulators of vascular tone. Oxygen is required for the synthesis of nitric 
oxide and of arachidonic acid derivatives, but the O2 -dependence of the relevant synthesis reactions varies 
between the different reactions (see Figure 4.1, which shows Km values for messenger synthesis in the order 
NO>20-HETE>PGs=EETs). This suggests that the relationship between the different signaling pathways will 
be altered as the oxygen concentration is changed. At in vivo oxygen levels, NO and 20-HETE synthesis 
would be expected to be significantly limited by oxygen availability. For this reason I carried out experiments 
at both 20% and 95% O2 to explore whether the responses at physiological and supra-physiological oxygen 
concentrations differ.  
The baseline vessel diameter was slightly but significantly lower in the vessels that were held (for at 
least an hour) and studied in 95% O2 conditions than those held and studied in 20% O2 conditions (p=1x10
-3
 
by independent samples t-test; Figure 4.2B). Nevertheless the baseline diameter of capillaries was not altered 
significantly in the short term (10 minutes) when the superfusion solution was changed from solution bubbled 
with 95% O2 to solution bubbled with 20% O2 (104.2±2.3% of initial diameter at 95% O2; p=0.08), perhaps 
because it takes time for vessel diameter to adapt to the change of O2 level. 
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In the remainder of this chapter, experimental results are presented for most manipulations at both 
20% and 95% O2. 
4.3.2 Capillary constriction by noradrenaline 
It has previously been shown that noradrenaline constricts capillaries in rat cerebellar slices (Peppiatt 
et al., 2006). As the first step in this study, I tested whether I could reproduce this result in solution containing 
either 20% or 95% O2 solution, and also investigated whether this response was maintained over the 
experimental time period I would use later for experiments investigating the effects of glutamate and signalling 
pathway blockers.  
I observed that 2 μM noradrenaline significantly constricted capillaries at spatially restricted locations 
of cerebellar capillaries in solution containing 95% oxygen (bright field images and a specimen time course 
are shown in Figure 4.3A and B). In the 7 capillaries studied the diameter was reduced to 51.8±11.2% of the 
diameter in the absence of drugs after 5 minutes of exposure (p=0.01 compared to no response) and there 
was no significant difference in the capillary diameter after 5 and 10 minutes of noradrenaline superfusion 
(p=0.94; Figure 4.3C). Thus, noradrenaline constricts cerebellar capillaries and this constriction is sustained 
over 10 minutes. This provides sufficient time to superimpose glutamate (in the presence or absence of 
signalling pathway blockers) on top of the noradrenaline and investigate the response in the presence of a 
constant vessel tone.  
A specimen response to noradrenaline at 20% O2 is shown in Figure 4.3D. This response appears 
less dramatic than that seen at 95% O2 in Figure 4.3B, and in fact the 13 capillaries studied at 20% O2 with 
long durations of noradrenaline application (Figure 4.3F) showed a larger constriction than the 7 capillaries 
studied at 95% O2 (Figure 4.3F). Nevertheless when all 59 capillaries studied at 20% O2 (i.e. mainly capillaries 
studied with only 5 minute applications of noradrenaline) were compared with all 155 capillaries at 95% O2  
then the constriction produced after 5 minutes noradrenaline superfusion was not significantly different (in 
noradrenaline the diameter was 79.4±3.6% and 81.1±1.9% of the diameter in the absence of drugs 
respectively; Figure 4.3E).  
In the sample of 13 capillaries measured for 10 minutes superfusion with noradrenaline at 20% O2, the 
noradrenaline-evoked constriction did not reach significance when p values were corrected for multiple 
comparisons (p=0.06 and 0.28 after 5 minutes and 10 minutes superfusion of noradrenaline; Figure 4.3F), 
however there was no significant decrease of the constriction on extending the superfusion to 10 mins 
(p=0.56; Figure 4.3F).   
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4.3.3 Capillary dilation by glutamate application  
Glutamate has been shown to dilate capillaries in cerebellar slices (Peppiatt et al., 2006). Having 
established that noradrenaline can be used as a means of constricting capillaries over the experimental time 
period I was interested in, I next replicated the glutamate-evoked dilation of preconstricted capillaries, as a 
prelude to assessing the signalling systems mediating these dilations. Bright field images of an example 
capillary before drug application, in 2 μM noradrenaline, as well as with 500 μM glutamate superimposed are 
shown in Figure 4.4A.  Specimen time courses for the diameter changes of capillaries during application of 
noradrenaline followed by glutamate are shown for both 20% and 95% oxygen in Figure 4.4B and 4.4C 
respectively. The diameter decreased on application of 2 μM noradrenaline (as in earlier Figures), but 
increased on application of 500 μM glutamate (in the maintained presence of the noradrenaline).  
The glutamate-evoked dilation (as a percentage of the diameter in the absence of drugs) in both O2 
conditions is shown in Figure 4.4D. On application of 500 μM glutamate a dilation of 18.2±3.2% and 
10.2±1.6% occurred at 20% and 95% oxygen, respectively, both of which were significant dilations   
(p=3.7x10
-7 
and p=3.2x10
-9 
respectively). The glutamate-evoked dilation was significantly larger at 20% O2 
when compared to the dilation at 95% O2 (p=0.01). This difference in dilation size at the two oxygen 
concentrations may be due to a difference in the production of vasoactive mediators at the different O2 levels, 
as the synthesis of each mediator has a different dependence on O2. For example, since 20-HETE synthesis 
requires a higher concentration of O2, one would expect the influence of the 20-HETE pathway to be less 
significant at 20% O2 (see Figure 4.1), allowing glutamate to evoke a larger dilation. 
4.3.4 The effect of TTX on capillary diameter and responses to noradrenaline and glutamate 
When noradrenaline or glutamate are applied to brain slices there may be changes of action potential 
firing that contribute to the capillary responses by releasing vasoactive agents. I therefore examined the effect 
of blocking action potentials (and downstream neurotransmitter release) on the baseline capillary diameter, 
the noradrenaline-evoked capillary constriction and the glutamate-evoked capillary dilation.  
When slices were superfused with the sodium channel blocker, TTX (1 μM), at 95% O2 there was no 
significant change in the capillary diameter (100.1±2.5% of the diameter in the absence of drugs; p=0.99; 
Figure 4.5B). Capillaries exposed to TTX still showed a significant noradrenaline-evoked constriction (to 
65.3±9.3% of the diameter in the absence of drugs; p=2x10
-3
; Figure 4.5A, C), which was not significantly 
different to that seen in the absence of TTX (p=0.1).  
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Capillaries exposed to TTX showed a significant glutamate-evoked dilation (dilating by 30.6±10.9% of 
the diameter in the absence of drugs; p=0.05; Figure 4.5A, D). The glutamate-evoked dilation in the presence 
of TTX showed a trend towards being larger than in the absence of TTX (p=0.09). This could reflect the 
capillaries chosen for these recent experiments being healthier than some of those studied early in my PhD 
and included in the global average of data in the absence of TTX. These results, showing that the glutamate-
evoked dilation in TTX is not smaller than that in the absence of TTX, argue against the idea that the dilation 
evoked by glutamate is partly mediated by glutamate evoking action potentials.  
4.3.5 The effect of NOS inhibition on capillary diameter and responses to noradrenaline and glutamate 
Arteriole dilation is often mediated by glutamate activating neuronal production of nitric oxide (Figure 
4.1 and see section 1.2.1). To examine the effect of nitric oxide production on capillary diameter, on 
noradrenaline-evoked capillary constriction and on glutamate-evoked capillary dilation, capillaries were treated 
with the general nitric oxide synthase inhibitor, L-N
G
-nitroarginine (L-NNA; 100 μM). The IC50 for L-NNA 
inhibiting cerebellar NO production evoked by NMDA application has been found to be <600 nM (East & 
Garthwaite, 1990; Arima et al., 1997). 
Application of 100 μM L-NNA significantly decreased the capillary diameter at 20% O2 (to 94.9±2.2% 
of the diameter in the absence of drugs; p=0.03; Figure 4.6A, B) and at 95% O2 (to 86.6±3.3% of the diameter 
in the absence of drugs; p=4x10
-4
; Figure 4.6B). Thus, there is tonic production of vasodilating NO in the slice. 
The constricting effect of L-NNA on the capillaries was not significantly different between 20% and 95% O2 
(p=0.1; Figure 4.6B).  
Capillaries exposed to L-NNA showed a further significant noradrenaline-evoked constriction at 20% 
O2, to 80.7±4.9% of the diameter in the absence of drugs (p=4x10
-3
; Figure 4.6A, C). Similarly at 95% O2, 
noradrenaline constricted capillaries to 84.4±5.9% of the diameter in the absence of drugs (p=0.01; Figure 
4.6C). The noradrenaline-evoked constriction was not significantly different in the absence or presence of L-
NNA (p=0.94 and p=0.82, at 20% and 95% O2 respectively).  
However, unlike in the absence of L-NNA, capillaries exposed to L-NNA did not show a significant 
glutamate-evoked dilation at 20% O2. The capillaries dilated by only 5.0±2.9% of the diameter in the absence 
of drugs (p=0.22; Figure 4.6A, D). Similarly at 95% O2, capillaries actually constricted by 2.0±4.5% of the 
diameter in the absence of drugs (p=0.66; Figure 4.6D). These responses to glutamate in the presence of L-
NNA were significantly different to the glutamate responses in control capillaries at 20% and 95% O2 (p=0.02 
and p=0.04 respectively).  
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Thus, inhibition of nitric oxide synthase with L-NNA slightly decreases the diameter of cerebellar 
capillaries and greatly inhibits the glutamate-evoked dilation. However L-NNA does not alter the 
noradrenaline-evoked constriction in capillaries. 
4.3.6 The effect of ODQ on capillary diameter and responses to noradrenaline and glutamate 
To examine whether nitric oxide mediates its effects on the glutamate-evoked dilation via cGMP 
production, slices were treated with ODQ (1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one; 10 μM). ODQ is a 
selective guanylyl cyclase inhibitor with an IC50 of approximately 20 nM (Garthwaite et al., 1995). At the 
concentration used ODQ has a rapid onset time, inhibiting approximately 90% of the guanylyl cyclase activity 
after a five second incubation (Bellamy and Garthwaite, 2002). ODQ application did not have a significant 
effect on the baseline capillary diameter at 20% or 95% O2 (100.0±3.9% and 101.0±3.1% of the diameter in 
the absence of the drug respectively; p=0.96 and p=0.74; Figure 4.7B). 
Capillaries exposed to 10 μM ODQ showed a significant noradrenaline-evoked constriction in both 
20% and 95% O2, to 74.3±5.4% and 69.4±6.4% of the diameter in the absence of drug respectively (p=1.4x10
-
4
 and p=1.1x10
-4
; Figure 4.7A, C). The noradrenaline-evoked constriction was not significantly different in the 
absence or presence of ODQ at 20% O2 (p=0.31) but was significantly increased in the presence of ODQ at 
95% O2 (p=0.04). 
Capillaries exposed to ODQ showed a significant glutamate-evoked dilation at 20% O2 (dilating by 
13.0±4.7% of the diameter in the absence of drugs; p=0.02; Figure 4.7A, D) but the glutamate-evoked dilation 
did not quite reach significance at 95% O2 (dilating by 10.9±6.2% of the diameter in the absence of drugs; 
p=0.09; Figure 4.7D).   The glutamate-evoked dilations seen at both 20% and 95% O2 were, however, not 
significantly different in the absence or presence of ODQ (p=0.55 and 0.56 respectively). This suggests that 
the glutamate-evoked dilation is still present when cGMP production is inhibited, and thus, that NO may be 
involved in the glutamate-evoked dilation via a signalling pathway separate from that mediated by ODQ-
sensitive guanylyl cyclase. 
4.3.7 The effect of blocking 20-HETE production on how NOS block affects responses to noradrenaline 
and glutamate 
As shown above, blocking NOS inhibits the glutamate-evoked dilation, but not by raising the level of 
cyclic GMP. However as mentioned in Chapter 1, nitric oxide may also mediate glutamate-evoked dilation by 
inhibiting 20-HETE production. The vasoconstricting arachidonic acid derivative 20-hydroxy-5,8,11,14-
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eicosatetraenoic acid (20-HETE) is thought to be produced from astrocyte arachidonic acid when neurons are 
active (Figure 4.1). To examine the effect of 20-HETE production on how NOS block affects noradrenaline-
evoked capillary constriction and glutamate-evoked capillary dilation, capillaries were treated with the 
cytochrome P-450 enzyme inhibitor, N-hydroxy-N′-(4-butyl-2-methylphenyl)-formamidine (HET0016; 1 μM) in 
combination with L-NNA (100 μM). HET0016 selectively inhibits the cytochrome P450 ω-hydroxylase 
enzymes, CYP4A and CYP4F, that produce 20-HETE, with an IC50 of 8.9±2.7 nM (Miyata et al., 2001). In the 
presence of both HET0016 and L-NNA the capillary diameter was not significantly altered at 20% or 95% O2 
(107.3±3.1% and 93.1±3.6% of the diameter in the absence of drugs respectively; both p=0.09; Figure 4.8B). 
HET0016 application significantly reduced the constricting effect of L-NNA at 20% O2 (p=4x10
-3
; Figure 4.8A, 
B) but this effect of HET0016 was not significant at 95% O2 (p=0.38; Figure 4.8B).  
Capillaries exposed to 1 μM HET0016 and 100 μM L-NNA showed a significant noradrenaline-evoked 
constriction at 95% O2 (to 66.1±8.8% of the diameter in the absence of drug; p=0.01; Figure 4.8A, C) but the 
constriction was not quite significant at 20% O2 (82.6±8.6% of the diameter in the absence of drugs; p=0.06; 
Figure 4.8C). The level of noradrenaline-evoked constriction in the presence of 100 μM L-NNA was, however, 
not significantly different in the absence and presence of 1 μM HET0016 at either oxygen level (p=0.84 and 
p=0.12 at 20% and 95% O2, respectively).  
In the presence of HET0016 and L-NNA, capillaries showed a significant glutamate-evoked dilation at 
20% O2 (dilating by 15.8±3.3% of the diameter in the absence of drugs; p=1x10
-3
; Figure 4.8A, D) and a trend 
towards a dilation at 95% O2 (dilating by 24.0±8.8% of the diameter in the absence of drugs; p=0.06; Figure 
4.8D). The glutamate-evoked dilation in the presence of HET0016 and L-NNA was significantly larger than the 
response to glutamate in L-NNA alone at both 20% and 95% O2 (both p=0.02), and indeed was not 
significantly different from the normal glutamate-evoked dilation seen in Figure 4.4D in the absence of L-NNA 
(p=0.79 and p=0.18 at 20% and 95% O2 respectively).  
These results indicate that inhibition of nitric oxide synthesis with L-NNA no longer decreases vessel 
diameter or glutamate-evoked dilation in cerebellar capillaries in the presence of HET0016, i.e. with 20-HETE 
synthesis inhibited. This suggests, firstly, that the tonic dilation produced by the level of NO release occurring 
in the slice is mainly mediated by a reduction of 20-HETE synthesis and, secondly, that suppression of 20-
HETE formation by NO is necessary for glutamate to evoke a significant dilation. The existence of a 
glutamate-evoked dilation in the presence of blockers of production of NO and 20-HETE suggests that the 
dilation is not primarily produced by NO (although NO needs to be present to suppress 20-HETE formation).  
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4.3.8 The effect of blocking 20-HETE production alone on capillary diameter and responses to 
noradrenaline and glutamate 
Since I saw an effect of HET0016 in the presence of L-NNA, I wanted to check whether it had an 
effect on capillary responses without L-NNA present. HET0016 application had no significant effect on the 
baseline capillary diameter at either 20% or 95% O2 (99.6±1.6% and 97.5±3.6% of the diameter in the 
absence of drugs respectively; p=0.79 and 0.49; Figure 4.9A, B). This suggests that there is no resting 20-
HETE production. 
Capillaries exposed to 1 μM HET0016 showed a significant noradrenaline-evoked constriction at 20% 
O2 (to 82±6.5% of the diameter in the absence of drugs; p=0.04; Figure 4.9A, C), but the constriction did not 
reach significance at 95% O2 (constriction to 87.8±7.1% of the diameter in the absence of drugs; p=0.11; 
Figure 4.9C). The noradrenaline-evoked constriction was, however, not significantly different in the absence 
and presence of HET0016 at either 20% or 95% O2 (p=0.93 and p=0.74 respectively), suggesting that this 
constriction is not mediated by noradrenaline acting on its receptors on astrocytes to increase 20-HETE 
production as has been suggested (Mulligan and MacVicar, 2004). 
Capillaries exposed to HET0016 showed a significant glutamate-evoked dilation both at 20% O2 
(dilating by 14.6±4.7% of the diameter in the absence of drugs; p=0.02; Figure 4.9A, D) and at 95% O2 
(dilating by 18.9±8.2% of the diameter in the absence of drugs; p=0.04; Figure 4.9D). The glutamate-evoked 
dilation was not significantly different in the absence or presence of HET0016 at 20% or 95% O2 (p=0.79 and 
p=0.18).  
Thus, in the absence of L-NNA, inhibition of 20-HETE production with HET0016 does not have an 
effect on the capillary diameter, nor on the noradrenaline-evoked capillary constriction or the glutamate-
evoked capillary dilation. The lack of effect on the glutamate-evoked dilation implies that NO release evoked 
by glutamate is normally sufficient to block 20-HETE production. 
 
4.3.9 The effect of the EET synthesis blocker MS-PPOH on responses to noradrenaline and glutamate 
To test for an effect of EET production on noradrenaline-evoked capillary constriction and glutamate-
evoked capillary dilation, slices were treated with the cytochrome P-450 enzyme inhibitor, MS-PPOH (N-
(methylsulfonyl)-2-(2-propynyloxy)-benzene-hexanamide; 20 μM). MS-PPOH selectively inhibits the 
cytochrome P450 epoxygenase enzymes, CYP4A2 and CYP4A3, that synthesise EETs, with an IC50 of 13 μM 
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in renal microsomes (Wang et al., 1998). MS-PPOH requires 30 minutes incubation to act, so it was not 
possible to measure the capillary diameter in the absence of MS-PPOH in the same vessels. 
Capillaries exposed to 20 μM MS-PPOH showed a significant noradrenaline-evoked constriction at 
20% O2 (to 77.2±5.5% of the diameter in the absence of drugs; p=2x10
-3
; Figure 4.10A, B), and 95% O2 
(53.6±5.8% of the diameter in the absence of drugs; p=2.6 x 10
-6
; Figure 4.10B). The noradrenaline-evoked 
constriction was not significantly different in the absence or presence of MS-PPOH, both at 20% or 95% O2 
(p=0.84 and p=0.94 respectively). 
In the presence of MS-PPOH capillaries showed a significant glutamate-evoked dilation both at 20% 
O2 (dilating by 15.3±3.3% of the diameter in the absence of drugs; p=7.2x10
-4
; Figure 4.10A, C) and at 95% 
O2 (dilating by 30.8±6.8% of the diameter in the absence of drugs; p=7.6x10
-4
; Figure 4.10C). The glutamate-
evoked dilation was not significantly different in the absence or presence of MS-PPOH at 20% or 95% O2 
(p=0.32 and p=0.66 respectively).  
These results show that inhibition of EET synthesis with MS-PPOH does not have an effect on the 
noradrenaline-evoked constriction or the glutamate-evoked dilation in cerebellar capillaries. 
4.3.10 The effect of the EP4 receptor blocker L161,982 on capillary diameter and responses to 
noradrenaline and glutamate 
To examine the role of PGE2 action in controlling baseline capillary diameter, noradrenaline-evoked 
capillary constriction and glutamate-evoked capillary dilation, slices were treated with the EP4 receptor 
blocker, L161,982 (N-[[4'-[[3-butyl-1,5-dihydro-5-oxo-1-[2-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-4-
yl]methyl][1,1'-biphenyl]-2-yl]sulfonyl]-3-methyl-2-thiophenecarboxamide; 1 μM). L161,982 is 200-fold more 
selective for EP4 than for the EP1-3 subtypes, with a Ki of 32nM (Machwate et al., 2001). L161,982 application 
had no significant effect on the baseline capillary diameter at 20% O2 (98.0±5.0% of the diameter in the 
absence of drugs; p=0.7; Figure 4.11A, B) or at 95% O2 (100.2±3.9% of the diameter in the absence of drugs; 
p=0.96; Figure 4.11B). Thus, there is no tonic activation of EP4 receptors in cerebellar slices. 
Capillaries exposed to 1 μM L161,982 showed a significant noradrenaline-evoked constriction at 20% 
O2 (to 73.6±7.1% of the diameter in the absence of drugs; p=7x10
-3
; Figure 4.11A, C), and 95% O2 (to 
57.5±5.2% of the diameter in the absence of drugs; p=1.8x10
-8
; Figure 4.11C). The noradrenaline-evoked 
constriction was not significantly different in the absence or presence of L161,982 at either 20% or 95% O2 
(p=0.87 and p=0.62 respectively). 
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Despite the lack of effect of EP4 receptor block on the capillary diameter and on the noradrenaline-
evoked constriction, capillaries exposed to L161,982 showed greatly reduced responses to glutamate. 
Capillaries did not show a significant glutamate-evoked dilation at 20% O2 (dilating by 2.9±6.3% of the 
diameter in the absence of drugs; p=0.65; Figure 4.11 A, D). There was a significant dilation at 95% O2 
(dilating by 10.5±4.4% of the diameter in the absence of drugs; p=0.04; Figure 4.11D), but this was only 
37.9% of the dilation seen in the absence of L161,982. The response to glutamate was significantly reduced in 
the presence of L161,982, compared to the response in the absence of drugs, at both 20% and 95% O2 
(p=0.05 and p=0.01 respectively; Figure 4.11A, D).  
These results indicate that EP4 receptor activation contributes to the glutamate-evoked dilation in 
cerebellar capillaries (but not to the noradrenaline-evoked constriction). Although I have not identified the 
molecule activating the EP4 receptor, studies on arterioles suggest it is likely to be prostaglandin E2 (Davis et 
al., 2004). 
4.4 Discussion 
 I have investigated the mechanisms by which glutamate dilates capillaries in the cerebellar slice 
preparation, by evoking constriction and dilation with noradrenaline and glutamate respectively, and then 
blocking action potentials (with TTX), nitric oxide synthase (with L-N
G
-nitroarginine), guanylyl cyclase (with 
ODQ) CYP enzymes that make 20-HETE (with HET0016) and EETs (with MS-PPOH), and inhibiting EP4 
receptors (with L161,982). The results from this study indicate that, firstly, glutamate-mediated dilation does 
not involve glutamate evoking action potentials (although normally it will be action potentials that evoke the 
glutamate release that causes dilation). Secondly, nitric oxide release is necessary for glutamate-evoked 
capillary dilation to occur. Thirdly, the mechanism by which nitric oxide exerts this effect does not involve 
guanylyl cyclase activation but, instead, involves an inhibition of 20-HETE production. Fourthly, EET 
production does not appear to be involved in glutamate-evoked capillary dilation. Finally, activation of EP4 
receptors is needed for glutamate-evoked capillary dilation. 
4.4.1 Glutamate-evoked capillary dilation requires nitric oxide to inhibit 20-HETE production 
My data suggest a similarity in the mechanisms of dilation at the capillary and arteriole level. Several 
studies have found an involvement of nitric oxide in glutamate-evoked dilation at the arteriole level in vivo 
(Dirnagl et al., 1993; Akgören et al., 1996; Lindauer et al., 1999). These studies showed a decrease in 
stimulation-evoked blood flow increase when nitric oxide synthase was inhibited (using L-N-nitroarginine or 7-
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nitroindazole). Liu et al (2008) suggested that, in response to stimulation in vivo, nitric oxide may be exerting 
its effect through 20-HETE inhibition, as I find. They found that, although a nitric oxide synthase inhibitor 
abolished stimulation-evoked dilations, application of HET0016, to inhibit 20-HETE production, restored the 
stimulation-evoked blood flow responses (Liu et al., 2008). Several studies have, however, unlike my work, 
found support for nitric oxide exerting its dilatory effects through cGMP production, which activates protein 
kinase G. Sobey and Faraci (1997) found that blocking cGMP production with ODQ inhibited nitric oxide-
mediated dilation in cortical pial arterioles by 82%. A further mechanism of nitric oxide-mediated dilation has 
been suggested by Bolotina et al. (1994). They suggest that nitric oxide may directly activate K
+
 channels, 
however it is possible that 20-HETE may be involved in this mechanism (Sun et al., 2000; Yu et al., 2002). 
The role of nitric oxide in neurovascular coupling at the arteriole level has been found to be different in 
different brain regions. In the cerebellum, nitric oxide has been reported to act as a direct mediator of 
neuronally evoked blood flow responses (Akgören et al., 1996) whereas in the cerebral cortex, although it is 
necessary for nitric oxide to be present in order for neural activity to induce dilation, changes in the level of 
nitric oxide are not the primary mediator of vasodilation since the tonic presence of nitric oxide is sufficient to 
allow activity to evoke a dilation (Lindauer et al., 1999). Although my study was on the vasculature of the 
cerebellum it was carried out at the capillary level rather than the arterioles (as studied by Akgören et al., 
1996). I found that nitric oxide was not directly responsible for the glutamate-evoked dilation of cerebellar 
capillaries but that its presence was required to inhibit a constriction generated by the release of 20-HETE. 
This suggests that there may be different mechanisms of glutamate-evoked dilation at arterioles and 
capillaries within the cerebellum. 
4.4.2 Glutamate-evoked capillary dilation requires EP4 receptor activation, presumably by 
prostaglandin E2 
Prostaglandin E2 has been found to be involved in neurovascular coupling at the level of arterioles. 
Application of prostaglandin E2 causes dilation of cerebral arterioles in slices and in vivo (Zonta et al., 2003; 
Takano et al., 2006), and in brain slices the COX inhibitor aspirin reduces the number of responses seen to t-
ACPD application and to electrical stimulation of either astrocytes or neuronal afferents (Zonta et al., 2003). 
Furthermore, in vivo non-specific COX inhibition, as well as inhibition of COX-1 and COX-2 separately, blocks 
functional hyperaemia (Niwa et al., 2000; Takano et al., 2006). 
Unlike in my study, there is evidence that EETs are involved in glutamate-evoked dilation at the 
arteriole level, at least outside the cerebellum. Inhibition of cytochrome P-450 epoxygenase activity, using 
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either miconazole or MS-PPOH, attenuated the cortical flow response to subdural glutamate or NMDA 
superfusion (Alkayed et al., 1997; Bhardwaj et al., 2000) as well as whisker stimulation (Peng et al., 2002), 
and reduced dilations evoked by light in retinal arterioles (Metea and Newman, 2007). This suggests that 
there may be differences in the mechanisms of glutamate-evoked dilation either between arterioles and 
capillaries, or for cortex and retina versus cerebellum.  
4.4.3 Methodological issues 
 Brain slice preparations offer the advantage of being able to control the composition of the fluid 
around capillaries better than in vivo studies, which allows better pharmacological studies, but there are 
several potential problems with studying neurovascular coupling in the slice preparation. These include the 
lack of blood flow and pressure in the preparation, which will alter the tone of the capillary. This may affect the 
timing of onset of capillary responses: indeed vessel responses are faster in in vivo studies (Zonta et al., 
2003; Takano et al., 2006). 
 In this study I have attempted to overcome the problem of loss of tone by preconstricting capillaries 
with noradrenaline. Pharmacological preconstriction is commonly used in slice studies (often using the 
thromboxane analog U46619). It is not clear, however, whether preconstriction will alter the signalling 
pathways that I am interested in. It is sometimes assumed that noradrenaline causes constriction by 
increasing astrocytic [Ca
2+
]i, by acting on α1 receptors (Duffy and MacVicar, 1995; Bekar et al., 2008), perhaps 
causing capillary constriction via the 20-HETE mediated pathway described in Chapter 1 and Figure 4.1. It is 
also possible that noradrenaline acts directly on pericytes as they express α2 receptors (Elfont et al., 1989). 
Activation of α2 receptors decreases cAMP production which ultimately increases phosphorylation of the 
myosin light chain, leading to contraction (Webb, 2003; see Chapter 1 section 1.4). 
 Another point to note for my study is the young age of the animals used (P12). There are many 
neurological changes during development that may affect neurovascular coupling (for more detail see Chapter 
7). Developmental changes include a down-regulation of the metabotropic glutamate receptors, mGluR5, on 
astrocytes (Sun et al., 2013). One may, therefore, speculate that astrocyte-mediated signalling would become 
less significant in adulthood, as mGluR5 expression in astrocytes decreases. This means that the data 
presented in this study cannot be used to make assumptions about the signalling pathways involved in 
capillary-level neurovascular coupling at later stages of development.  
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4.4.4 Conclusion 
 My data suggest that pericytes are involved in neurovascular coupling at the capillary level and that 
the signalling pathways involved are broadly similar to those found at the arteriole level, but with some 
differences. I have identified the messenger that dilates cerebellar capillaries in response to glutamate as 
prostaglandin E2 (or a related species active at EP4 receptors), but also found that this dilation requires NO 
release to suppress 20-HETE formation. This finding suggests that blood flow control occurs not only at the 
level of larger cerebral vessels but also involves capillaries.  
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Figure 4.1: Hypothesised mechanisms by which glutamate regulates cerebral blood flow at the 
capillary level. Major pathways from astrocytes and neurons (left) that may regulate blood flow by sending 
messengers (arrows) to influence pericytes on the capillaries that supply oxygen and glucose to the tissue 
(right, shown as the capillary lumen surrounded by endothelial cells and pericyte soma). This diagram is 
based on pathways known to regulate arteriole tone (Attwell et al., 2010) as shown in figure 1.1. In neurons, 
synaptically-released glutamate acts on N-methyl-D-aspartate receptors (NMDAR) to raise [Ca
2+
]i.  In some 
neurons (mainly interneurons) this causes neuronal nitric oxide synthase (nNOS) to release NO, which 
activates smooth muscle guanylate cyclase. This generates cGMP to dilate vessels. Glutamate raises [Ca
2+
]i 
in astrocytes by activating metabotropic glutamate receptors (mGluR; but see Sun et al., 2013), generating 
arachidonic acid and thus three types of metabolite: prostaglandins (by COX-1 and possibly COX-3, and 
COX-2 in pathological situations) and EETs (by P450 epoxygenase) in astrocytes, which dilate vessels, and 
20-HETE (by P450 ω-hydroxylase) in the pericyte, which constricts vessels. (There is also some 
prostaglandin production in neurons: not shown). A rise of [Ca
2+
]i in astrocyte endfeet may also activate Ca
2+
-
gated K
+
 channels (BK(Ca)), releasing K
+
, which also dilates vessels. The concentration of O2 in the 
extracellular space is 20–60μM. This is significantly higher than the effective Km for O2 activating the enzymes 
synthesizing EETs and prostaglandins, but is in a range in which changes in O2 concentration may modulate 
the production of NO and 20-HETE. 
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Figure 4.2: Methodology. A Schematic displaying how capillary responses to noradrenaline and glutamate 
were measured. Diameter in the absence of drugs is represented by A. Diameter in noradrenaline is 
represented by B. Change in diameter on glutamate application is represented by C. B Mean (±s.e.m) 
capillary diameter in the absence of drugs at 20% and 95% O2. P value above the bars assesses the 
significance of the difference between the diameters in 20% and 95% O2 using an independent samples t-test.  
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Figure 4.3: Localised constriction of capillary in cerebellar molecular layer by noradrenaline. A Image 
of a capillary in the molecular layer before and during 2 μM noradrenaline superfusion (in solution containing 
95% O2). Red blood cells can be seen within the lumen of the capillary. In the presence of noradrenaline the 
capillary constricts at a spatially localised point near a pericyte soma (indicated by yellow arrows). B Plot of 
diameter of the capillary in A at the region constricted by a pericyte during 2 μM noradrenaline superfusion. 
Arrows indicate points at which the capillary diameter was measured for statistical analysis: the first arrow 
indicates the diameter in the absence of drugs, the second arrow indicates the diameter in 2 μM noradrenaline 
after 5 minutes exposure, and the third arrow indicates the diameter in noradrenaline after 10 minutes 
exposure. C Mean (±s.e.m) capillary diameter after 5 and 10 minutes superfusion of 2 μM noradrenaline, as a 
percentage of the diameter in the absence of drugs, at 95% O2. P values on the bars assess the significance 
of the noradrenaline-evoked constriction compared to 100% using a one-sample t-test. P value above the bars 
assesses the significance of the difference between the noradrenaline-evoked constriction at the two time 
points using an independent samples t-test. D Plot of capillary diameter at a region constricted by a pericyte 
during application of 2 μM noradrenaline in solution containing 20% O2. Arrows indicate points at which the 
diameter was measured for statistical analysis: the first arrow indicates the diameter in the absence of drugs, 
the second arrow indicates the diameter in 2 μM noradrenaline after 5 minutes exposure, and the third arrow 
indicates the diameter in noradrenaline after 10 minutes exposure. E Mean (±s.e.m) capillary diameter 
following 5 minutes of exposure to 2 μM noradrenaline as a percentage of the diameter in the absence of 
drugs, in solution containing 20% and 95% O2.  P values on the bars assess the significance of the 
noradrenaline-evoked constriction compared to 100% by one-sample t-test. P value above the bars assesses 
the significance of the difference in the noradrenaline-evoked constriction between 20% and 95% O2 using an 
independent samples t-test. F Mean (±s.e.m) capillary diameter after 5 and 10 minutes superfusion of 2 μM 
noradrenaline, as a percentage of the diameter in the absence of drugs, in solution containing 20% O2. P 
values on the bars assess the significance of the noradrenaline-evoked constriction compared to 100%, using 
a one-sample t-test. P value above the bars assesses the significance of the difference between the 
noradrenaline-evoked constriction at the different time points using an independent samples t-test.  
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Figure 4.4: Capillaries preconstricted with noradrenaline dilate on application of glutamate.  A Image of 
a capillary in the molecular layer before drug application, during 2 μM noradrenaline application, and during 2 
μM noradrenaline and 500 μM glutamate application (in solution containing 95% O2). Red blood cells can be 
seen within the lumen of the capillary. In the presence of noradrenaline the capillary constricts at a spatially 
localised point in the capillary near a pericyte (visible to the right of the capillary). In the presence of glutamate 
the capillary dilates. B Plot of diameter of the capillary in A at the region constricted by a pericyte. C Plot of 
capillary diameter at a region constricted by a pericyte in solution containing 20% O2. D Mean (±s.e.m) 
increase of capillary diameter evoked by 500 μM glutamate in solution containing 20% and 95% O2 at regions 
constricted by pericytes when noradrenaline was applied (as a percentage of the diameter in the absence of 
drugs). P values on the bars assess the significance of the glutamate-evoked dilation (compared to no 
response) using the Wilcoxon signed-rank test at 20% O2 and a one-sample t-test at 95% O2. P value above 
bars assesses the significance of the difference in response between the two oxygen levels using a Mann-
Whitney U-test.  
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Figure 4.5: Effect of TTX on capillary diameter and responses to noradrenaline and glutamate. A Plot of 
the capillary diameter (at a region constricted by a pericyte when noradrenaline was applied), in solution 
containing 95% O2. B Mean (±s.e.m) capillary diameter in 1 μM TTX (as a percentage of the diameter in the 
absence of drugs) at a region constricted by a pericyte when noradrenaline was applied, in solution containing 
95% O2. P value assesses the significance of the TTX-evoked diameter change compared to 100% using a 
one-sample t-test. C Mean (±s.e.m) capillary diameter in 2 μM noradrenaline (as a percentage of the diameter 
in the absence of drugs) in the absence (control) and in the presence of 1 μM TTX. P values on bars assess 
the significance of the constriction compared to 100% using a one-sample t-test. P value above bars assesses 
the significance of the difference between the noradrenaline-evoked constriction in the absence and presence 
of TTX using an independent samples t-test. D Mean (±s.e.m) increase in diameter (as a percentage of the 
diameter in the absence of drugs) in 500 μM glutamate, in the absence and presence of 1 μM TTX. P values 
on bars assess the significance of the diameter increase (compared to no response) using a one-sample t-
test. P value above the bars assesses the significance of the difference between the glutamate-evoked 
dilation in the absence and presence of TTX using an independent samples t-test. All data in this figure were 
obtained in solution containing 95% O2. 
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Figure 4.6: Effect of the NOS blocker L-NG-nitroarginine on capillary diameter and responses to 
noradrenaline and glutamate. A Plot of capillary diameter (at a region constricted by a pericyte when 
noradrenaline was applied) in solution containing 20% O2. B Mean (±s.e.m) capillary diameter (as a 
percentage of the diameter in the absence of drugs) in 100 μM L-N
G
-nitroarginine in solution containing 20% 
and 95% O2. P values on bars assess the significance of any diameter change evoked by L-N
G
-nitroarginine 
compared to 100% using one-sample t-tests. P value above the bars assesses the significance of the L-N
G
-
nitroarginine-evoked diameter change between 20% and 95% O2 using an independent samples t-test. C 
Mean (±s.e.m) capillary diameter (as a percentage of the diameter in the absence of drugs) in 2 μM 
noradrenaline in the absence and presence of 100 μM L-N
G
-nitroarginine. P values on the bars assess the 
significance of the noradrenaline-evoked constriction compared to 100% using one-sample t-tests. P value 
above the bars assesses the significance of the difference between noradrenaline-evoked constriction in the 
presence and absence of L-N
G
-nitroarginine using independent samples t-tests. D Mean (±s.e.m) capillary 
dilation (as a percentage of the diameter in the absence of drugs) evoked by 500 μM glutamate in the 
absence and presence of 100 μM L-N
G
-nitroarginine. P values on the bars assess the significance of the 
glutamate-evoked dilation (compared to no response) using a one-sample t-test. P values above the bars 
assess the significance of the difference between the glutamate-evoked dilation in the presence and absence 
of L-N
G
-nitroarginine using independent samples t-tests. 
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Figure 4.7: Effect of the guanylate cyclase blocker ODQ on cerebellar capillary diameter and on the 
response to noradrenaline and glutamate. A Plot of the capillary diameter (at a region constricted by a 
pericyte when noradrenaline was applied) in solution containing 20% O2. B Mean (±s.e.m) capillary diameter 
(as a percentage of the diameter in the absence of drugs) in the absence and presence of 10 μM ODQ, in 
solution containing 20% and 95% O2. P values on the bars assess the significance of ODQ-evoked diameter 
changes compared to 100% using one-sample t-tests. P value above bars assesses the significance of the 
difference between O2 conditions using an independent samples t-test. C Mean (±s.e.m) capillary diameter 
(as a percentage of the diameter in the absence of drugs) in 2 μM noradrenaline in the absence and presence 
of 10 μM ODQ, at 20% and 95% O2. P values on the bars assess the significance of the noradrenaline-evoked 
constriction compared to 100% using a one-sample t-test. P values above bars assess the significance of the 
difference between noradrenaline-evoked constriction in the presence and absence of ODQ using 
independent samples t-tests. D Mean (±s.e.m) capillary dilation (as a percentage of the diameter in the 
absence of drugs) evoked by 500 μM glutamate, in the absence and presence of 10 μM ODQ, at 20% and 
95% O2. P values on the bars assess the significance of the glutamate-evoked dilations (compared to no 
response) using a one-sample t-test. P values above the bars assess the significance of the difference 
between the glutamate-evoked dilation in the absence and presence of ODQ using independent samples t-
tests. 
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Figure 4.8: In the presence of HET0016, L-NG-nitroarginine does not alter cerebellar capillary diameter 
or the response to glutamate. A Plot of the capillary diameter (at a region constricted by a pericyte when 
noradrenaline was applied) in solution containing 20% O2. B Mean (±s.e.m) capillary diameter (as a 
percentage of diameter in the absence of drugs) in 100 μM L-N
G
-nitroarginine with or without 1 μM HET0016, 
in solution containing 20% and 95% O2. P values on bars assess the significance of L-N
G
-nitroarginine and 
HET0016-evoked changes in diameter compared to 100% using a one-sample t-test. P values above the bars 
assess the significance of the difference between oxygen conditions using an independent samples t-test. C 
Mean (±s.e.m) capillary diameter (as a percentage of the diameter in the absence of drugs) in 2 μM 
noradrenaline, in 100 μM L-N
G
-nitroarginine with or without 1 μM HET0016, at 20% and 95% O2. P values on 
the bars assess the significance of the noradrenaline-evoked constriction compared to 100% using a one-
sample t-test. P values above the bars assess the significance of the difference between noradrenaline-
evoked constriction in L-N
G
-nitroarginine in the absence or presence of HET0016 using independent samples 
t-tests. D Mean (±s.e.m) capillary dilation (as a percentage of the diameter in the absence of drugs) evoked by 
500 μM glutamate in the presence of 100 μM L-N
G
-nitroarginine, in the absence or presence of HET0016, at 
20% and 95% O2. P values on the bars assess the significance of the glutamate-evoked dilation (compared to 
no response) using a one-sample t-test. P values above the bars assess the significance of the difference 
between the glutamate-evoked dilation in the absence and presence of HET0016 using independent samples 
t-tests. 
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Figure 4.9: Effect of HET0016 alone on capillary diameter and on the response to noradrenaline and 
glutamate. A Plot of the capillary diameter (at a region constricted by a pericyte when noradrenaline was 
applied) in solution containing 20% O2. B Mean (±s.e.m) capillary diameter (as a percentage of the diameter 
in the absence of drugs) in the absence and presence of 1 μM HET0016. P values on the bars assess the 
significance of any change of diameter evoked by HET0016 compared to 100% using one-sample t-tests. P 
value above the bars assesses difference between the diameters in solution containing 20% and 95% O2 
using an independent samples t-test. C Mean (±s.e.m) capillary diameter in 2 μM noradrenaline (as a 
percentage of the diameter in the absence of drugs) in the absence and presence of 1 μM HET0016 in 
solution containing 20% and 95% O2. P values on the bars assess the significance of the noradrenaline-
evoked constriction compared to 100% using one-sample t-tests. P values above the bars assess the 
significance of the difference between the noradrenaline-evoked constriction in the absence and presence of 
HET0016 using independent samples t-tests. D Mean (±s.e.m) capillary dilation (as a percentage of the 
diameter in the absence of drugs) evoked by 500 μM glutamate in the absence and presence of 1 μM 
HET0016 at 20% and 95% O2. P values on the bars assess the significance of the dilations (compared to no 
response) using one-sample t-tests. P values above the bars assess the significance of the difference 
between the glutamate responses in the absence and presence of HET0016 using independent samples t-
tests. 
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Figure 4.10: Effect of the EET synthesis inhibitor MS-PPOH on capillary diameter and responses to 
noradrenaline and glutamate. A Plot of the capillary diameter (at a region constricted by a pericyte when 
noradrenaline was applied) in solution containing 20% O2. B Mean (±s.e.m) capillary diameter in 2 μM 
noradrenaline (as a percentage of the diameter in the absence of drugs) in the absence and presence of 20 
μM MS-PPOH, in solution containing 20% and 95% O2. P values on the bars assess the significance of the 
noradrenaline-evoked constriction compared to 100% using one-sample t-tests. P values above the bars 
assess the significance of the difference between the noradrenaline-evoked constriction in the absence and 
presence of MS-PPOH using independent samples t-tests. C Mean (±s.e.m) capillary dilation (as a 
percentage of the diameter in the absence of drugs) evoked by 500 μM glutamate in the absence or presence 
of 20 μM MS-PPOH, at 20% and 95% O2. P values on the bars assess the significance of the glutamate-
evoked dilations (compared to no response) using one-sample t-tests. P values above the bars assess the 
significance of the difference between the glutamate-evoked dilations in the absence and presence of MS-
PPOH, using independent samples t-tests.  
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Figure 4.11: Effect of the EP4R blocker, L161,982 on capillary diameter and responses to 
noradrenaline and glutamate. A Plot of the capillary diameter (at a region constricted by a pericyte when 
noradrenaline was applied) in solution containing 20% O2. B Mean (±s.e.m) capillary diameter (as a 
percentage of the diameter in the absence of drugs) in the absence and presence of 1 μM L161,982. P values 
on the bars assess the significance of any change of diameter evoked by L161,982 compared to 100%, using 
one-sample t-tests. P value above the bars assesses difference between the diameters, in solution containing 
20% and 95% O2, using an independent samples t-test. C Mean (±s.e.m) capillary diameter in 2 μM 
noradrenaline (as a percentage of the diameter in the absence of drugs) in the absence and presence of 1 μM 
L161,982, in solution containing 20% and 95% O2. P values on the bars assess the significance of the 
noradrenaline-evoked constriction compared to 100% using one-sample t-tests. P values above the bars 
assess the significance of the difference between the noradrenaline-evoked constriction in the absence and 
presence of L161,982 using independent samples t-tests. D Mean (±s.e.m) capillary dilation (as a percentage 
of the diameter in the absence of drugs) evoked by 500 μM glutamate in the absence and presence of 10 μM 
L161,982, at 20% and 95% O2. P values on the bars assess the significance of the glutamate-evoked dilations 
(compared to no response) using a one-sample t-test. P values above the bars assess the significance of the 
difference between the glutamate-evoked dilations in the absence and presence of L161,982, using 
independent samples t-tests. 
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Figure 4.12: Diagram showing mechanisms by which glutamate regulates cerebral blood flow at the 
capillary level. This diagram updates Figure 4.1 according to the data obtained. Active neurons release 
glutamate, which acts on both NMDA receptors on neurons and mGluRs on astrocytes. As a result [Ca
2+
]i 
rises in both cell types, releasing NO and derivatives of arachidonic acid. The production of the 
vasoconstricting arachidonic acid metabolite 20-HETE is suppressed by NO. The vasodilatory arachidonic 
acid metabolite prostaglandin E2 acts on EP4 receptors producing capillary dilation. 
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Chapter 5: Electrical responses of cerebellar and cortical pericytes 
5.1 Introduction 
 It is likely that a crucial mechanism underlying the constrictions and dilations of pericytes (seen in 
Chapter 4) lies in the plasma membrane of these cells, where a change in membrane voltage may trigger 
voltage-gated calcium channels to alter the intracellular calcium concentration and thus alter the contraction of 
the pericyte myofilaments.  
Retinal pericytes express several types of voltage-sensitive potassium channels, including inward-
rectifying (Kir) channels (von Beckerath et al., 2000; Cao et al., 2006), voltage-gated potassium channels (von 
Beckerath et al., 2000) and big and small conductance calcium-activated potassium channels (BKCa and SKCa; 
Wiederholt et al., 1995; Quignard et al., 2003) as well as, voltage-insensitive ATP-sensitive potassium 
channels (KATP; Li and Puro, 2001). Activation of these potassium channels causes hyperpolarization, 
decreasing calcium influx through voltage-gated calcium channels, and producing dilation. Several agonists 
have been found to cause hyperpolarization and relaxation of pericytes, including nitric oxide (Haefliger et al., 
1994; Sakagami et al., 2001) and adrenomedullin (Takata et al., 2009). The capillary dilation evoked by 
glutamate application (Peppiatt et al., 2006; Chapter 4) may therefore be triggered by a pericyte 
hyperpolarization.  
Pericyte constrictions, on the other hand, appear to be evoked by rises of intracellular calcium 
concentrations (Sakagami et al., 1999, 2001; Kamouchi et al., 2004; Sugiyama et al., 2005; Peppiatt et al., 
2006). Calcium entry may occur through voltage-gated calcium channels (VGCC; Sakagami et al., 1999; 
Kamouchi et al., 2004), nonspecific cation channels (Sakagami et al., 1999), and calcium activated chloride 
channels (ClCa, which cause depolarization in these cells due to a high intracellular chloride concentration; 
Kawamura et al., 2002). Activation of any of these channels causes depolarization and calcium concentration 
increase, leading to pericyte contraction. Pericytes express α-adrenergic receptors (Elfont et al., 1989), and 
noradrenaline has been found to produce membrane depolarization and contraction of pericytes (Helbig et al., 
1992; Peppiatt et al., 2006). 
In this chapter, I use NG2-DsRed mice to begin to investigate the electrical properties of cerebellar 
and cortical pericytes, using the patch-clamp technique to record the currents that underlie the response of 
pericytes to the vasoconstrictor, noradrenaline, and the vasodilator, glutamate. 
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5.2 Methods 
5.2.1 Preparations 
 Experiments were performed on 200 μm coronal forebrain and sagittal cerebellar slices
 
from P10-P15 
NG2-DsRed C57BL/6J mice. Solutions and tissue preparation are described in Chapter 2, sections 2.1.1, 
2.3.1 and 2.3.2. 
 5.2.2 Patch-clamp recordings 
Pericytes were identified as DsRed-expressing cells located on capillaries. Pericytes were whole-cell 
clamped between -40 and -75 mV with pipettes containing solution as described in Chapter 2 section 2.1.3. 
Pipettes were pulled from thick-walled borosilicate glass to a resistance of 7-9 MΩ (with a tip of approximately 
1 μm). Electrode junction potentials were compensated. Patch-clamped cells were morphologically confirmed 
to be pericytes by dye filling and checking that the intracellular dye was in the same cell as the DsRed. The 
series resistance was 21.9 ± 3.8 MΩ. In 11 cells, the mean resting potential was -58.5 ± 8.9 mV, and the 
mean input resistance at the resting potential was 132.0 ± 20.3 MΩ.  
5.3 Results 
5.3.1 Electrical properties of pericytes 
I used the fluorescent labelling of pericytes in NG2-DsRed mice to target pericytes for patch-clamping 
and then dye-filled the patched cells with alexa488. Figure 5.1 shows images of a pericyte before patch-
clamping, in bright-field during patch-clamping and when dye-filled during patch-clamping (white arrow). The 
patch pipette is attached to the cell body of the pericyte, obscuring the view in Figure 5.1C. Several processes 
can be seen lining the vessel (which itself can clearly be seen in the bright-field image; Figure 5.1B). Pericytes 
have small cell bodies (approximately 10 μm in diameter) and are enclosed by a thick layer of collagenous 
basement membrane making it very difficult to make whole-cell patch clamp recordings with a good access 
resistance. For the cell pictured in Figure 5.1, Rm and Cm were 223 MΩ and 29 pF respectively. The resting 
membrane potential was measured (when the current was 0) as -30 mV, a value comparable with the range of 
values recorded from cultured retinal pericytes (between -20 and -50 mV; Helbig et al., 1992). Current 
responses typical of patch-clamped pericytes in response to a series of voltage steps are shown in Figure 
5.2A. The average current responses for 11 cells are shown in Figure 5.2B. No time-dependent currents were 
observed. The steady-state current-voltage responses are approximately ohmic, varying linearly with voltage. 
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5.3.2  The effect of glutamate receptor activation on pericyte membrane current 
Glutamate application produces a capillary dilation, which is attributed to pericyte relaxation (Chapter 
4 and see Peppiatt et al., 2006). This might be produced by a hyperpolarization of pericytes. To investigate 
whether this is the case, I measured pericyte currents in response to bath application of 500 μM glutamate 
and, the glutamate receptor agonist, NMDA (100 μM). 
I found that glutamate application produced a small initial inward current in some pericytes. The 
average current observed was -12.6 ± 10.5 pA, however only two out of eleven cells showed any measurable 
inward current. This response was followed by a larger, and more consistent, outward current of 34.2 ± 12.3 
pA (with measurable responses seen in 7 out of 11 cells; Figure 5.3A and 5.3B). On a second application of 
glutamate, the inward current was negligible (-5.5 ± 5.5 pA with only 1 out of 5 cells showing a measurable 
response) but the outward current was reproduced (30.2 ± 16.0 pA with 3 out of 5 cells showing a measurable 
response; Figure 5.3B). Similarly, application of NMDA produced an outward current of 28.6 ± 21.7pA with no 
preceding inward current (2 out of 4 cells showed measurable responses; Figure 5.3A and 5.3C). In the case 
of one cell there were membrane current oscillations that were abolished on glutamate application (Figure 
5.3D). 
The finding that glutamate receptor activation leads to an outward current in pericytes provides a 
possible mechanism underlying glutamate-evoked capillary dilations (Chapter 4; Peppiatt et al., 2006). The 
hyperpolarization produced by an outward current would be expected to cause a decrease in calcium ion 
influx and thus relaxation (Webb, 2003). The fact that only a proportion of the pericytes that I patch-clamped 
showed measurable current responses to glutamate receptor activation supports the finding that not all 
pericytes dilate capillaries in response to glutamate application (Peppiatt et al., 2006) 
Membrane current oscillations have been observed in vasa recta pericytes (Zhang et al., 2008). 
Anecdotally, I patch-clamped one cortical pericyte that appeared to have similar oscillations in membrane 
current. These oscillations were inhibited by glutamate application (Figure 5.3D). 
 
5.3.3  The effect of noradrenaline on pericyte membrane current 
 Noradrenaline causes constriction of arterioles and pericytes (Raichle et al., 1975; Peppiatt et al., 
2006), and it has been shown to depolarize cultured retinal pericytes (Helbig et al., 1992). I bath applied 2 μM 
noradrenaline to brain slices and recorded the current response of pericytes. 
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 Noradrenaline application evoked an inward current in pericytes (-33.0 ±19.7 pA; Figure 5.4A and 
5.4B). A measurable response to noradrenaline was recorded in three out of six pericytes patch-clamped.  
 This inward current in pericytes in brain slices is consistent with findings that noradrenaline 
depolarizes retinal pericytes (Helbig et al., 1992) and may be responsible for generating the capillary 
constriction seen in response to noradrenaline application (Chapter 4; Peppiatt et al., 2006). The fact that not 
all of the pericytes showed a measurable current response to noradrenaline application supports existing 
evidence that not all pericytes constrict capillaries on application of noradrenaline (Peppiatt et al., 2006). 
5.4 Discussion 
 These preliminary results have found that pericytes can be whole-cell patch-clamped in situ in cortical 
and cerebellar brain slices. Pericytes show little voltage-evoked current but glutamate receptor activation 
produces an outward current while noradrenaline application produces an inward current. These responses 
could explain the dilation and constriction of pericytes seen in response to these signalling agents. 
5.4.1 Glutamate receptor activation causes an outward current in pericytes 
 The glutamate evoked outward current in pericytes supports a dilatory role for glutamate at the 
capillary level. Glutamate is thought to produce smooth muscle relaxation through activation of EP4 receptors 
(see Chapter 4). EP4 receptor activation leads to increased intracellular cAMP concentration, promoting 
dilation by decreasing the sensitivity of contractile apparatus, inhibiting calcium channels and activating 
potassium channels (Karaki et al., 1997, Ishikawa et al., 1993, Quayle et al., 1997). Prostaglandins also 
hyperpolarize arteriolar smooth muscle by activating calcium-dependent potassium channels (Serebryakov et 
al., 1994), reducing voltage-gated calcium entry into the cells, and thus decreasing contraction. The findings of 
Chapter 4 suggest that this pathway is also present at the pericyte level, so the outward current that I observe 
might be expected to be blocked by an EP4 receptor blocker. Unfortunately, the difficulty of these experiments 
precluded me testing this during my PhD. 
 The observation, in one cell, that glutamate prevents current oscillations in the pericyte, sits well with 
evidence found that depolarizing agents, such as noradrenaline, produce spike-like calcium oscillations in 
retinal pericytes (Helbig et al., 1992). Similarly, oscillations are seen in pericytes, in the kidney, in response to 
angiotensin II (Zhang et al., 2008). The oscillations were attributed to repetitive cycles of calcium entry (Zhang 
et al., 2008) or calcium release and reuptake from intracellular stores (Borysova et al., 2013). Exposing retinal 
pericytes to calcium free extracellular solution inhibited current oscillations (Helbig et al., 1992), suggesting 
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that oscillations may be involved in regulating contractile behaviour. Similar oscillations have been observed in 
smooth muscle cells (Somlyo and Somlyo, 1968; Nelson et al., 1990).  
5.4.2 Noradrenaline causes an inward current in pericytes 
Noradrenaline produces an inward current in pericytes, consistent with previous findings that 
noradrenaline application causes membrane depolarization and contraction (Helbig et al., 1992; Peppiatt et 
al., 2006). Noradrenaline is a vasoconstrictor used to pre-constrict vessels in Chapter 4. Noradrenaline is 
thought to produce pericyte constriction through α-adrenoceptor activation (Weiss et al., 1977; Chapter 1.3). 
Helbig et al. (1992) found that prazosin inhibited noradrenaline induced pericyte depolarization, suggesting it 
acts through the α1 receptor. A study into the adrenoceptor expression of cortical pericytes, however, found 
that these cells do not express α1 receptors but that they do express α2 and, to a lesser extent, β receptors 
(Elfont et al., 1989). Activation of α2 receptors reduces the production of cAMP, promoting contraction (see 
Chapter 1.4).  Another possibility is that noradrenaline acts on the α1 receptors of astrocytes to increase 
astrocytic calcium (Duffy and MacVicar, 1995; Bekar et al., 2008) which then leads to an increased production 
of 20-HETE (Mulligan and MacVicar, 2004), which can then depolarize pericytes in the same way that it acts 
on smooth muscle cells, increasing calcium entry through voltage-gated calcium channels (see Chapter 1 and 
4; Lange et al., 1997; Gebremedhin et al., 1998).  
5.4.3 Conclusion 
I found that not every cell responded to drug application with a current response. This may be due to 
heterogeneity of pericytes and agrees with data showing that not all pericytes constrict or dilate in response to 
signalling agents. Li and Puro (2001) found that, although not every retinal pericyte showed a change in tone 
on application of the potassium channel activator pinacidil, all cells responded with a hyperpolarization. This 
suggests a difference between retinal and cerebral pericytes.  
Overall, these results provide support for the roles of glutamate and noradrenaline laid out in Chapter 
4 and gives insight into the mechanisms by which these transmitters act. Glutamate produces an outward 
current in pericytes that would explain pericyte relaxation and capillary dilation, whereas noradrenaline 
produces an inward current that would explain the pericyte contraction and capillary constriction observed in 
imaging experiments. 
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Figure 5.1: Morphology of patch-clamped pericyte. A DsRed positive pericytes in a cortical brain slice are 
indicated by arrows B Bright-field image of the same field of view as in A. Pericytes cannot be seen well in the 
bright-field image but are still indicated by arrows. The pipette can be seen in the left of the image. The pipette 
is attached to the pericyte indicated by the white arrow. C Image showing the pericyte with Alexa 488 
introduced from the patch pipette (indicated by white arrow). The cell body is obscured by the patch pipette 
but the cells processes can be seen enwrapping the vessel. The pericyte indicated by the yellow arrow is not 
filled with dye. 
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Figure 5.2: Electrical properties of pericytes. A The responses of a pericyte to a series of positive and 
negative voltage steps from -114 mV to +26 mV. The voltage clamp protocol is shown below the traces. B The 
average current voltage relation for the 11 pericytes patch-clamped. 
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Figure 5.3: The effect of glutamate receptor activation on pericyte currents. A A trace showing that 
application of glutamate (500 μM) and NMDA (100 μM) leads to an outward current in a patch-clamped 
pericyte held at -55 mV B Mean ± s.e.m inward and outward currents evoked by 1
st
 and 2
nd
 applications of 
glutamate C Mean ± s.e.m inward and outward currents evoked by NMDA D A trace showing that application 
of glutamate inhibits current oscillations in a patch-clamped pericyte. 
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Figure 5.4: The effect of noradrenaline on pericyte currents. A A trace showing application of 
noradrenaline (2 μM) leads to an inward current in patch-clamped pericyte held at -55 mV B Mean ± s.e.m 
current evoked by application of noradrenaline. 
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Chapter 6: The pericyte response to ischaemia  
6.1 Introduction  
Ischaemia is known to constrict pericytes (Peppiatt et al., 2006) and this constriction has been 
suggested to be long lasting following an ischaemic insult (Yemisci et al., 2009). It has also been found that 
pericytes are vulnerable to death following exposure to reactive oxygen species and hypoxia in culture 
(Shojaee et al., 1999; Yu et al., 2012). In vivo, following middle cerebral artery occlusion (MCAO) and 
reperfusion, pericytes are unhealthy, with disrupted membranes that allow a labelling antigen to leak from the 
cells (Fernández-Klett et al., 2013). Pericyte constriction and death may be at least partly responsible for the 
long lasting decrease of blood flow that is observed following ischaemia and reperfusion (Ames, 1968; Leffler 
et al., 1989; Hauck et al., 2004; see Section 1.7.6 for more details). A chronic decrease in blood flow following 
ischaemia may exacerbate neuronal death by limiting oxygen and glucose delivery to, and removal of CO2 
from, the tissue that is struggling to recover from metabolic disruption.  
As reviewed in Chapter 1, ischaemia kills cells by many mechanisms. A reduced energy supply 
initially causes neuronal depolarization because there is insufficient energy to fuel the pumps that maintain the 
resting membrane potential. This leads to an excessive release of glutamate, initially through synaptic release 
of glutamate and then, more importantly, through reversal of glutamate transporters (Szatkowski and Attwell, 
1994; Rossi et al., 2000). The released glutamate activates postsynaptic receptors causing a further large 
influx of positively charged (sodium and calcium) ions culminating in cell death (Sattler and Tymianski., 2001). 
Intracellular calcium concentration increases can lead to cell death through accumulation in mitochondria 
(Sciamanna et al., 1992; Schinder et al., 1996). Mitochondrial depolarization, due to calcium entry, promotes 
opening of the mitochondrial permeability transition pore (MPTP; Dubinsky and Levi, 1998) which in turn 
impairs oxidative phosphorylation, causes release of apoptogenic proteins and generates reactive oxygen 
species (ROS; Piantadosi and Zhang, 1996; Dubinsky and Levi, 1998; Starkov et al., 2004). In addition, 
ischaemic activation of neuronal nitric oxide synthase (NOS) by the rise of [Ca
2+
]i occurring increases the 
production of NO, which can react with superoxide to form the potent oxidant, peroxynitrite (Saran et al., 
1990). Peroxynitrite has many damaging effects including cell membrane disruption and enzyme inactivation 
through lipid peroxidation and protein oxidation (Halliwell, 1992). The rise of [Ca
2+
]i produced by ischaemia 
also activates phospholipases and thus increases the concentration of arachidonic acid and its metabolites, 
including several types of eicosanoid (Tegtmeier et al., 1990). After ischaemia, when a thrombus is cleared, 
the re-introduction of oxygen by reperfusion is thought to contribute to delayed secondary brain damage. As 
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discussed in Chapter 1.7, the mechanisms of damage at this stage include many of the pathways described 
above (Schaller and Graf, 2004).  
In this Chapter I examine pericyte death in response to simulated ischaemia, as well as ischaemia 
followed by reoxygenation. The approach used was to quantify pericyte death in brain slices following 
incubation in oxygen and glucose free solution (mimicking an ischaemic insult) and then reintroduction of 
oxygen and glucose (mimicking reperfusion following an ischaemic insult), while pharmacologically 
manipulating the pathways potentially involved in pericyte death. The results obtained in slices were then 
extended to the in vivo situation using a MCAO model of stroke (see Chapter 2.7.2). 
6.2 Methods 
6.2.1 Preparations 
Experiments were performed on 200 μm coronal forebrain slices from P21 Sprague Dawley rats, or on 
anaesthetised adult Wistar rats (weighing 253-312g), all of male sex. Solutions and tissue preparation used 
are described in Chapter 2, sections 2.1.1, 2.1.2 and 2.3.2. 
6.2.2 Oxygen and glucose deprivation 
To quantify pericyte death in response to ischaemia, in vitro slices were incubated in oxygen and 
glucose deprived (OGD) solution. This involved incubating slices at 37⁰ C in aCSF in which glucose was 
replaced with 7mM sucrose, and oxygen was removed by equilibrating solutions with 5% CO2 and 95% N2 for 
1 hour.  Control slices were incubated at 37⁰ C in aCSF and gassed with 5% CO2, 95% O2. All slices were 
incubated in isolectin B4-FITC conjugate (IB4, 10μg/ml) which labels blood vessels, including pericytes, and in 
propidium iodide (PI, 37μM) which labels dead cells (as shown in Figure 6.1A). PI is a 669 Dalton molecular 
weight dye that enters cells when membrane integrity has been lost and, once inside, it intercalates into the 
fragmented DNA and becomes fluorescent. Slices were then fixed for 20 minutes in 4% PFA and mounted for 
imaging. 
In initial experiments, slices were labelled with an NG2 antibody as in Figure 6.1A (for the protocol, 
see Chapter 2, section 2.4.2). NG2 is a commonly used pericyte marker (see Chapter 3.3.1). However, I found 
that the NG2 labelling had very poor depth penetration. Because of this I mainly used IB4 labelling and 
morphology to identify pericytes, as described in Chapter 3.3.3.  
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6.2.3 Middle cerebral artery occlusion 
To quantify pericyte death in response to ischaemia in vivo, I prepared 200 μm brain slices from the 
brain tissue of rats that had been subjected to middle cerebral artery occlusion (MCAO) for 90 minutes 
followed by 22.5 hours of recovery. As described in more detail in Chapter 2.7.2, MCAO was produced by 
inserting a filament into the internal carotid artery and advancing it to block the opening of the middle cerebral 
artery. As a control, slices were prepared from naïve animals and animals that underwent a sham operation. 
The sham operation involved insertion of a filament into the internal carotid artery, as in the MCAO protocol, 
but in these cases the filament was not advanced to occlude the middle cerebral artery. During procedures, 
cerebral blood flow was continuously monitored by placing a laser Doppler probe over a thinned skull of the 
MCA territory approximately 4 mm lateral and 1.5 mm caudal to bregma. In MCAO animals, averaged over the 
period of occlusion, blood flow fell to 34.9±7.1% of baseline (n=6), while in sham animals it dropped 
significantly less to only 67.9±11.0% (n=3, t-test p = 0.035; a drop still occurs because of occlusion of the 
common and internal carotid arteries).  After 22.5 hours of reperfusion, neurological deficit was assessed by 
investigating limb symmetry, motor function, activity and sensory stimulation. A maximum score of 15 equates 
to severe neurological deficit, while a minimum score of 0 implies no neurological deficit. MCAO animals had a 
mean score of 7.5+1.7, which was significantly greater than that of sham animals (0.3+0.3, p = 0.027). In both 
the MCAO and sham animals the right hemisphere was operated on, and thus is referred to as the lesioned 
hemisphere. In the naïve animals, neither hemisphere was operated on but the right hemisphere is still 
referred to as the lesioned hemisphere. My colleague, Brad Sutherland, at Oxford University carried out the 
surgery.  
The slices obtained from these animals were then labelled, as in described in section 6.2.2, with 
isolectin B4-FITC conjugate and propidium iodide. Example images from this tissue can be seen in Figure 
6.1B. 
6.2.4 Imaging 
After fixation and labelling, slices from both the in vitro and the in vivo experiments were imaged with 
a Zeiss LSM 700 or 710 confocal microscope using a x20 water immersion objective. 
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6.2.5 Analysis and statistics 
Prior to analysis, image identities were recoded using a custom-written Image J macro so that I was 
blind to the condition that each tissue slice had undergone. PI-positive dead perivascular cells were counted 
using ImageJ. Dead or alive pericytes were identified by their “bump on a log” morphology on vessels 
surrounded by IB4 labelling (see Chapter 3.3.3). Endothelial cells were identified by their elongated cell body. 
Since only the cell bodies of dead cells were visible, only dead endothelial cells could be counted. The total 
number of endothelial cells present, and therefore the percentage of dead endothelial cells, was estimated 
from the total number of pericytes, assuming a 1:3 ratio of pericytes to endothelial cells (Pardridge, 1999) 
There were high levels of cell death within the surface 20 μm of the slice (Figure 6.1C), which was 
thought to be caused by the trauma of slicing. Because of this, the surface 20 μm of each slice were excluded 
from analysis. 
Data are presented as mean ± s.e.m Results in each condition are compared to results in the 
absence of drugs. All control experiments without drugs were pooled together, although comparing drug data 
with control data obtained on the same day gave essentially identical results. Statistical methods are given in 
Chapter 2, section 2.8. All statistical analysis was conducted using IBM SPSS21 statistics software or 
Microsoft Excel. 
6.3 Results 
6.3.1 Pericyte death in oxygen-glucose deprivation and reoxygenation, in cortical slices 
The model of ischaemia used in these experiments was oxygen and glucose deprivation (OGD). 
Exposure to 1 hour of OGD significantly increased pericyte death from 7.1±1.6% to 41.9±3.0% of all pericytes 
counted (p=8.7x10
-7
; Figure 6.1D). Because this model of ischaemia is reversible, I was also able to 
investigate pericyte death when OGD was followed by a period of oxygen and glucose reintroduction 
(reoxygenation). Exposure to 1 hour of OGD followed by an hour of reoxygenation increased pericyte death 
from 12.7±2.2% to 65.8±2.5% of all pericytes counted (p=5.7x10
-16
; Figure 6.1D). Thus, the percentage of 
pericytes that die in OGD was significantly increased when OGD was followed by an hour of reoxygenation 
(p=6.6x10
-7
; Figure 6.1D).    
These results indicate that pericytes die following OGD, and that this death is increased if OGD is 
followed by the reintroduction of oxygen and glucose. 
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6.3.2 The effect of inhibiting glutamate receptors on pericyte death in OGD and reoxygenation, in 
cortical slices  
 Cell death in ischaemia may be caused by glutamate excitotoxicity. Exposure of neurons in culture 
and in slices to glutamate or glutamate receptor agonists leads to cell death (Choi, 1985; Garthwaite & 
Garthwaite, 1986). In order to investigate whether the pericyte death observed in OGD, and OGD with 
reoxygenation, was due to activation of glutamate receptors, I used inhibitors of either ionotropic or 
metabotropic glutamate receptors.  
In the presence of ionotropic glutamate receptor blockers (D-AP5, 7-CK and NBQX), pericyte death 
was still significantly increased after 1 hour of OGD as well as after 1 hour of OGD followed by an hour of 
reoxygenation (p=2x10
-3
 and p=1.9x10
-8 
respectively; Figure 6.2A). The pericyte death observed after either 1 
hour of OGD or 1 hour of OGD followed by 1 hour reoxygenation, all in the presence of the ionotropic 
glutamate receptor blockers, was, however, reduced by 37.2% and 29.6% respectively i.e. significantly lower 
than that seen in the absence of drugs (p=7x10
-3
 and p=1.7x10
-4
; Figure 6.2A)  
In the presence of the metabotropic glutamate receptor blocker (MCPG), pericyte death was no longer 
significantly increased after 1 hour of OGD (p=0.31; Figure 6.2B) there was, however, no significant difference 
in the death in the absence and presence of MCPG following 1 hour of OGD (p=0.3; Figure 6.2B). When 1 
hour of OGD was followed by 1 hour of reoxygenation, all in the presence of MCPG, there was a significant 
increase in pericyte death (p=1.4x10
-4
; Figure 6.2B), and in fact there was an increase in pericyte death when 
compared to results in the absence of MCPG (p=2.7x10
-3
; Figure 6.2B).   
These results suggest that inhibition of ionotropic glutamate receptors reduces pericyte death in 
response to OGD, as well as the pericyte death seen with OGD followed by reoxygenation. It appears that 
inhibition of metabotropic glutamate receptors, however, may increase pericyte death when OGD is followed 
by reoxygenation. This increase in death seen on reoxygenation in the presence of a metabotropic glutamate 
receptor antagonist may support the notion of a protective role of metabotropic glutamate receptor activation 
following ischaemia: it was previously found that application of a metabotropic glutamate receptor blocker 
following MCAO reduced excitotoxicity (Chiamulera et al., 1992). 
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6.3.3 The effect of removing calcium or inhibiting mitochondrial calcium uptake on pericyte death in 
OGD and reoxygenation, in cortical slices  
 Glutamate-mediated cell death is to a large extent calcium-dependent (Choi, 1985; Garthwaite & 
Garthwaite, 1986). In order to investigate whether the pericyte death observed in response to OGD, or OGD 
with reoxygenation, involved a calcium influx, I removed calcium from the extracellular solution.  
On removal of extracellular calcium, pericyte death was no longer significantly increased after 1 hour 
of OGD or 1 hour of OGD followed by an hour of reoxygenation (p=0.07 and p=0.09 respectively; Figure 
6.3A). Pericyte death in calcium free solution was significantly reduced compared to the pericyte death seen 
when calcium was present in the solution in both conditions, with a reduction in pericyte death of 46.1% and 
56.1% respectively (p=0.01 and p=4.1x10
-6
; Figure 6.3A).  
One of the mechanisms through which calcium is thought to produce cell death is through uptake into 
the mitochondria. During calcium overload mitochondria act as a sink for calcium. Mitochondrial calcium 
accumulation triggers the assembly and opening of a high-conductance pore in the inner mitochondrial 
membrane, causing a collapse of the electrochemical gradient for protons, stopping ATP production and 
triggering production of reactive oxygen species. Furthermore, during reperfusion, isolated mitochondria show 
a calcium-concentration dependent morphological damage and swelling, which is thought to be due to the loss 
of the mitochondrial membrane potential and an increase in reactive oxygen species production (Li et al., 
2012). 
In the presence of a mitochondrial calcium uptake inhibitor (Ru360), pericyte death was significantly 
increased after 1 hour of OGD as well as after 1 hour of OGD followed by reoxygenation (p=8.8x10
-4
 and 
p=0.03 respectively; Figure 6.3B). The pericyte death observed after an hour of OGD in the presence of 
Ru360 was not significantly different to the death seen in the absence of the drug (p=0.06), but the pericyte 
death after 1 hour of OGD and reoxygenation, all in the presence of Ru360, was reduced by 21.1% i.e. 
significantly lower than that seen in the absence of drugs (p=0.04; Figure 6.3B). 
These results suggest that calcium influx contributes to the pericyte death seen in response to OGD 
as well as the pericyte death seen in OGD followed by reoxygenation. Mitochondrial calcium uptake does not 
appear to contribute to pericyte death in OGD but may contribute to pericyte death during reoxygenation.  
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6.3.4 The effect of inhibiting 20-HETE production on pericyte death in OGD and reoxygenation, in 
cortical slices  
 Ischaemia increases the release of free fatty acids, including arachidonic acid (Tegtmeier et al., 
1990). As mentioned in Chapters 1 and 4, there are several vasoactive metabolites of arachidonic acid 
including 20-HETE. Increased arachidonic acid release may thus lead to increased 20-HETE production. 20-
HETE constricts smooth muscle by inhibiting potassium channels, depolarizing the cell and thus increasing 
voltage-gated Ca
2+
 influx and activating protein kinase C (Lange et al., 1997), as well as by directly activating 
L-type Ca
2+ 
channels (Gebremedhin et al., 1998). These mechanisms may also occur at capillary level 
pericytes. Increases in intracellular calcium concentration would be expected to lead to a constriction of 
smooth muscle or pericytes, but may also lead to a calcium concentration high enough to cause cell death. In 
order to investigate whether the pericyte death observed in or after OGD involved 20-HETE production, I used 
HET0016, a ω-hydroxylase enzyme inhibitor (for more information on HET0016 see Chapter 4.3.7). 
In the presence of HET0016, pericyte death was significantly increased after 1 hour of OGD as well 
as after 1 hour of OGD followed by an hour of reoxygenation (p=6.1x10
-4
 and p=2.1x10
-5
 respectively; Figure 
6.4). Pericyte death in the presence of HET0016 was not significantly different to the pericyte death in the 
absence of HET0016, for either condition (p=0.88 and p=0.95 respectively; Figure 6.4). 
 These results suggest that 20-HETE production does not contribute to the pericyte death seen in 
response to OGD or the pericyte death seen in OGD followed by reoxygenation. It is nevertheless possible 
that the increased release of free fatty acids in OGD causes cell death through another mechanism, possibly 
through free radical production (Lipton, 1999).  
6.3.5 The effect of inhibiting oxidative-nitrative stress on pericyte death in OGD and reoxygenation, in 
cortical slices 
It has been suggested that oxidative and nitrative stress lead to constriction of pericytes (Yemisci et 
al., 2009) and it is known that production of reactive oxidative species, especially peroxynitrite, causes cell 
death (Halliwell, 1992). As peroxynitrite is formed from nitric oxide and superoxide, I investigated whether the 
pericyte death observed in OGD, and OGD with reoxygenation, was reduced by incubation with a nitric oxide 
synthase inhibitor or a superoxide scavenger.  
In the presence of the nitric oxide synthase inhibitor L-NNA (L-N
G
-nitroarginine), pericyte death was 
significantly increased after 1 hour of OGD as well as after 1 hour of OGD followed by an hour of 
reoxygenation (p=3x10
-3
 and p=4x10
-6
 respectively; Figure 6.5A). Pericyte death in the presence of L-NNA 
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after 1 hour of OGD, or 1 hour of OGD followed by 1 hour reoxygenation, was not significantly different to the 
pericyte death in the absence of L-NNA (p=0.17 and p=0.24; Figure 6.5A). Similarly, in the presence of the 
superoxide scavenger MnTBAP (Szabó et al., 1996), pericyte death was significantly increased after 1 hour of 
OGD as well as after 1 hour of OGD followed by reoxygenation (p=0.04 and p=4.4x10
-8
 respectively; Figure 
6.5B), but the pericyte death observed in either condition in the presence of MnTBAP was not significantly 
different to the death seen in the absence of the drug (p=0.5 and p=0.1 respectively; Figure 6.5B). 
 In order to confirm the results found with MnTBAP, I carried out experiments with another superoxide 
scavenger, PBN (Carney and Floyd, 1991). In the presence of PBN, pericyte death was significantly increased 
after 1 hour of OGD as well as after 1 hour of OGD followed by reoxygenation (p=1.3x10
-6
 and p=0.04 
respectively; Figure 6.5B). However, the pericyte death in either condition in the presence of PBN was not 
significantly different to the death seen in the absence of the drug (p=0.95 and p=0.50 respectively; Figure 
6.5B).   
These results suggest that neither nitric oxide production nor superoxide production contribute to the 
pericyte death seen in response to OGD, nor to the pericyte death seen in OGD followed by reoxygenation. 
6.3.6: Pericyte death in the striatum following MCAO compared to naïve and sham conditions 
In order to test whether pericyte death was also observed in response to ischaemia in vivo, I 
quantified death in the striatum where the core of an ischaemic lesion occurs following MCAO. I compared the 
pericyte death in these animals with the pericyte death observed in naïve animals and animals that underwent 
a sham operation.  
In naïve animals, that had no surgery, pericyte death in the striatum was not significantly different 
between the ‘lesioned’ hemisphere and the control hemisphere (p=0.37; Figure 6.6).  
In animals that had a sham operation, pericyte death in the striatum showed a trend towards 
increased death in the lesioned hemisphere when compared to the control hemisphere, increasing from 
17.8±4.0% in the control hemisphere to 43.4±9.4% in the lesioned hemisphere, but this difference was not 
significant (p=0.09; Figure 6.6). There was also a trend towards increased death in the striatum of the 
lesioned hemisphere of the sham animal when compared to the ‘lesioned’ hemisphere of the naïve animal, but 
this difference also did not reach significance (p=0.07; Figure 6.6). Both of these increases in death may 
reflect the 32.1% decrease of blood flow that is produced even with the sham operation because the common 
carotid artery is ligated and the occluding filament is inserted partly into the internal carotid artery. 
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In animals that had MCAO, which decreased the blood flow measured in the MCA territory decreased 
by 65.1%, pericyte death was significantly increased in the striatum of the lesioned hemisphere when 
compared to the control hemisphere, increasing from 28.0±5.7% in the control hemisphere to 70.5±5.1% in 
the lesioned hemisphere (p=1.2x10
-8
; Figure 6.6). The pericyte death in the lesioned hemisphere was 
significantly higher than the pericyte death seen in the corresponding hemisphere of both the sham and the 
naïve animals (p=0.02 and p=3.3x10
-7
 respectively; Figure 6.6). 
These results demonstrate that pericyte death increases in the striatum in response to MCAO 
followed by 22.5 hours reperfusion.  
6.3.7: Pericyte death in the cortex following MCAO compared to naïve and sham conditions 
The striatum, in which I quantified pericyte death for Figure 6.6, is where the core of the ischaemic 
lesion produced by MCAO occurs. In order to test whether pericyte death in response to ischaemia in vivo 
was also seen in the penumbra of the lesion produced by MCAO, I quantified death in the cortex.  
As for the striatum, in naïve animals that had no surgery or in sham operated animals, pericyte death 
was not significantly different between the lesioned hemisphere and the control hemisphere (p=0.84 and 
p=0.16 respectively; Figure 6.7). Similarly, the death in the lesioned hemisphere of the sham animal was not 
significantly different to that in the ‘lesioned’ hemisphere of the naïve animal (p=0.21; Figure 6.7).  
In animals that had MCAO, pericyte death was significantly increased in the lesioned hemisphere 
when compared to the control hemisphere, increasing from 16.4±6.5% in the control hemisphere to 
50.9±12.7% in the lesioned hemisphere (p=1.3x10
-3
; Figure 6.7). The pericyte death in the lesioned 
hemisphere of the MCAO animal was significantly higher than the pericyte death seen in the lesioned 
hemisphere of the naïve animals (p=0.03; Figure 6.7) but was not significantly higher than the pericyte death 
seen in the lesioned hemisphere of sham animals (p=0.18; Figure 6.7). 
Thus, just as in the core of the lesion, in the cortical penumbra pericyte death increases in response 
to MCAO followed by 22.5 hours reperfusion.  
6.3.8: Endothelial cell death in the striatum and cortex following MCAO compared to naïve and sham 
conditions           
 Some studies have found that vascular endothelial cells die in response to hypoxia and ischaemia 
(Gobbel et al., 1994; Zhang et al., 2000; Walford et al., 2004) In order to compare endothelial cell vulnerability 
to ischaemia in vivo with that of pericytes, I quantified endothelial cell death in the striatum and cortex 
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following MCAO. Endothelial cell death in MCAO animals was compared with the death observed in naïve 
animals and animals that underwent a sham operation.   
In naïve animals, that had no surgery, endothelial cell death was not significantly different between 
the ‘lesioned’ hemisphere and the control hemisphere in the striatum or cortex (p=0.55 and p=0.64 
respectively; Figure 6.8 and 6.9). In animals that had a sham operation, endothelial cell death was also not 
significantly different between the lesioned hemisphere and the control hemisphere in the striatum or cortex 
(p=0.60 and p=0.79 respectively; Figure 6.8 and 6.9), and there was no difference in the level of endothelial 
cell death in the lesioned hemisphere of the sham animal when compared to the ‘lesioned’ hemisphere of the 
naïve animal (p=0.46 and p=0.93 respectively; Figure 6.8 and 6.9). Following MCAO, in the striatum, there 
was no significant difference in endothelial cell death between hemispheres (p=0.07; Figure 6.8), with no 
significant difference between the level of endothelial cell death in the lesioned hemisphere of the MCAO 
animals when compared to the ‘lesioned’ hemisphere of the naïve animals (p=0.1; Figure 6.8). There was, 
however, significantly higher endothelial cell death in the lesioned hemisphere of the MCAO animal than was 
observed in the lesioned hemisphere of the sham animals (p=1.6x10
-4
; Figure 6.8).  
In the cortex, endothelial cell death was significantly higher in the lesioned hemisphere than in the 
control hemisphere following MCAO (p=6.5x10
-4
; Figure 6.9). The endothelial cell death in the lesioned 
hemisphere of the MCAO animal was also significantly higher than the endothelial cell death seen in the 
lesioned hemisphere of either the sham or the naïve animals (p=8x10
-3
 and p=2.6x10
-4 
respectively; Figure 
6.9). 
These results suggest that endothelial cell death increases in both the striatum and the cortex in 
response to MCAO (although variability in the striatal data from the naive, but not the sham, animals 
prevented this increase reaching significance). However, the endothelial cell death produced by MCAO is 
much less dramatic than the pericyte death (2.5±1.6% of endothelial cells died in cortex compared to 
50.9±12.7% of pericytes; p=4.7x10
-10
).  
6.4 Discussion 
  I have investigated the mechanisms by which pericytes die in response to ischaemia, by quantifying 
pericyte death following OGD alone, and after OGD followed by reoxygenation, and blocking various 
mechanisms that might contribute to the death. The results indicate that, firstly, pericytes die in response to 
OGD. Secondly, pericyte death in response to OGD is increased when OGD is followed by reoxygenation. 
Thirdly, pericyte death can be reduced by inhibiting ionotropic, but not metabotropic, glutamate receptors. 
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Fourthly, pericyte death can be reduced by removing extracellular calcium. Fifthly, pericyte death is not altered 
in the presence of nitric oxide synthase inhibition or application of superoxide scavengers. Finally, I also found 
that pericytes die in response to ischaemia in vivo, following MCAO, and that this death was far higher than 
the death of endothelial cells. 
6.4.1 Pericyte death in OGD and reoxygenation involves ionotropic glutamate receptor activation 
Inhibition of ionotropic glutamate receptors decreases pericyte death in OGD and OGD followed by 
reoxygenation. It is not known whether pericytes express glutamate receptors themselves but they are known 
to respond to bath application of glutamate (see Chapters 1 and 4, and Peppiatt et al., 2006). Under 
physiological conditions glutamate is thought to hyperpolarize pericytes and cause relaxation (see Chapter 5). 
In ischaemia glutamate release increases, due to neuronal depolarization and reversal of glutamate 
transporters (Szatkowski and Attwell, 1994; Rossi et al., 2000), and this excessive release of glutamate may 
produce a pathological response in the pericyte. Pericyte constriction in ischaemia (Peppiatt et al., 2006; 
Yemisci et al., 2009) suggests that, in these conditions, glutamate causes a depolarization and calcium influx 
rather than hyperpolarization. It is unclear from this study where glutamate is acting to cause pericyte death 
after OGD. 
6.4.2 Pericyte death in OGD and reoxygenation involves extracellular calcium 
Removal of calcium from the extracellular solution decreased pericyte death produced by OGD or 
OGD followed by reoxygenation. In ischaemia the level of extracellular calcium decreases dramatically as it 
enters cells (Kristián and Siesjö, 1998). A large influx of calcium into the pericyte in ischaemia may trigger cell 
death, along with the observed constriction (Peppiatt et al., 2006; Yemisci et al., 2009). One pathway through 
which calcium is thought to cause cell death is mitochondrial calcium accumulation (Sciamanna et al., 1992; 
Schinder et al., 1996), though it has also been speculated that calcium uptake into mitochondria is 
neuroprotective (Nicholls, 1985). Inhibition of calcium uptake into mitochondria had no effect on pericyte death 
in OGD but slightly reduced pericyte death when OGD was followed by reoxygenation. Thus, pericyte death 
during reoxygenation may be partly due to calcium accumulation in the mitochondria.  
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6.4.3 Pericyte death in OGD and reoxygenation does not involve oxidative or nitrative stress 
Inhibition of nitric oxide production and application of superoxide scavengers did not reduce pericyte 
death in OGD, nor in OGD followed by reoxygenation. This suggests that, unlike the pericyte constriction 
occurring in ischaemia, pericyte death in ischaemia is not caused by oxidative and nitrative stress. Yemisci et 
al. (2009) found that pericyte constriction, in response to ischaemia and reperfusion, could be prevented by 
both nitric oxide synthase inhibition or by application of superoxide scavengers. These results imply that the 
mechanism through which pericyte constriction and death is produced are different. It has, however, 
previously been found that both nitric oxide synthase inhibition and application of superoxide scavengers can 
be neuroprotective, decreasing infarct size following ischaemia (Cao and Phillis, 1994; Margaill et al., 1997) or 
reducing neuronal death following excitotoxicity (Patel, 1996) and PBN application improves recovery of brain 
energy state following ischaemia (Folbergrová et al., 1995). Thus it is possible that oxidative and nitrative 
stress is involved in neuronal death following ischaemia. Controversially, however, application of nitric oxide 
donors have also been found to protect neurons following ischaemia and reperfusion (Jung et al., 2006). 
Similarly, a protective effect of peroxynitrite has been suggested (Bolanos et al., 2004). These contradictory 
findings demonstrate that the role of nitric oxide and its free radical products in ischaemia are not fully 
understood. My results, however, strongly suggest that oxidative and nitrative stress is not involved in pericyte 
death in ischaemia or reperfusion. 
6.4.4 Pericytes are more vulnerable to death than endothelial cells following MCAO and reperfusion in 
vivo 
Confirming my results in brain slices, pericytes die following MCAO (and 22.5 hours reperfusion) in 
vivo and the pericyte death occurring was much higher than that seen for endothelial cells. These data 
support previous observations that pericyte damage precedes endothelial cell damage following ischaemia 
(Fernández-Klett et al., 2013) as well as the finding that pericytes are more vulnerable to apoptosis, following 
exposure to ROS, than endothelial cells (Shojaee et al., 1999). The greater vulnerability of pericytes, 
compared to endothelial cells, suggests that pericytes may be a more important therapeutic target than 
endothelial cells. 
6.4.5 Conclusion 
My data suggest that pericytes are vulnerable to death in ischaemia and reperfusion, and that the 
mechanism of pericyte death involves activation of ionotropic glutamate receptors and calcium influx, but does 
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not involve oxidative-nitrative stress. I also found that pericytes are more vulnerable to death following 
ischaemia and reperfusion than endothelial cells.  
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Figure 6.1: Methodology. A Example of cortical tissue from in vitro OGD experiment labelled with isolectin 
B4-FITC conjugate (IB4; green), propidium iodide (PI; red) and NG2 (magenta). Live pericytes in control tissue 
are labelled with IB4 and NG2 (indicated by white arrows). Dead pericytes in OGD tissue are labelled with IB4, 
NG2 and PI (indicated by red arrows). Dead endothelial cells in OGD are labelled with IB4 and PI (indicated by 
pink arrows). B Example of cortical tissue from in vivo MCAO experiment labelled with IB4 and PI, and PI 
alone. Live pericytes in control tissue are labelled with IB4 (indicated by white arrows). Live and dead pericytes 
in MCAO tissue are labelled with IB4 and PI (indicated by white and red arrows respectively). Dead endothelial 
cells in MCAO tissue are labelled with IB4 and PI (indicated by pink arrows). Image showing PI alone allow 
identification of a dead endothelial cell, in MCAO condition, that was obscured by IB4 labelling. C Plot of the 
number of live and dead pericytes per 1 μm depth bin as a function of depth in a cortical slice which was not 
exposed to OGD. The number of dead pericytes increases at the surface of the slice. The grey bars indicate 
the surface 20 μm of the slice, these regions were not included in subsequent cell counts. The apparent 
thickness of the slice (120 m) is less than the thickness the slices were cut at (200 m) because of tissue 
shrinkage during fixation. D Mean (± s.e.m) pericyte death after an hour of OGD (No Reoxy.) or an hour of 
OGD followed by an hour of reoxygenation (Reoxy.). P values assess the significance of the difference in 
pericyte death between the control and OGD conditions, and the significance of pericyte death between OGD 
alone and OGD followed by a reoxygenation period. 
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Figure 6.2: Effect of ionotropic and metabotropic glutamate receptor blockers on pericyte death in 
OGD and reoxygenation in cortical slices. A Mean (± s.e.m) pericyte death after an hour of OGD (No 
Reoxy.) or an hour of OGD followed by an hour of reoxygenation (Reoxy.) in the absence of drugs (data 
repeated from Fig 6.1) and in the presence of the ionotropic glutamate receptor blockers, D-AP5 (50 μM), 7-
CK (100 μM) and NBQX (25 μM). P values assess the significance of the difference in pericyte death between 
the control and OGD conditions and the significance of the difference in pericyte death in the absence and 
presence of D-AP5, 7-CK, and NBQX. B Mean (± s.e.m) pericyte death after an hour of OGD (No Reoxy.) or 
an hour of OGD followed by an hour of reoxygenation (Reoxy.) in the absence of drugs and in the presence of 
metabotropic glutamate receptor blocker, MCPG (500 μM). P values assess the significance of the difference 
in pericyte death between the control and OGD conditions and the significance of the difference in pericyte 
death in the absence and presence of MCPG. 
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Figure 6.3: Effect of calcium removal and mitochondrial calcium uptake inhibition on pericyte death in 
OGD and reoxygenation in cortical slices. A Mean (± s.e.m) pericyte death after an hour of OGD (No 
Reoxy.) or an hour of OGD followed by an hour of reoxygenation (Reoxy.) in control solution (data repeated 
from Fig 6.1) and solution containing zero calcium (0 [Ca
2+
]O). P values assess the significance of the 
difference in pericyte death between the control and OGD conditions and the significance of the difference in 
pericyte death between OGD in control solution and solution containing zero calcium. B Mean (± s.e.m) 
pericyte death after an hour of OGD (No Reoxy.) or an hour of OGD followed by an hour of reoxygenation 
(Reoxy.) in the absence of drugs and in the presence of the mitochondrial calcium uptake inhibitor, Ru360 (50 
μM). P values assess the significance of the difference in pericyte death between the control and OGD 
conditions, or the significance of pericyte death between OGD in the absence and presence of Ru360. 
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Figure 6.4: Effect of HET0016 on pericyte death in OGD and reoxygenation in cortical slices. Mean (± 
s.e.m) pericyte death after an hour of OGD (No Reoxy.) or an hour of OGD followed by an hour of 
reoxygenation (Reoxy.) in the absence of drugs (data repeated from Fig 6.1) and in the presence of HET0016 
(1 μM). P values assess the significance of the difference in pericyte death between the control and OGD 
conditions and the significance of the difference in pericyte death between OGD in the absence and presence 
of HET0016. 
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Figure 6.5: Effect of nitric oxide synthesis inhibition and superoxide scavenging on pericyte death in 
OGD and reoxygenation in cortical slices. A Mean (± s.e.m) pericyte death after an hour of OGD (No 
Reoxy.) or an hour of OGD followed by an hour of reoxygenation (Reoxy.) in the absence of drugs (data 
repeated from Fig 6.1) and in the presence of nitric oxide synthase inhibitor, L-NNA (100 μM). P values 
assess the significance of the difference in pericyte death between the control and OGD conditions and the 
significance of the difference in pericyte death in the absence and presence of L-NNA. B Mean (± s.e.m) 
pericyte death after an hour of OGD (No Reoxy.) or an hour of OGD followed by an hour of reoxygenation 
(Reoxy.) in the absence of drugs (data repeated from Fig 6.1) and in the presence of superoxide scavengers, 
MnTBAP (150 μM) or PBN(100 μM). P values assess the significance of the difference in pericyte death 
between the control and OGD conditions and the significance of the difference in pericyte death in the 
absence and presence of MnTBAP or PBN. 
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Figure 6.6: Pericyte death in the striatum in vivo following MCAO compared to naïve and sham 
conditions. Mean (± s.e.m) pericyte death in the striatum of control and lesion hemispheres of naïve animals 
(naïve), animals that underwent sham surgery followed by 22.5 hours recovery (sham), and animals that 
underwent the MCAO procedure followed by 22.5 hours recovery (MCAO). P values assess the significance 
of the difference in pericyte death in the striatum between the control hemisphere and the lesioned 
hemisphere, and the significance of the difference in pericyte death within the lesioned hemisphere between 
different conditions. 
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Figure 6.7: Pericyte death in the cortex in vivo following MCAO compared to naïve and sham 
conditions. Mean (± s.e.m) pericyte death in the cortex of control and lesion hemispheres of naïve animals 
(naïve), animals that underwent sham surgery followed by 22.5 hours recovery (sham), and animals that 
underwent the MCAO procedure followed by 22.5 hours recovery (MCAO). P values assess the significance 
of the difference in pericyte death between the cortex of the control hemisphere and the lesioned hemisphere, 
and the significance of the difference in pericyte death within the lesioned hemisphere between different 
conditions. 
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Figure 6.8: Endothelial cell death in the striatum in vivo following MCAO compared to naïve and sham 
conditions. Mean (± s.e.m) endothelial cell death in the striatum of control and lesion hemispheres of naïve 
animals (naïve), animals that have undergone sham surgery followed by 22.5 hours recovery (sham), and 
animals that have undergone the MCAO procedure followed by 22.5 hours recovery (MCAO). P values assess 
the significance of the difference in endothelial cell death between the striatum of the control hemisphere and 
the lesioned hemisphere, and the significance of the difference in endothelial cell death within the lesioned 
hemisphere between different conditions. 
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Figure 6. 9: Endothelial cell death in the cortex in vivo following MCAO compared to naïve and sham 
conditions. Mean (± s.e.m) endothelial cell death in the cortex of control and lesion hemispheres of naïve 
animals (naïve), animals that have undergone sham surgery followed by 22.5 hours recovery (sham), and 
animals that have undergone MCAO procedure followed by 22.5 hours recovery (MCAO). P values assess the 
significance of the difference in endothelial cell death between the control hemisphere and the lesioned 
hemisphere, and the significance of the difference in endothelial cell death within the lesioned hemisphere 
between different conditions. 
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Chapter 7: The physiology of developmental changes in BOLD functional imaging 
signals 
7.1 Introduction 
Most of my PhD work involved experimental analysis of how neuronal activity evokes local increases 
of cerebral blood flow. As explained in Chapter 1 section 1.10, these local increases of blood flow are the 
main generator of the BOLD fMRI (blood oxygenation level dependent, functional magnetic resonance 
imaging) signal. BOLD fMRI provides a widely used means of measuring brain activity in humans. Critically, 
the technique is non-invasive and thus safe for use across all age groups, including children. This makes fMRI 
potentially the most powerful tool available today for studying the neural underpinnings of the vast cognitive 
and social development that occurs during the first years of life. Over the past twenty years, fMRI has been 
vital in providing insight into the normal development of the neural strategies involved in human language 
acquisition, visual recognition, and memory (Baird et al., 1999; Casey et al., 1995; Gaillard et al., 2000; 
Thomas et al., 1999). fMRI is also well suited to studying abnormal neural development in diseases such as 
epilepsy and schizophrenia, and in disorders such as dyslexia and ADHD (Gaillard, 2000; Gur and Gur, 2010; 
Pugh et al., 2000; Vaidya et al., 1998).  
It is important to note, however, that the conclusions drawn from developmental fMRI studies often 
rely on the assumption that the BOLD signal reflects the same set of processes in the developing brain as in 
the adult brain (despite neuronal signalling changes as dramatic as GABA switching from being an excitatory 
transmitter in early development to being inhibitory later: see section 7.5.3). This assumption is worth 
assessing critically because the BOLD signal is not a direct measure of any one component of neural activity, 
but in fact reflects the behaviour of several different brain processes, which all undergo massive 
developmental changes in the early years of life. For example, regional blood flow, the levels of neuronal and 
astrocytic enzymes that regulate blood vessel diameter, astrocyte morphology, and hence neurovascular 
coupling, may all change alongside neural activity. These changes in neurovascular coupling mechanisms, 
and in cellular energy use, may compromise the power of BOLD imaging to detect “real” developmental 
changes in neuronal information processing, possibly producing changes of BOLD signal with development 
when there is no change in neuronal processing (false positives), or obscuring BOLD signal changes that 
would otherwise occur as neuronal signalling changes with age (false negatives). An extreme example of such 
interpretational problems, discussed in detail later (section 7.4), is that sensory stimulation evokes a “normal” 
positive BOLD signal in neonates and adults, but a negative BOLD signal in infants and young children, 
implying that there are two transitional ages at which no BOLD signal is produced by neural activity. For 
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robust interpretation of developmental fMRI data, therefore, it is crucially important to understand in as much 
detail as possible the developmental changes of brain processes other than neuronal activity which may 
influence the BOLD signal.  
This chapter provides a review, based on the expertise I gained in carrying out the experiments for my 
PhD, of the physiological changes that occur in neuronal and vascular networks in the developing brain, with a 
particular focus on those features that may alter the BOLD signal with age. I then discuss which factors are 
primarily responsible for changes in the BOLD signal during development, and outline the main considerations 
that should be taken into account when interpreting the results of developmental fMRI studies. This chapter, 
apart from some updating added for this thesis, has been published as Harris, Reynell & Attwell (2011) to 
which I made a 50% contribution. 
7.2 Changes in neural circuitry with development 
As the brain develops, its processing capabilities become increasingly sophisticated through changes 
in several components of the neural circuitry. These include experience-dependent and -independent changes 
to synaptic architecture, transmitter signalling, cell numbers, temporal response characteristics and 
myelination. Here, I will describe several of these changes from birth, through childhood and adolescence, to 
adulthood. 
Inevitably, much of our knowledge of developmental changes in neural circuitry and in the systems 
mediating neurovascular coupling has come from animals (particularly rodents) rather than humans. In what 
follows, therefore, it is useful to bear in mind the following approximate correspondence between the stages of 
rodent and human brain development. The main period of corpus callosum myelination in rats and mice 
occurs from about P7 to P35 (Hamano et al., 1998), corresponding to human ages from birth to ~18 years 
(Pujol et al., 1993; Lenroot and Giedd, 2006). Human adolescence has been suggested to map onto rat ages 
P30-P42 (Spear and Brake, 1983), with the rat brain being regarded as adult by P60. As detailed data for 
developmental changes were not available for all the species from which data were taken for this review, and 
developmental comparisons may be complicated by interspecies differences in the order of developmental 
events, in what follows age classifications are limited to the broad time windows of childhood, adolescence 
and adulthood. 
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7.2.1 Cortical thickness and wiring 
One of the most remarkable developmental circuitry changes is apparent in the increase in thickness 
and then slower thinning of human cortical grey matter which occurs over the period from childhood through 
adolescence into early adulthood (Paus 2005; Shaw et al., 2008; Ostby et al., 2009; Tamnes et al., 2010), 
which at least partly reflects the excess formation and then selective deletion of synapses (this is after the 
main period of neurogenesis and programmed cell death that occurs earlier in brain development: Chan et al., 
2002). The initial phase of expansion – underpinned by synaptogenesis in parallel with dendritic growth (Rakic 
et al., 1994) – coincides with rapid changes in the functional properties of neurons and cortical circuitry 
(Khazipov et al., 2001). The slower thinning phase – underpinned by activity-dependent synaptic pruning 
(Huttenlocher, 1990; Bourgeois and Rakic, 1993) – allows for the deletion of unnecessary synapses, thereby 
increasing processing efficiency (Mimura et al., 2003).  
While this general pattern is followed across cortical areas, the exact time-course of the expansion 
and thinning phases differs depending on the region, and appears closely related to the developmental 
timeline of the behaviour that the region subserves. Synaptogenesis in the human primary visual cortex, for 
example, begins in the foetus, reaching a maximum at around 8 months postnatally, after which visual 
experience-dependent pruning decreases synaptic density to the adult level (about 60% of the maximum) by 
11 years (Garey and Courten, 1983). This timescale correlates with the period of visual plasticity in infant 
monkeys, and with the establishment of visual acuity, stereopsis and oculomotor function in humans (Garey 
and Courten, 1983). In the human prefrontal cortex (PFC), on the other hand, grey matter density increases 
up until the onset of puberty and then decreases throughout adolescence and into early adulthood (Sowell et 
al., 2003; Toga et al., 2006). Over the period of grey matter reduction there is a marked behavioural 
maturation in the social skills that the PFC is considered responsible for, namely, an understanding of other 
people’s intentions, beliefs and desires, and an ability to predict the behaviour of others (Blakemore, 2008). 
Over the period of synaptic density changes, specific neuronal connections are developed and 
maintained. The determinants of which connections become stable are likely to vary depending on the 
function of the region, but one common principle is the wiring up of similarly tuned cells. This is clearly seen in 
topographic maps, where the spatial layout of sensory input or motor output varies systematically across a 
cortical region, and neurons that are tuned to the same spatial field have a higher likelihood of being 
connected (Alonso and Martinez, 1998; Hubel and Wiesel, 1963). The formation of these maps tends to rely 
both on an intrinsic organisation mechanism – the retinotectal map, for example, is patterned in the 
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nasotemporal and dorsoventral planes from the earliest stages of tectal innervation (Holt and Harris, 1983) – 
and a component of experience-dependent development – proper binocular organisation in the visual cortex 
map, for example, depends on visual input from both eyes (Blakemore, 1979). In addition to sensory and 
motor regions, topographic maps have recently been found in human cortical areas associated with high order 
cognition: visual field topography has been observed in the parietal (Sereno et al., 2001) and frontal (Kastner 
et al., 2007) cortex, and may be important for spatial attention, working memory and decision making (Silver 
and Kastner, 2009). It is as yet unclear, however, on what time course these higher-order maps develop and 
on what processes their development depends. 
7.2.2 Inhibition 
 Another important principle of synaptic connectivity that develops early on is lateral inhibition, where 
the neighbours of excited neurons are inhibited by GABAergic interneurons, thus sharpening the neural 
response to a stimulus (Sillito, 1975; Crook et al., 1998; Gabernet et al., 2005). This effect requires inhibitory 
circuitry to develop alongside excitatory circuitry and, indeed, there is evidence that, within days of sensory 
experience, inhibitory responses to sensory stimulation become increasingly selective and correlated with 
excitatory responses (in rat auditory cortex; Dorrn et al., 2010; in mouse visual cortex; Gandhi et al., 2008). In 
addition to shaping receptive fields, the balance between excitation and inhibition becomes critical for 
regulating firing rates and information flow in the developing network (Akerman and Chine, 2007). To achieve 
this balance, in most brain regions different GABAergic interneuron classes appear at different times, which 
are related to critical periods in network development. In monkey visual cortex, for example, calbindin-
containing interneurons appear early in development, correlated with the onset of the thalamocortical 
innervation, while parvalbumin-containing interneurons appear after birth, correlated with the onset of visually 
driven activity (Hendrickson et al., 1991). In humans the GABAergic system in visual cortex continues to 
mature well into adulthood (Pinto et al., 2010), undergoing three distinct developmental changes during 
childhood (when receptor subunits change), adolescence (when proteins mediating GABA synthesis increase 
in level while vesicular uptake falls) and adulthood (when GABA synthesis decreases and vesicular uptake 
increases). 
 The development of interneuron networks also plays a role in shaping the temporal characteristics of 
circuit-level activity. While early development is characterized by spontaneous bursts of synchronous activity 
which are thought to be critical for the activity-dependent wiring of similarly tuned cells (Meister et al., 1991; 
Garaschuk, et al., 1998), later development is characterized by more oscillatory network-level activity, 
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particularly in the gamma frequency range (30-100 Hz). Werkle-Bergner et al (2009), for example, used EEG 
in humans to show that visually-evoked synchronous gamma oscillations developed by 11 years, but were not 
maximally sensitive to stimulus changes until adulthood. Gamma oscillations are thought to be generated by 
an interaction between stimulus-driven excitatory and inhibitory activity (Atallah and Scanziani, 2009; Ray & 
Maunsell, 2010), and therefore the integration of GABAergic interneurons into the excitatory circuitry may be 
important in the development of several behavioural functions. For example, gamma oscillations have been 
suggested as a solution to the binding problem (Singer and Gray, 1995; but see Ray and Maunsell, 2010), 
promoting integration of distributed information for its coherent processing and possibly contributing to the 
improving executive function seen throughout adolescence (Blakemore and Choudhury, 2006). Gamma 
oscillations may also have a direct role in learning and memory, as their synchronisation of synaptic inputs 
has been shown to directly enhance synaptic strength (König et al. 1995; Salinas and Sejinowski, 2001).  
7.2.3 Myelination 
 Synaptic synchrony is also increased throughout development by myelination, which is now known to 
play a role in fine tuning the timing of spike arrival (Salami et al., 2003; Seidl et al., 2010) and thus increasing 
connection efficiency (Hagmann et al., 2010). The human corpus callosum, for example, undergoes an 
intricate myelination process throughout childhood and adolescence, with several thickness changes thought 
to result from varying the degree of myelination (Luders et al., 2010), possibly in order to fine tune input arrival 
times in cortical areas. A similar process of myelin maturation, involving changes in axonal diameter and 
myelin wrap number and density, occurs postnatally across the whole brain in a wave from posterior to 
anterior regions. The progression is slow, with the frontal lobes being the last to myelinate towards the end of 
adolescence (Fields, 2008) and the white matter not becoming fully mature until well into adulthood (20-30 
years, Benes et al., 1994; Yakovlev and Lecours, 1967). One potential benefit of this slow progression is in 
maintaining white matter plasticity in regions that can be influenced by experience and learning, through 
activity-dependent effects on myelination (reviewed in Markham and Greenough, 2004; Ullen, 2009). For 
example, Bengtsson et al. (2005) used diffusion tensor imaging (DTI) to show that myelination in many 
regions, including the corticospinal tract (a white matter tract involved in voluntary skilled movements of distal 
limbs) is positively correlated with the amount of piano practice in children. They also found a positive 
correlation between myelination and piano practice in adults, but mainly in corticocortical pathways and not in 
the now mature corticospinal tract. 
 
 145 
7.2.4 Amine system development 
Another relatively slow process is the maturation of amine neurotransmitter systems, which are 
thought to play key roles in cognitive development, but also in control of cerebral blood flow (see below). The 
dopamine, serotonin and noradrenaline networks, which are closely involved in mood and attention, undergo 
large-scale changes at several developmental stages, from the infant to the ageing brain. Catecholamines and 
serotonin, for example, show early postnatal surges of development on different timescales (Lambe et al., 
2000; Murrin et al., 2007), influencing the functional development of different cortical systems (Levitt et al., 
1997). Broadly speaking, noradrenaline synthesis and endogenous concentration increases steadily 
throughout the brain until adulthood (Goldman-Rakic and Brown, 1982). Serotonergic development occurs 
more quickly, reaching mature levels of synthesis and concentration by childhood, with the largest percentage 
increases occurring in the parietal and occipital cortex (Goldman-Rakic and Brown, 1982). Dopamine 
synthesis and concentration, on the other hand, tend to peak during adolescence, and gradually decrease 
towards adulthood, remaining the highest in frontal regions (Goldman-Rakic and Brown, 1982). These 
changes are accompanied by dramatic changes in those behaviours that the dopamine system is thought to 
subserve, namely, reward-seeking and incentive-driven action, which also peak during adolescence 
(Wahlstrom et al., 2010).  
7.2.5 Plasticity in the mature brain 
Finally, even after these large-scale neural features have reached maturity, the brain retains a high 
level of plasticity. Synapses can alter their strength on the basis of activity, allowing us to learn and remember 
new things, throughout life. Entire cortical regions retain the capacity to reorganise themselves, and may do 
so in extreme circumstances, such as the loss of part of a limb (Merzenich and Jenkins, 1993).  
7.2.6 Implications 
 The developmental neural circuitry changes discussed here (and schematized in Figure 7.1), which 
can be closely linked to behavioural changes, are often the very neurophysiological features that researchers 
hope to track across ages with fMRI, and their particular effects on the BOLD signal are discussed in Section 
7.5. However, less commonly considered are parallel developmental changes in the microvasculature and 
neurovascular coupling, which may have confounding age-related effects on the BOLD signal. It is therefore 
important to have a clear picture of how these components of the vascular system develop alongside the 
neural circuitry. 
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7.3 Changes in neurovascular coupling with development 
The relationship between neuronal activity and blood flow depends critically on the characteristics of 
the signalling pathways regulating blood flow. It not only varies between brain regions (Sloan et al., 2010), but 
can depend on which set of afferents to a brain area are activated. For example, even at a fixed 
developmental stage, Enager et al. (2009) found that the relationship between neural activity and blood flow 
response differed within the same small cortical area, the barrel field of the primary somatosensory cortex, 
depending on which set of synaptic inputs was activated. Stimulating at a low frequency evoked a larger blood 
flow response when stimulation was applied to the thalamocortical afferents than when applied to trans-
callosal inputs from the contralateral cortex, whereas at high stimulation frequencies the relative influence of 
the two pathways was reversed. Thus neurovascular coupling exhibits pathway-specific signalling differences, 
possibly reflecting differences in the signalling molecules involved (Gotoh et al., 2001) or in the anatomical 
arrangement of the neurons (and astrocytes) relative to the blood vessels they control. These differences in 
the dependence of blood flow on neural activity in the same cortical area and at the same developmental 
stage show that a constant relationship between BOLD signal and neural activity cannot be taken for granted 
as neurovascular coupling changes during brain development. This is reinforced by the fact that human 
regional cerebral blood flow at the age of 5-6 years is 50-85% higher than that in an adult or at birth (Chiron et 
al., 1992). During development the brain undergoes many changes which have the potential to alter 
neurovascular coupling, ranging from the development of the vasculature to changes of the expression of 
enzymes responsible for producing vasoactive mediators. This section will give an overview of the changes 
that occur in neurovascular coupling during development. 
7.3.1 Vascular development 
At birth vascular development is incomplete, and the vasculature matures as the brain develops. From 
newborn to adult, the primate cerebral vascular vessel volume increases 2.7-fold and the mean distance 
between any point in the tissue and the nearest vessel decreases by 32% (Risser et al., 2009). Similarly, in 
rat, the capillary volume fraction increases 3-fold between postnatal days 7 and 20 (corresponding in humans 
roughly to the period from birth to adolescence) and then decreases slowly to become approximately 30% 
less in adulthood (Keep & Jones, 1990). These changes in blood volume fraction will, other things being 
equal, produce proportional changes in BOLD signal with development (Ogawa et al., 1993; Bandettini & 
Wong, 1997; Mandeville & Marota, 1999; Buxton et al., 2004). Vessel growth results from a mismatch in 
microvascular supply and metabolic demand, so areas that use more energy become more highly 
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vascularised than less active areas (Riddle et al., 1993; Weber et al., 2008). In both the cerebral and the 
cerebellar cortices of rats, the vascular density increases through early development from the inside to the 
outside of the tissue (Conradi et al., 1980; Yu et al., 1994), while in cat visual cortex the rich capillary supply to 
the highly active layer IV is not present at birth but appears at 5 weeks postnatally (Tieman et al., 2004). 
Similarly, human cerebral cortical studies show a rapid increase in blood vessel density between either 26-35 
gestational weeks (Mito et al., 1991) or post 36 gestational weeks (Miyawaki et al., 1998). In a study of foetal 
and juvenile vasculature, radially orientated vessels were seen at 15 gestational weeks, with lateral branching 
observed at 20-27 weeks (Norman and O’Kusky, 1986). Branching occurs at an earlier stage in the lower half 
of the cortex, in keeping with the inside to outside pattern mentioned above. Capillary formation occurs after 
birth and is most prominent in vascular layer 3/neuronal laminae IV and Va (starting between term and 3 
months postnatal: Norman and O’Kusky, 1986). Other post-birth changes in vasculature include a decrease in 
pial vessel coverage of the brain’s surface occurring over the first postnatal years (Norman and O’Kusky, 
1986). During the developmental increases of blood vessel density in the brain parenchyma, neural activity 
presumably is not coupled to blood flow increases as efficiently as when the vasculature is fully developed. 
7.3.2 Neuronal NOS development 
Interneuron numbers and the vasoactive substances they produce show developmental changes, 
which will alter the neuronal pathway of neurovascular coupling. In mice the number of nNOS containing 
interneurons in the cerebral cortex decreases somewhat with age (Eto et al., 2010), with higher expression for 
the first two postnatal weeks and a decrease from four to eight weeks (i.e. through adolescence and into 
adulthood). There is disagreement over whether the number of nNOS expressing neurons then increases or 
decreases as animals become senile (Reuss et al., 2000; Sánchez-Zuriaga et al., 2007). The total level of 
nNOS (reflecting number of cells expressing NOS and expression level per cell) has also been studied in the 
first few weeks of rodent postnatal life (Ogilvie et al., 1995; Riobo et al., 2002). Cytoplasmic nNOS is 
expressed weakly at embryonic stages and increases in early development. The age at which the peak 
expression is reached varies between brain regions being, for example, P9 in the neocortex and P20 in the 
cerebellum. Expression then declines to an adult level, with the time taken for this process varying between 
regions, occurring between P12-15 in the neocortex and P20-60 in the cerebellum (Ogilvie et al., 1995). 
Studies of nNOS development in human cortex have focussed on foetal and adult expression, and information 
on juvenile and adolescent expression is lacking. Expression of nNOS in the human cerebral cortex has a 
similar distribution to that in the foetal brain but at a lower density: the density of nNOS expressing cells 
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increases from 13 to 32 gestational weeks (GW) and then decreases (Ohyu and Takashima, 1998; Downen et 
al., 1999). Two types of nNOS positive interneuron are found in developmental studies (Estrada and DeFelipe, 
1998; Ohyu and Takashima, 1998). Type 1 cells are large and intensely stained. These cells appear at 15-18 
GW (Ohyu and Takashima, 1998; Yan et al., 1996), and reach an adult distribution at 32 GW. Type 2 cells are 
smaller and more weakly stained, and appear at 26-32 GW (Ohyu and Takashima, 1998; Yan et al., 1996), 
and increase in expression until term. The pattern of expression follows the inside to outside development 
mentioned above.   
7.3.3 Astrocyte development 
Astrocytes also show developmental changes in size and connectivity which may affect the size and 
spatial extent of blood flow responses caused by neuronal activity. An immunocytochemical study of cat visual 
cortex found that mature astrocytes only develop in the 3
rd
 postnatal week, reaching adult density at the 4
th
 
week and then continuing to mature until 7 weeks after birth (Müller, 1992). Astrocytes increase in number 
and size during development, reaching their adult number by about P24 in rat hippocampus and P50 in rat 
cortex (Stichel et al., 1991; Nixdorf-Bergweiler et al., 1994). Changes in density and size are accompanied by 
changes in morphology, such as branching and orientation. Gap junctional coupling of astrocytes, which may 
enlarge the area over which neuronal activity can influence blood flow, develops by P11 in rat visual cortex, 
and remains stable throughout development (Binmöller and Müller, 1992), although before this stage 
astrocytes appear not to be coupled.  
Developmental changes in the expression of the metabotropic glutamate receptors (mGluR5: Romano 
et al., 1995) which raise astrocyte [Ca
2+
]i in response to neuronal activity may alter the astrocytic pathway of 
neurovascular coupling. Early studies showed that globally, mGluR5 is highly expressed in the brain during 
early life (rat postnatal day 1) and decreases within the first postnatal weeks to an adult level between P30 
and P60 (Catania et al., 1994). The decrease in expression differs between brain regions: mGluR5 expression 
in the hypothalamus decreases 6 fold, whereas in the cortex expression decreases by only 3 fold (Van den 
Pol et al., 1995). More recently, astrocyte specific mGluR5 expression has been found to peak at P7 in mice, 
falling sharply by P14, and eventually showing no expression in adulthood (P70-84; Sun et al., 2013). 
Similarly, adult human cortical and hippocampal astrocytes showed no mGluR5 expression (Sun et al., 2013). 
These findings suggest that the astrocytic mGluR5-mediated contribution to neurovascular coupling may only 
be relevant early in development.    
Prostaglandin signalling from astrocytes to blood vessels is probably altered during development. 
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Prostaglandin synthesis in rat brain homogenates or induced by convulsions in the in vivo brain is low at 
postnatal day 1 and increases strongly to adult levels in three weeks (Seregi et al., 1987), suggesting that 
prostaglandin induced dilations will increase with development. Similarly, expression of prostaglandin 
receptors is lower in newborn pigs than in adults (Li et al., 1995). However, the signalling consequences of 
upregulation of prostaglandin synthesis and receptor density with development are opposed, over the first 
postnatal month in mice, by an increase in expression of the transporter (PGT) which terminates prostaglandin 
signalling (Scafidi et al., 2007). 
Astrocyte-mediated increases in blood flow may also be altered by developmental changes in the 
expression or properties of potassium channels, including the calcium-activated large conductance (BKCa) K
+
 
channels expressed on astrocyte endfeet, as well as inward rectifying potassium channels on vascular smooth 
muscle (Filosa et al., 2006). For example, in rabbit Müller cells (astrocyte-like cells found in the retina), the 
open probability of BKCa channels strongly decreases within the early postnatal period, possibly due to the 
resting potential becoming more negative (Bringmann et al., 1999). As a result, to activate the channel in older 
cells requires both a strong depolarization and an increase in intracellular calcium, whereas in early postnatal 
cells only a small change in membrane potential is needed to activate the channels, suggesting that 
neurovascular coupling mediated by these channels might become less efficient with age. 
7.3.4 Vasoconstricting pathways 
All of these developmental changes in vasodilating pathways may be potentiated or opposed by 
corresponding effects on constricting pathways, including either the aminergic pathways that help to set the 
basal tone of the arterioles (Blanco et al., 2008) or the 20-HETE pathway which can constrict vessels in 
response to astrocyte [Ca
2+
]i increases (Mulligan and MacVicar, 2004).  
7.3.5 Implications   
The complex developmental changes in components of the signalling systems mediating 
neurovascular coupling that I have outlined above do not provide a simple prediction for how neuronal activity 
evoked blood flow changes, and hence the BOLD response, will alter, suggesting that far more research is 
needed to understand this. However, they highlight the importance of considering how developmental 
changes in the BOLD signal may in some cases reflect factors other than neuronal activity.   
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7.4 Changes in neural energy use with development 
 In both Chapter 1 and Section 7.1 I explained that the magnitude of the BOLD signal is affected by the 
O2 use of the area of brain being studied - the larger is the increase of O2 use evoked by neural activity 
(relative to the increase of blood flow) the smaller is the positive BOLD response. Although many factors affect 
the O2 use, most brain energy in primates is predicted to be used on synaptic transmission (Attwell and 
Laughlin, 2001), and this conclusion has been reinforced by the fact that action potentials are now thought to 
use 3-fold less energy than was originally believed (Alle et al., 2009). Thus, the neural activity evoked 
increase of O2 consumption is expected to increase with the increase of synaptic density that occurs over the 
first ~10 years of life, and to decrease as synaptic pruning occurs later on. Indeed, O2 usage has been 
reported to rapidly increase with synapse development in children (Muramoto et al., 2002) and later to 
decrease by ~0.5% per year with ageing in the adult (Pantano et al., 1984; Leenders et al., 1990; Takada et 
al., 1992).  
 A greater fractional increase of neural activity-evoked energy (O2) use than of blood flow has been 
postulated to occur in infants and young children to explain why (in contrast to the situation in neonates and 
adults for whom the blood flow increase exceeds the increase of O2 use) infants and young children over a 
few years of early development show negative BOLD signals in response to sensory stimulation, i.e. a 
decrease of MRI signal rather than the usual increase (Yamada et al., 1997; Born et al., 1998; Anderson et al., 
2001; Muramoto et al., 2002). Of concern for the interpretation of developmental changes in BOLD signals, 
the transition from a negative BOLD signal (in infants, when the task-evoked increase in O2 use outweighs the 
increase in blood flow) to a positive BOLD signal (when, as is usual in adults, the increase of blood flow 
outweighs the increase in O2 consumption) implies that at some intermediate developmental stage it is 
possible for an active area to show no BOLD response. This would occur if the increase of O2 use and the 
increase of blood flow cancel out each other’s effects on the deoxyhaemoglobin level (see Chapter 1.10). For 
a study starting from this (young) age, the developmental increase in task-evoked blood flow increase (relative 
to that of O2 use) would result in the appearance of activation in an area that previously did not show it, even if 
that area was equally involved in processing the information at all ages.  
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7.5 How do developmental changes of neural circuitry and of neurovascular coupling 
combine to produce developmental changes in BOLD signals? 
 Many of the neural changes that underpin behavioural changes during development are expected to 
have clear effects on the BOLD signal, making their detection possible with fMRI. It would be ideal if this 
notion could be reversed, so that changes in BOLD signals could be assumed to reflect a change in the 
underlying neuronal processing of information. Conclusions based on BOLD data, however, depend critically 
on the usually unstated assumption that there are no confounding changes in the neurovascular coupling that 
generates the BOLD signal. Given the vast array of developmental changes in the mechanisms mediating 
neurovascular coupling, which I have described above, it would be extremely surprising if they did not 
contribute significantly to at least some of the developmental changes in BOLD signals that have been 
observed experimentally. 
 Developmental changes reported in BOLD signals include those showing the appearance at one 
developmental stage of a BOLD response in an anatomical region where it does not occur at another 
developmental stage (e.g. Monk et al., 2003; Passarotti et al., 2003; Blakemore et al., 2007), a change in the 
amplitude of the BOLD signal at one anatomical location (e.g. Casey et al., 1995; Kwon et al., 2002; Monk et 
al., 2003; Durston et al., 2006; Wang et al., 2006; Turkeltaub et al., 2008; Maril et al., 2010; Keulers et al., 
2011), or an expansion or contraction of the spatial area activated within one anatomical region (e.g. Casey et 
al., 2002; Durston et al., 2006; Gaillard et al., 2000, 2003; Golarai et al., 2007; Kwon et al., 2002; Passarotti et 
al., 2003). I will now consider the possible problems of interpreting each of these kinds of change. 
7.5.1 Alterations of activation locus  
 In general, a movement of the locus of BOLD activation is interpreted as the involvement of a new 
area for processing of information to perform a task, as the neural wiring progresses and regional 
specialisation develops. For example, tasks taxing social cognition start to activate the right superior temporal 
sulcus more (and the prefrontal cortex less) as development proceeds (Blakemore et al., 2007), suggesting a 
change in the neural strategies underpinning social cognition. Similarly, Monk et al. (2003) found a loss of the 
amygdala response to viewing fearful faces ongoing from adolescence to adulthood, and Holland et al. (2001) 
found increased left hemispheric lateralization of responses with age during a verb generation task. Alteration 
of the anatomical location of an activated area is the developmental change in BOLD response that is most 
likely to unequivocally reflect changes occurring in the underlying neuronal information processing (but see 
Section 7.4 for a scenario where activity could evoke no BOLD response at a young age and a positive BOLD 
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response in the adult, as a result of a decrease with development of the ratio of O2 use evoked by activity to 
blood flow increase evoked by activity).  
7.5.2 Alterations of BOLD amplitude at one anatomical location  
 Increases or decreases in BOLD signal amplitude with development are usually interpreted as 
indicating more or less involvement of neuronal activity in the activated area in the task being performed. For 
this conclusion to be secure, however, it is necessary to be sure that the altered amplitude does not simply 
reflect a change in blood volume fraction (see Section 7.3.1) or in the strength of neurovascular coupling, for 
example producing a larger increase of blood flow for the same amount of neural activity and energy use, and 
thus producing a larger BOLD signal. 
 In rats, BOLD signals increase in amplitude and decrease in latency with development (Colonnese et 
al., 2008) and some human studies also report a shorter latency for BOLD signals in adults than in children 
(Brauer et al., 2008; but see Richter and Richter, 2003). This might be expected from many of the 
developmental changes in the neural circuitry summarised in Section 7.2, e.g. the development and 
refinement of synaptic connections leading to more effective excitation in adults (indeed Colonnese et al. 
(2008) found that neural excitation occurred with a decreased latency at older ages), increased myelination 
leading to more synchrony of incoming synaptic activation (Olesen et al., 2003; Fornari et al., 2007), and 
perhaps a greater influence of attention mediated by amine transmitter systems. However, the many 
developmental changes in neurovascular coupling noted in Section 7.3 are also likely to contribute to 
developmental alterations of BOLD signal amplitude and latency.  
 First, as noted in Section 7.4, a developmental increase in the amplitude of the positive BOLD signal 
can result from the activity-evoked blood flow increasing more with age than the activity-evoked O2 use, for 
example as a result of the developmental maturation of the systems mediating neurovascular coupling. To 
complicate this, however, the extra blood flow and O2 use evoked by neural activity may have different 
dependencies depending on the amount of neural activity occurring, as seen in visual cortex where increasing 
the number of active neurons apparently increases O2 use more than it increases blood flow, resulting in an 
unchanged or even a smaller BOLD signal (Goodyear and Menon, 1998; Marcar et al., 2004a,b). This implies 
that the age-related changes of BOLD signal may depend critically on the amount of neural activity produced 
by the task.  
 Second, the increase of vascular volume fraction that develops with age (Keep & Jones, 1990; Risser 
et al., 2009) is expected to increase the BOLD signal (Ogawa et al., 1993; Bandettini & Wong, 1997; 
 153 
Mandeville & Marota, 1999; Buxton et al., 2004), all other factors being equal. On the other hand, the increase 
in vascular density may lead to a decrease in the fall of deoxyhaemoglobin level occurring during activity and 
thus decrease the BOLD signal, as suggested by Marcar et al. (2004b) when comparing the more highly 
vascularized visual cortical area V1 with V2 (although differences in the information processing occurring in 
V1 and V2 could also contribute to the differences observed). An increased vascular density, perhaps 
decreasing the distance that neurovascular messengers must diffuse to increase blood flow, may also explain 
the decrease of BOLD latency with development (which is too large to be accounted for by alterations of the 
onset of neural activity: Colonnese et al., 2008).  
Third, developmental alterations of the basal tone provided by amine transmitter systems may alter 
the blood flow response to neural activity, and thus alter the BOLD response, even in the absence of changes 
of neuronal information processing. However, it is currently unclear exactly how an increased baseline 
vasoconstriction might alter the BOLD signal. One possibility is that an overall greater restriction of blood flow 
would simply reduce the BOLD signal. On the other hand, tighter vasoconstriction might increase the amount 
by which a vessel can dilate in response to glutamatergic transmission, thereby increasing activity-related 
blood flow responses and BOLD signals (Blanco et al., 2008). Consistent with this, dilation of blood vessels 
with CO2 to increase basal blood flow has been shown to decrease the BOLD response (Cohen et al., 2002) 
and also alters the apparent area of activation by altering the signal to noise ratio (Thomason et al., 2005). Of 
course developmental changes in amine systems will also produce developmental changes in neuronal 
function, for example dopamine system development between childhood and adulthood can directly modulate 
the excitability of interneurons in the prefrontal cortex (Tseng and O’Donnell, 2007). The challenge, as with 
“pharmacological fMRI” of adults in which amine systems are manipulated with drugs (Attwell and Iadecola, 
2002) is to separate amine effects on neuronal function from effects on neurovascular coupling. 
7.5.3 Expansion or contraction of the spatial area activated within one anatomical region 
  Changes in the area showing BOLD activation within an anatomical region are often used to infer 
changes in the underlying neuronal processing. An expansion of the activated area of V1 after trace (but not 
after delay) eyeblink conditioning of rabbits (Miller et al., 2008) was interpreted as showing that more neurons 
were activated after learning to carry out the more cognitively complex task. In humans, expansion of 
activated somatosensory and motor areas over a three week period of motor skill acquisition was considered 
to reflect the cortical plasticity that underpinned performance improvement (Karni et al., 1998; Hluštík et al., 
2004). Importantly, while Miller et al’s work studied relatively rapid changes in synaptic strength, allowing 
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unequivocal conclusions to be reached, for longer-term learning and developmental studies over greater time 
durations changes in neurovascular coupling need to be ruled out as a cause of the activated area altering in 
size. In addition, because changes of the amplitude of the BOLD signal also commonly occur during 
development, it is essential to consider the possibility that the activated area merely appears to change in size 
because of an altered signal to noise ratio.  
  Changes in the spatial scale of neurovascular coupling may come about as a consequence of the 
developmental changes described in Section 7.3. Alterations of enzyme levels (see Section 7.3) will change 
the spatial area over which levels of neurovascular messengers are produced at a high enough concentration 
to affect blood vessels, and the development of the astrocyte network (Binmöller and Müller, 1992) may allow 
neurons to influence more distant vessels. Furthermore, the development of the vascular network itself may 
either provide more spatially localised control of blood flow (due to local control of individual vessels 
developing within a network which has increased in vessel density) or allow activity in one area to influence 
blood flow over a larger area (if vascular dilatory responses propagate back to larger vessels which feed a 
larger volume of brain: Iadecola et al., 1997). However, whereas the expansion of the activated area reported 
by Miller et al. (2008) occurred on a millimetre scale, neurovascular coupling changes seem more likely to 
alter blood flow on a scale of a few hundred microns. 
Frequently, brain development is associated with a decrease in the area activated in BOLD studies, 
correlating with the refinement of cortical wiring being accompanied by a shift from spatially diffuse task-
specific brain activity to more focal brain activity, as regional specialisation emerges. For example, Casey et 
al. (2002) in the striatum and hippocampus, and Gaillard et al. (2000) and Passarotti et al. (2003) in the 
cortex, using stimulus-response compatibility, verbal fluency, and face matching tasks, respectively, found that 
progression from childhood to adulthood was accompanied by a shift from diffuse to more focal activation. 
This supports the idea that, before precise pruning, the less efficient connections that exist result in more 
widespread activity in response to tasks that later activate only highly specialised brain areas.  
Part of the increasing spatial localization of BOLD signals that occurs may reflect the development of 
inhibitory circuits. GABAergic signalling is thought to decrease the BOLD signal by inhibiting excitatory cells, 
thus reducing glutamate release and decreasing the local CBF response (Lauritzen, 2005; Lauritzen and 
Gold, 2003; Muthukumaraswamy et al., 2009; Donahue et al., 2010). This may enhance the spatial 
localization of positive BOLD responses by generating an area of decreased neuronal firing and decreased 
blood flow around a central area of increased cell firing (Devor et al., 2007). This development of inhibitory 
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responses may also contribute to sparser stimulus-evoked activation. In adult monkeys, for example, visual 
object learning is associated with more selective object representation in the inferior temporal cortex (Baker et 
al., 2002; Sigala and Logothetis, 2002), and in humans, the fusiform face area (FFA) has been shown to 
respond to faces with increasing selectivity across development from childhood to adulthood (Peelen et al., 
2009). Similarly, the spatial receptive field organisation in topographically mapped regions becomes 
increasingly refined, and blocking inhibition removes this specificity (Sillito, 1975; Crook et al., 1998). As noted 
in Section 7.3.2, some inhibitory interneurons release nitric oxide. Thus, in addition to indirectly reducing the 
BOLD signal by inhibiting glutamatergic neurons, interneuron activity can influence the BOLD signal through 
the release of NO and other vasoactive agents that directly regulate the local blood flow. 
 In early development, GABA is not inhibitory but produces depolarizing potentials, perhaps providing 
an excitatory drive for synapse formation before glutamate takes over (Ben-Ari et al., 1989; Ben-Ari, 2002; 
Cherubini et al., 1991; Tyzio et al., 2011; but see Rheims et al., 2009). This occurs because at young ages the 
Nernst potential for the Cl
-
 ions that pass through GABAA receptors is more positive than the resting potential. 
The reduction and spatial sharpening of the BOLD signal by inhibitory activity may, therefore, not be in effect 
until glutamate and GABA are well established in their mature roles as excitatory and inhibitory 
neurotransmitters. Once GABA is inhibitory, increases in the strength of GABAergic inhibition may decrease 
the size of the BOLD signal (Muthukumaraswamy et al., 2009; Donahue et al., 2010), thus decreasing the 
signal to noise ratio and possibly decreasing the area apparently activated, or even induce negative BOLD 
signals (Northoff et al., 2007).  
7.6 Can neurovascular coupling changes ever be ruled out as a cause of 
developmental BOLD changes?  
 The main message of this chapter is that developmental changes in neurovascular coupling are likely 
to contribute to observed developmental changes in BOLD signals. How, then, can the BOLD researcher 
reliably attribute changes in BOLD signals to a change in neural information processing rather than a change 
of blood flow control? While there is no simple answer to this question, I believe there are three approaches to 
the problem.  
 First, being aware (for example from animal work) of the changes of neurovascular coupling and 
blood volume fraction that are occurring in the region of interest over the period under consideration, it may be 
possible to rule them out as a cause of the changes seen. For example, changes in the spatial scale of BOLD 
responses may be larger than is plausible to be explained by changes in astrocyte morphology or blood 
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vessel branching patterns, as outlined above. Similarly, changes that occur rapidly as a result of learning, at a 
time after the enzyme systems controlling blood flow have matured, are unlikely to reflect alterations of 
neurovascular coupling or blood volume fraction. However, it is always possible that studies which document 
a change during development in the amplitude of the BOLD signal in a particular area may be confounded by 
developmental changes of neurovascular signalling mechanisms (or neuronal energy use) that have yet to be 
discovered by researchers working at the cellular level. Measuring how development alters some parameter of 
the stimulus that evokes a BOLD response may suggest an explanation in terms of changes of neural 
information processing (e.g. an increase in a parameter describing the specificity of a stimulus may be 
interpreted in terms of increasing lateral inhibition between cortical columns or between different cortical 
areas), but it is still necessary to consider whether non-linear changes in the relationship between neuronal 
activity and blood flow could account for the data. It is not obvious how any kind of subtractive protocol design 
can get around the need to consider possible confounding by changes of neurovascular coupling.  
Second, detailed information on the changes of neurovascular coupling and of neural energy use 
occurring over the period of a study will often not be available, particularly for humans. In this case a 
functional approach needs to be taken. Church et al. (2010) have put forward the notion that neurovascular 
coupling changes cannot be the cause of changes of BOLD signal during development if different tasks 
produce opposing changes with development in the same area (i.e. one task produces an increase in 
response with development, while the other task produces a decrease with development). This is a promising 
approach, but one needs to be sure that the same input connections to the area studied are activated for both 
tasks. As noted in Section 7.3, the relationship between blood flow and neuronal activity is different for 
different inputs to cortical regions (Enager et al., 2009), and so may undergo different developmental changes.  
Thirdly, it may be advantageous to document, and try to understand, developmental BOLD changes in 
simpler “low level” neural circuits, such as the visual, somatosensory and auditory cortices, the wiring and 
function of which are reasonably well known, in order to have a better framework for interpreting changes of 
BOLD signals in “higher” areas where the neural basis of the information processing is far more poorly 
understood. I therefore advocate the construction of a publicly accessible database as a repository in which to 
deposit atlases of BOLD responses to standard stimuli, recorded in a standardised imaging setting at key 
developmental stages. The stimuli used could include stationary and drifting gratings or random moving dots 
for the visual system, vibration to the skin for the somatosensory system, and tone sequences for the auditory 
system (some stimuli for which BOLD signals in sensory cortices are reasonably well understood in terms of 
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the responses of neurons are collected by Schölvinck et al. (2008).  
Ultimately, a full understanding of developmental changes in BOLD responses is likely to require 
much work characterising how neurovascular coupling alters, in order to isolate changes produced by the 
maturation of neural information processing. Being aware of this issue is crucial for the rigorous interpretation 
of developmental fMRI studies.  
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Figure 7.1: Summary of the developmental time courses of changes in neural information processing 
mechanisms (top) and of components of the signalling pathways regulating blood flow and thus 
controlling the BOLD response (bottom). Changes shown in blue are from human data; green is from 
macaque; lilac from rat or mouse; red from cat; pink from pig; light orange from rabbit. 
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Chapter 8: Discussion 
8.1 Introduction 
 In this Chapter I will summarize and evaluate the findings presented within this thesis. I have 
discussed my findings at the end of each preceding results chapter, so here I will briefly review these results 
and describe possible future experiments that could further the work. 
8.2 Distinguishing pericytes from other perivascular cell classes 
8.2.1 Discussion 
 As there is no specific marker for pericytes and different pericytes may have different developmental 
origins (Díaz-Flores et al., 2009) suggesting that there may be several distinct populations of these cells, it is 
of use to have multiple markers that label the same population to increase confidence in cell identification. 
Although I mainly used NG2 as the marker for pericytes in this thesis, because I was able to use the NG2-
DsRed transgenic mice, I confirmed in Chapter 3 that other markers could also be used to identify the same 
population of cells that I was studying, specifically PDGFRβ or isolectin-B4. I also showed that some pericytes 
appear to express the contractile proteins desmin and αSMA, however these results were not conclusive. 
Lastly, I found that pericytes defined by NG2 expression do not overlap with endothelial cells (defined by vWF 
expression) or perivascular immune cells (defined by Iba-1 expression). 
It is possible that not all perivascular immune cells were labelled by Iba1. There is a marker, ED2, that 
is thought to be specific for perivascular immune cells (part of the scavenger receptor CD163; Graeber et al., 
1989). I tried to label brain tissue from the NG2-DsRed mice with an antibody for ED2 but in my hands this 
antibody showed only nonspecific labelling.  
Due to their suggested role in blood flow control it was of great interest to investigate the contractile 
protein expression of these cells. My findings supported previous work showing that pericytes on larger 
capillaries express contractile protein but pericytes on smaller, true, capillaries did not. However, to be able to 
make any statements about the proportion or subpopulation of pericytes that are contractile, further work will 
be needed to study the expression profile throughout the arterio-venous axis. My study only focused on a 
small population of capillaries. 
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8.2.2 Future work 
Although there was no overlap between the endothelial cell population, or immune cells labelled with 
Iba1, and pericytes, it is possible that there are other, less well characterized perivascular cells that could be 
mistaken for pericytes, such as stem cell progenitors (Zimmerlin et al., 2011; Crisan et al., 2008; Corselli et al., 
2010). Using the same technique as I did in Chapter 3, labelling of NG2-DsRed tissue using an antibody that 
targets mesenchymal stem cells (such as CD44, CD73, CD90, and CD105; Corselli et al., 2010), I could 
investigate whether the cells that I identify as pericytes express mesenchymal stem cell markers. 
The majority of the experiments in this chapter were carried out on juvenile animals between postnatal 
days 10 and 15. As I discussed in Chapter 1 (section 1.5.2), pericytes are thought to have different functions 
at different developmental stages, and thus it may be expected that the proteins they express change with 
development. In order to explore whether the pericyte markers that I investigated in this thesis (NG2, 
PDGFRβ and isolectin-B4) change with maturation, I could carry out labelling experiments in adult brain tissue. 
This would enable me to compare any possible overlap in expression of these markers at different 
developmental stages. If I were to see the occurrence of cells that share expression of these markers that 
may lead to further questions about changes in pericyte function at different developmental stages.   
The labelling studies I carried out using antibodies for contractile proteins markers (αSMA and 
desmin) did not enable me to quantify the proportion of pericytes that express contractile proteins. In order to 
get more solid data for this, I think that work needs to go into the rigorous classification of vessels. It has been 
said that ‘true’ capillary pericytes do not express contractile proteins and my work supports the finding that 
expression is more likely on larger capillaries. What is not clear, however, is when we should define a vessel 
as an arteriole rather than a capillary. Pericytes are present on both of these classes of vessel. There are 
morphological differences in these cells throughout the microvasculature, and apparently changes in protein 
expression, but they are still currently classed as the same cell type. The definition of capillaries that I used in 
this thesis was that capillaries are vessels of less than 10 μm in diameter (although the average diameter of 
the vessels studied in Chapter 4 was in fact 4.88±0.97 μm) that do not have a continuous lining of smooth 
muscle. Many vessels that would be classed by others as pre-capillary arterioles have a diameter similar to 
the vessels that I studied and may not have a smooth muscle layer as seen using bright field imaging. The few 
imaging studies that I have carried out trying to investigate neurovascular coupling at the level of arterioles led 
to ambiguity in distinguishing them from capillaries and venules. Using brain tissue from the NG2-DsRed 
mouse I could carry out a study looking at the morphology of vascular smooth muscle cells and pericytes 
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starting from large pial vessels, following the same vessel into the tissue and investigating the changes that 
occur as the vessel branches, such as the change in the distance between the nuclei of smooth muscle 
cell/pericytes, the change in the morphology of these cells and the change in expression within them of 
contractile proteins (such as αSMA). This may help to prevent misclassification of vessels, or even to allow a 
further sub-classification of vessel types.  
8.3 Signalling pathways underlying pericyte dilation of CNS capillaries in response to 
glutamate 
8.3.1 Discussion 
 It was found by Peppiatt et al. (2006) that glutamate produces capillary dilation in cerebellar slices. I 
replicated these experiments and investigated the mechanisms by which glutamate evokes this response. I 
found that nitric oxide is needed for glutamate-evoked dilation, but that it is not acting through generating 
cGMP but rather by inhibiting 20-HETE production. In addition, activation of EP4 receptors, presumably by 
PGE2, produces dilation. 
 These results show similarities to studies looking at the signalling pathways involved in neurovascular 
coupling at the arteriole level, which suggests that capillaries are also actively involved in neurovascular 
coupling. However, most evidence (including mine) supporting an active role of pericytes in controlling blood 
flow has come from in vitro studies, either in culture, in retinal whole mounts or in brain slices.  
8.3.2 Future work 
 For the experiments in Chapter 4 I used bath application of glutamate to mimic neuronal activity. 
Synaptic glutamate release, during neuronal activity, has a very different time frame from bath application of a 
drug (milliseconds compared to minutes). In order to look at more physiologically realistic responses it would 
be interesting to use electrical stimulation of neurons whilst imaging nearby capillaries. In the cerebellum it 
would be possible to stimulate the parallel fibres whilst imaging the vessels that span the molecular layer. 
These experiments would provide a more physiologically relevant model of neuronal activity. Based on the 
work in this thesis, Anusha Mishra and Fergus O’Farrell in the lab have found that parallel fibre stimulation 
does indeed give a dilation of cerebellar capillaries which is blocked by an EP4 receptor antagonist. 
 I carried out the imaging experiments in this Chapter using bright-field imaging. Because of this I 
could not always visualise pericytes on the capillaries that I imaged. Carrying out the same experiments using 
the NG2-DsRed mice and fluorescence imaging would allow me to identify pericytes as well as pericyte 
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processes on the vessels that I image. Using only fluorescence imaging, it is possible to measure the 
diameter of the vessel by measuring the light intensity profile of the vessel (using the DsRed). This however 
does not measure the vessel lumen well but measures the inner or outer diameter of pericytes on the outside 
of the endothelial cells. In the few experiments I have carried out using this technique, diameter changes 
measured using the DsRed fluorescence were very small. This may be because the change in diameter 
assessed from the pericyte being imaged does not reflect the change in diameter of the underlying vessel 
lumen. In order to confirm the presence of pericytes but also measure capillary lumen diameter, I could 
combine fluorescence and bright-field imaging.  
The pharmacological work described in Chapter 4 took about 1.5 years to perform, but still leaves 
some uncertainties. In order to rule out the involvement of (constitutive) endothelial nitric oxide production I 
could use a specific inhibitor of endothelial nitric oxide synthase. Similarly, to confirm that the agonist 
activating EP4 receptors is PGE2, I could pharmacologically block PGE2 production with cyclooxygenase 
inhibitors (SC-560 to block COX-1 and NS-398 to block COX-2). There is still a slight glutamate-evoked 
dilation in the presence of L-161,982 (Chapter 4.3.10). While this may just reflect incomplete block, it would be 
of interest to carry out experiments with a combination of L-NNA and L-161,982 (or a cyclooxygenase 
inhibitor) to confirm that the glutamate-evoked dilation is completely abolished with both the nitric oxide and 
prostaglandin pathways blocked. There are many other vasoactive mediators that may also be involved (e.g. 
adenosine, potassium, PGI2; see Attwell et al., 2010) so it is possible that there may be another pathway 
contributing to the glutamate-evoked capillary dilation. 
The pharmacological agents I used in this thesis were mostly antagonists. It has been suggested that 
different results can be found when using agonists rather than antagonists. PGE2, specifically, has been 
shown to cause arteriole constriction (Dabertrand et al., 2013), which contradicts research using blockers that 
suggest PGE2 is a vasodilator (Zonta et al., 2003). Dabetrand and colleagues (2013) suggest that blocking 
prostaglandin production alters synaptic signalling and thus indirectly alters neurovascular coupling. I could 
carry out experiments to investigate whether application of PGE2 would evoke a cerebellar capillary dilation 
similar to the dilation observed on application of glutamate.  
The magnitude of the response to stimulation has been found to depend on the tone of vessel (Fergus 
et al., 1995; Blanco et al., 2008). In order to achieve a more physiological vessel tone, and thus allow more 
physiological responses to glutamate (or electrical stimulation), it may be possible to penetrate an upstream 
arteriole and perfuse with solution (Lovick et al., 2004). This would most likely cause damage to the arteriole, 
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but would hopefully not have an effect at the site of the downstream capillary that is being imaged. This 
technique may produce more reliable pre-constriction than application of noradrenaline, which only constricts 
approximately 50% of vessels (Peppiatt et al., 2006). However Lovick reports that this technique is extremely 
difficult (personal communication to David Attwell). 
It would be interesting to see whether similar pathways are involved in the glutamate-evoked capillary 
dilation in all other brain regions, since there is evidence that neurovascular coupling varies over different 
brain regions (Devonshire et al., 2012). Based on my work, Anusha Mishra in the lab has shown that EP4 
receptor block also inhibits glutamate-evoked capillary dilation in cortical capillaries. 
8.4 Electrical responses of cerebellar and cortical pericytes 
8.4.1 Discussion 
 In Chapter 5, I reported that pericytes can be patch-clamped in slices and that glutamate application 
produces an outward current in pericytes while noradrenaline application produces an inward current, which 
are expected to produce dilation and constriction respectively. 
8.4.2 Future work 
 In order to study further the link between pericyte membrane currents and tone, I would like to look at 
the effect of the pharmacological agents that I used in Chapter 4 on pericyte membrane currents. If pericyte 
hyperpolarization does underlie capillary dilation then I would expect the glutamate-induced outward current to 
be suppressed by L-NNA and L161,982.  
As I stated above, glutamate application is not the most physiologically relevant model of neuronal 
activity and I would like to carry out further experiments using electrical stimulation to mimic neuronal activity 
and release of endogenous glutamate. It would be of interest to see if electrical stimulation produces a 
hyperpolarization of pericytes.   
My success rate in patch-clamping pericytes was not very high. These cells are covered in basement 
membrane and I found that the pipette resistance increased by very little, even when the pipette was clearly 
touching the cell. Previous studies have incubated tissue in a collagenase enzyme before carrying out 
experiments to break down the basement membrane and increase accessibility to the cell (Peppiatt et al., 
2006). I would like to try this, but if I am still unable to successfully patch-clamp enough cells I could use 
calcium imaging (with AM-ester dye-loading) to monitor pericyte intracellular signalling. This technique could 
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be used alongside measurement of vessel diameter, to allow investigation of the extent to which [Ca
2+
] 
changes are solely responsible for controlling pericyte tone. 
8.5 The pericyte response to ischaemia 
8.5.1 Discussion 
In Chapter 6 I demonstrated that pericytes were vulnerable to death when exposed to oxygen and 
glucose deprivation as well as OGD followed by reperfusion. Pericyte death was reduced when slices were 
incubated with ionotropic glutamate receptor blockers or in calcium free extracellular solution. I also found that 
pericyte death following MCAO was much more pronounced that endothelial cell death. 
These results suggest that pericytes may be a useful therapeutic target for reducing damage following 
stroke. Preventing pericyte death following ischaemia may improve cerebral blood flow recovery. The resulting 
increased energy supply to the brain may reduce further neuronal death.  
8.5.2 Future work 
 Although I was able to target some pathways that were able to reduce pericyte death in OGD and 
reperfusion, I was not able to identify a drug that could be translated to the in vivo setting. Ideally, carrying out 
the same experiments using other drugs that are thought to be involved in excitotoxic death might identify a 
drug that could be taken thorough to in vivo experiments, and potentially clinical trials.  
There is a possibility that the mitochondrial calcium uptake inhibitor that I tested in Chapter 6, Ru360, 
may fail to penetrate cells sufficiently to produce a response (personal communication with Martin Lauritzen). 
There is also evidence that Ru360 undergoes oxidation, and thus inactivation, in room air (Abramov and 
Duchen, 2008). Because of these issues it may be worth repeating these experiments with an alternative 
calcium uptake inhibitor.  
 In order to investigate the mechanisms of pericyte death during OGD and reoxygenation I could carry 
out experiments similar to those carried out in Chapter 6 but only expose the brain slices to the ‘drug’ (or 
calcium free solution) for either the OGD period or the reoxygenation period. I would be interested in 
identifying a mechanism of pericyte death, and hopefully recovery, that was specific to the reoxygenation 
period because this is the more realistic therapeutic window for treatment. 
 Although previous work has supported a role for oxidative stress in pericyte constriction in ischaemia 
(Yemisi et al., 2010), I found little effect of PBN and L-NNA on pericyte death in OGD with or without 
reoxygenation. These findings do not disagree with each other, because they measure different things, but 
 165 
they do suggest that there are separate signalling pathways controlling pericyte constriction and pericyte 
death. I could carry out further studies to measure the diameter of capillaries that have been exposed to OGD 
and reoxygenation in the presence of blockers, especially PBN and L-NNA, in order to confirm the finding of 
Yemisci et al. (2010).  
8.6 The physiology of developmental changes in BOLD functional imaging signals 
8.6.1 Discussion 
 In Chapter 7, I discussed the information processing and cognitive changes that occur over 
development that many psychology researchers are interested in investigating using BOLD fMRI. I then 
speculated how these changes may be obscured in fMRI experiments by corresponding changes in 
neurovascular coupling and energy use over the same time period. I described example case studies in which 
changes in BOLD responses were observed over development and discussed the possible ways that 
information processing changes could be clearly distinguished from changes in energy use and neurovascular 
coupling. 
8.6.2 Future work 
 As discussed in Chapter 7 section 7.6, several potential ways of ruling out potential differences in 
neurovascular coupling and energy use between participants experimentally have been proposed. The most 
promising way of increasing our understanding of the relationship between neuronal activity and the BOLD 
signal is by using a combination of imaging and physiological research in animals (Devonshire et al., 2012; 
Schulz et al., 2012). In human studies, researchers can use a combination of BOLD and measurement of 
electrical activity through EEG.  
Along with experimental techniques, researchers can make sure they are aware of the possible 
changes in neurovascular coupling that are occurring over the period of study and take this in to account when 
interpreting their results. I believe that the field will benefit greatly from being aware of the confounds that 
measuring neuronal activity with BOLD fMRI indirectly introduces. I have co-written another review with Julia 
Harris discussing similar problems that may arise when comparing the BOLD responses between participants 
with autism and control participants (Reynell and Harris, 2013). Much like in development, neurovascular 
coupling pathways may be altered in autism. Similar literature reviews would be beneficial for other participant 
differences, such as gender and medication state. Although these literature reviews are highly speculative, it 
is of use for researchers to make themselves aware of the issues that may be influencing their results. 
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8.7 Conclusions 
 In summary, the work presented in this thesis has investigated the characteristics of CNS pericytes 
and the role they play in neurovascular coupling in physiological and pathological conditions. The experiments 
undertaken provide information which will further the understanding of the regulation of brain blood supply in 
health and disease. They also provide insight into the cellular mechanisms which underlie functional brain 
imaging, and will aid our understanding and interpretation of these signals. 
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